|
G
|
Aadat
|
aminoadipate aminotransferase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624769:1,586,036...1,611,092
Ensembl chrNW_004624769:1,581,727...1,610,793
|
|
G
|
Abca1
|
ATP binding cassette subfamily A member 1
|
severity
|
ISO
|
mRNA:decreased expression:liver (human)
|
RGD |
PMID:16941710 PMID:30580964 |
RGD:1598532 RGD:24922199 |
NCBI chrNW_004624758:6,449,583...6,590,244
Ensembl chrNW_004624758:6,449,629...6,588,664
|
|
G
|
Abcc3
|
ATP binding cassette subfamily C member 3
|
|
ISO
|
mRNA:increased expression:liver
|
RGD |
PMID:25842354 |
RGD:11535155 |
NCBI chrNW_004624795:6,516,384...6,558,332
Ensembl chrNW_004624795:6,516,224...6,557,892
|
|
G
|
Abce1
|
ATP binding cassette subfamily E member 1
|
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:21932399 |
RGD:11041873 |
NCBI chrNW_004624853:4,059,271...4,087,313
Ensembl chrNW_004624853:4,065,206...4,085,777
|
|
G
|
Abl1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ISO
|
|
RGD |
PMID:32171747 |
RGD:126907997 |
NCBI chrNW_004624760:4,878,811...5,032,719
Ensembl chrNW_004624760:4,878,556...5,031,491
|
|
G
|
Acaca
|
acetyl-CoA carboxylase alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21147110 |
|
NCBI chrNW_004624871:4,103,014...4,364,690
Ensembl chrNW_004624871:4,105,067...4,412,325
|
|
G
|
Ace
|
angiotensin I converting enzyme
|
susceptibility
|
ISO
|
CTD Direct Evidence: therapeutic DNA:insertion/deletion:intron 16:
|
CTD RGD |
PMID:16328049 PMID:25208933 |
RGD:11343535 |
NCBI chrNW_004624849:998,262...1,019,305
Ensembl chrNW_004624849:998,277...1,019,521
|
|
G
|
Acer3
|
alkaline ceramidase 3
|
disease_progression
|
ISO
|
|
RGD |
PMID:30097213 |
RGD:35673325 |
NCBI chrNW_004624863:37,148...96,550
Ensembl chrNW_004624863:37,148...95,211
|
|
G
|
Acly
|
ATP citrate lyase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21147110 |
|
NCBI chrNW_004624795:1,872,413...1,910,495
Ensembl chrNW_004624795:1,872,454...1,911,004
|
|
G
|
Aco2
|
aconitase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624752:7,074,148...7,113,773
Ensembl chrNW_004624752:7,074,153...7,113,773
|
|
G
|
Acox1
|
acyl-CoA oxidase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12771043 PMID:15565109 |
|
NCBI chrNW_004624801:5,844,824...5,867,439
Ensembl chrNW_004624801:5,846,729...5,867,427
|
|
G
|
Acsl4
|
acyl-CoA synthetase long chain family member 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19363144 |
|
NCBI chrNW_004624803:6,272,954...6,372,815
Ensembl chrNW_004624803:6,336,964...6,372,815
|
|
G
|
Actb
|
actin beta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19363144 PMID:21472284 |
|
NCBI chrNW_004624740:28,087,051...28,090,359
Ensembl chrNW_004624740:28,087,736...28,090,512
|
|
G
|
Adamts1
|
ADAM metallopeptidase with thrombospondin type 1 motif 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19514085 |
|
NCBI chrNW_004624745:14,802,703...14,811,568
Ensembl chrNW_004624745:14,802,371...14,811,203
|
|
G
|
Adamts13
|
ADAM metallopeptidase with thrombospondin type 1 motif 13
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624760:1,865,474...1,889,394
Ensembl chrNW_004624760:1,865,376...1,889,203
|
|
G
|
Add1
|
adducin 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19363144 |
|
NCBI chrNW_004624755:24,854,742...24,927,912
Ensembl chrNW_004624755:24,854,742...24,928,006
|
|
G
|
Adgrg7
|
adhesion G protein-coupled receptor G7
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624789:14,189,844...14,299,742
Ensembl chrNW_004624789:14,189,844...14,299,742
|
|
G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
susceptibility
|
ISO
|
DNA:SNP:intron:+276T>G (rs1501299) (human)
|
RGD |
PMID:23740135 |
RGD:14401720 |
NCBI chrNW_004624730:69,941,963...69,959,266
Ensembl chrNW_004624730:69,941,001...69,957,012
|
|
G
|
Adra1a
|
adrenoceptor alpha 1A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624758:21,557,161...21,665,432
Ensembl chrNW_004624758:21,569,908...21,665,244
|
|
G
|
Adra2b
|
adrenoceptor alpha 2B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624749:2,226,809...2,230,413
Ensembl chrNW_004624749:2,226,738...2,230,381
|
|
G
|
Afp
|
alpha fetoprotein
|
disease_progression treatment severity
|
ISO
|
protein:increased expression:serum (human) associated with hepatitis B CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:9029167 PMID:15276417 PMID:22147961 PMID:22392353 PMID:24012840 PMID:25968302 PMID:25999787 PMID:28284560 PMID:28611981 PMID:32961231 More...
|
RGD:125097525 RGD:126790579 RGD:126790583 RGD:14401581 RGD:152177911 |
NCBI chrNW_004624735:34,072,257...34,092,540
Ensembl chrNW_004624735:34,072,192...34,092,604
|
|
G
|
Aicda
|
activation induced cytidine deaminase
|
|
ISO
|
|
RGD |
PMID:18997814 |
RGD:127285629 |
NCBI chrNW_004624860:4,912,938...4,927,846
Ensembl chrNW_004624860:4,912,656...4,926,634
|
|
G
|
Ak3
|
adenylate kinase 3
|
|
ISO
|
protein:decreased expression:liver
|
RGD |
PMID:17203974 |
RGD:13842477 |
NCBI chrNW_004624736:9,428,736...9,494,645
|
|
G
|
Akr1a1
|
aldo-keto reductase family 1 member A1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:32805337 |
|
NCBI chrNW_004624906:1,463,201...1,474,001
Ensembl chrNW_004624906:1,462,693...1,474,214
|
|
G
|
Akt1
|
AKT serine/threonine kinase 1
|
treatment exacerbates
|
ISO
|
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver
|
RGD CTD |
PMID:25999787 PMID:31801250 PMID:32045588 PMID:37460115 |
RGD:151893509 RGD:152177911 RGD:408364960 |
NCBI chrNW_004624734:507,880...525,295
Ensembl chrNW_004624734:509,368...525,295
|
|
G
|
Akt2
|
AKT serine/threonine kinase 2
|
|
ISO
|
protein:increased phosphorylation:liver (mouse) protein:increased phosphorylation:liver cancer cell (rat)
|
RGD |
PMID:19309364 PMID:28100771 |
RGD:127285675 RGD:2313299 |
NCBI chrNW_004624925:262,590...322,440
Ensembl chrNW_004624925:273,881...326,984
|
|
G
|
Alb
|
albumin
|
susceptibility
|
ISO
|
associated with hepatitis C;protein:decreased expression:serum protein:decreased expression:serum (human)
|
RGD |
PMID:22392353 PMID:23892757 PMID:29040987 |
RGD:11035269 RGD:125097525 RGD:14694841 |
NCBI chrNW_004624735:34,105,237...34,123,479
Ensembl chrNW_004624735:34,104,537...34,123,624
|
|
G
|
Aldh2
|
aldehyde dehydrogenase 2 family member
|
susceptibility no_association severity
|
ISO
|
associated with hepatitis B;DNA;missense mutation, haplotype:cds: (rs671) (human) DNA:missense mutation:cds: (rs671) (human) DNA:missense mutation:cds, exon 12:p.E487K (human) DNA:missense mutation:exon 12: (human) mRNA, protein:decreased expression:liver (human) associated with alcoholic liver cirrhosis;DNA:missense mutation:cds:p.E487K (human) associated with alcohol use disorder;DNA:missense mutation:cds: (human) protein:decreased expression: liver (human) associated with hepatitis C:DNA:SNP:exon 12 (human)
|
RGD |
PMID:1916152 PMID:10737710 PMID:12940444 PMID:18439068 PMID:25778454 PMID:26150517 PMID:26827895 PMID:28027570 PMID:29765251 More...
|
RGD:11054822 RGD:14696699 RGD:14696778 RGD:14696779 RGD:14700899 RGD:15036809 RGD:15042857 RGD:15042859 RGD:15042862 |
NCBI chrNW_004624747:20,407,190...20,438,605
Ensembl chrNW_004624747:20,403,717...20,438,690
|
|
G
|
Aldh7a1
|
aldehyde dehydrogenase 7 family member A1
|
severity
|
ISO
|
mRNA:altered expression:liver tumor (human)
|
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chrNW_004624774:15,048,825...15,099,443
Ensembl chrNW_004624774:15,048,627...15,101,856
|
|
G
|
Aldoc
|
aldolase, fructose-bisphosphate C
|
|
ISO
|
mRNA:increased expression:liver
|
RGD |
PMID:3830170 |
RGD:2301136 |
NCBI chrNW_004624786:1,158,270...1,162,801
Ensembl chrNW_004624786:1,158,248...1,162,916
|
|
G
|
Alx4
|
ALX homeobox 4
|
ameliorates
|
ISO
|
mRNA, protein:decreased expression:liver
|
RGD |
PMID:28081728 PMID:31132711 |
RGD:153323329 RGD:153323330 |
NCBI chrNW_004624767:3,770,755...3,808,511
Ensembl chrNW_004624767:3,770,762...3,805,323
|
|
G
|
Angptl6
|
angiopoietin like 6
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624828:2,291,682...2,301,165
Ensembl chrNW_004624828:2,290,511...2,296,341
|
|
G
|
Ank3
|
ankyrin 3
|
|
ISO
|
protein:decreased expression:liver
|
RGD |
PMID:26652480 |
RGD:153344559 |
NCBI chrNW_004624791:3,299,287...3,633,631
|
|
G
|
Anln
|
anillin actin binding protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624740:24,756,633...24,831,168
Ensembl chrNW_004624740:24,756,234...24,830,978
|
|
G
|
Antxr1
|
ANTXR cell adhesion molecule 1
|
treatment
|
ISO
|
|
RGD |
PMID:20650339 |
RGD:9684932 |
NCBI chrNW_004624762:4,051,479...4,377,237
Ensembl chrNW_004624762:4,128,127...4,377,278
|
|
G
|
Anxa10
|
annexin A10
|
disease_progression
|
ISO
|
mRNA:decreased expression:liver (human)
|
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004624932:1,268,193...1,335,246
Ensembl chrNW_004624932:1,268,330...1,333,965
|
|
G
|
Anxa2
|
annexin A2
|
|
ISO
|
mRNA, protein:increased expression:liver (human)
|
RGD |
PMID:33675609 |
RGD:152999436 |
NCBI chrNW_004624781:11,781,893...11,820,440
Ensembl chrNW_004624781:11,781,886...11,821,816
|
|
G
|
Anxa4
|
annexin A4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624762:3,562,656...3,641,465
Ensembl chrNW_004624762:3,562,446...3,641,770
|
|
G
|
Anxa6
|
annexin A6
|
disease_progression
|
ISO
|
associated with tumor vascularization; protein:decreased expression:liver tumor (human)
|
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chrNW_004624733:41,024,503...41,071,390
Ensembl chrNW_004624733:41,024,514...41,071,353
|
|
G
|
Apc
|
APC regulator of WNT signaling pathway
|
|
ISO
|
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
|
OMIM ClinVar |
PMID:1316610 PMID:8381579 PMID:8381580 PMID:8395941 PMID:9101302 PMID:9536098 PMID:9585611 PMID:9824584 PMID:10713886 PMID:11001924 PMID:11247896 PMID:11317365 PMID:11466687 PMID:11748858 PMID:14961559 PMID:15311282 PMID:15459959 PMID:16461775 PMID:16650078 PMID:17064931 PMID:17293347 PMID:17411426 PMID:17489848 PMID:17576681 PMID:17963004 PMID:18199528 PMID:19531215 PMID:19793053 PMID:20223039 PMID:20685668 PMID:21859464 PMID:21901162 PMID:22135120 PMID:22425061 PMID:22431159 PMID:22447671 PMID:22703879 PMID:23159591 PMID:23460355 PMID:23484150 PMID:24033266 PMID:24448499 PMID:24573554 PMID:24599579 PMID:24728327 PMID:25085752 PMID:25142776 PMID:25186627 PMID:25479140 PMID:25559809 PMID:25590978 PMID:25637381 PMID:25741868 PMID:25925381 PMID:25980754 PMID:26207792 PMID:26447891 PMID:26467025 PMID:26508446 PMID:26530882 PMID:26580448 PMID:26690363 PMID:26845104 PMID:26900293 PMID:26976419 PMID:27028212 PMID:27081525 PMID:27150160 PMID:27600092 PMID:27852271 PMID:28051113 PMID:28127413 PMID:28135048 PMID:28135145 PMID:28195569 PMID:28492532 PMID:28526081 PMID:28726808 PMID:28828701 PMID:28873162 PMID:29510987 PMID:29641532 PMID:29684080 PMID:30267214 PMID:30374176 PMID:30426508 PMID:30458888 PMID:30897307 PMID:31111538 PMID:31159747 PMID:31175917 PMID:31422818 PMID:31428572 PMID:31937788 PMID:32187665 PMID:32390703 PMID:33294277 PMID:34250417 PMID:34426522 PMID:35189564 PMID:35264596 PMID:37038467 PMID:38136308 PMID:38504345 More...
|
|
NCBI chrNW_004624743:30,517,034...30,635,740
Ensembl chrNW_004624743:30,546,323...30,635,737
|
|
G
|
Apcs
|
amyloid P component, serum
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19363144 |
|
NCBI chrNW_004624794:1,689,619...1,690,700
Ensembl chrNW_004624794:1,689,774...1,691,362
|
|
G
|
Apex1
|
apurinic/apyrimidinic endodeoxyribonuclease 1
|
treatment
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:25109342 PMID:33841550 |
RGD:152998960 |
NCBI chrNW_004624825:4,711,921...4,714,926
Ensembl chrNW_004624825:4,708,093...4,714,921
|
|
G
|
Apln
|
apelin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624797:8,857,490...8,866,157
Ensembl chrNW_004624797:8,857,070...8,866,329
|
|
G
|
Apoa1
|
apolipoprotein A1
|
disease_progression
|
ISO
|
protein:decreased expression:plasma (human) associated with hepatitis B; CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:21472284 PMID:23935864 PMID:31211449 |
RGD:153350082 RGD:25671438 |
NCBI chrNW_004624784:12,249,283...12,251,215
Ensembl chrNW_004624784:12,249,283...12,251,136
|
|
G
|
Apoa2
|
apolipoprotein A2
|
|
ISO
|
associated with hepatitis B; mRNA:increased expression:liver
|
RGD |
PMID:31211449 |
RGD:153350082 |
NCBI chrNW_004624794:164,351...165,676
Ensembl chrNW_004624794:164,370...166,248
|
|
G
|
Apoa4
|
apolipoprotein A4
|
disease_progression
|
ISO
|
associated with hepatitis B;
|
RGD |
PMID:31211449 |
RGD:153350082 |
NCBI chrNW_004624784:12,237,329...12,240,013
Ensembl chrNW_004624784:12,233,593...12,239,763
|
|
G
|
Apoc1
|
apolipoprotein C1
|
disease_progression
|
ISO
|
associated with hepatitis B;
|
RGD |
PMID:31211449 |
RGD:153350082 |
NCBI chrNW_004624907:1,758,671...1,760,611
Ensembl chrNW_004624907:1,758,696...1,760,611
|
|
G
|
Apoc2
|
apolipoprotein C2
|
|
ISO
|
associated with hepatitis B; mRNA:increased expression:liver
|
RGD |
PMID:31211449 |
RGD:153350082 |
NCBI chrNW_004624907:1,765,467...1,769,786
Ensembl chrNW_004624907:1,765,481...1,769,781
|
|
G
|
Apoc3
|
apolipoprotein C3
|
susceptibility disease_progression
|
ISO
|
associated with Chronic Hepatitis B;DNA:SNP: :rs2854116(human) associated with hepatitis B;
|
RGD |
PMID:27547913 PMID:31211449 |
RGD:153344620 RGD:153350082 |
NCBI chrNW_004624784:12,244,565...12,246,790
Ensembl chrNW_004624784:12,244,646...12,246,790
|
|
G
|
Apoe
|
apolipoprotein E
|
|
ISO
|
protein:increased expression:liver, serum (mouse)
|
RGD |
PMID:21644509 |
RGD:6903288 |
NCBI chrNW_004624907:1,752,322...1,755,308
|
|
G
|
Apof
|
apolipoprotein F
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624802:11,640,942...11,645,030
|
|
G
|
Aprt
|
adenine phosphoribosyltransferase
|
|
ISO
|
protein:increased activity:hepatoma (rat)
|
RGD |
PMID:6327016 |
RGD:5135035 |
NCBI chrNW_004624746:805,742...807,963
Ensembl chrNW_004624746:805,758...807,963
|
|
G
|
Ar
|
androgen receptor
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:18639551 |
|
NCBI chrNW_004624891:3,135,824...3,330,487
Ensembl chrNW_004624891:3,138,848...3,329,459
|
|
G
|
Arg1
|
arginase 1
|
disease_progression
|
ISO
|
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
|
RGD |
PMID:17210712 PMID:30901224 |
RGD:152995286 RGD:4140476 |
NCBI chrNW_004624753:5,737,720...5,749,313
Ensembl chrNW_004624753:5,737,237...5,752,966
|
|
G
|
Arhgap11a
|
Rho GTPase activating protein 11A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624804:1,713,261...1,735,357
|
|
G
|
Arhgap44
|
Rho GTPase activating protein 44
|
exacerbates
|
ISO
|
protein:decreased expression:liver (human)
|
RGD |
PMID:31136984 |
RGD:401901276 |
NCBI chrNW_004624877:662,595...851,762
Ensembl chrNW_004624877:661,998...850,431
|
|
G
|
Arhgef39
|
Rho guanine nucleotide exchange factor 39
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624868:5,126,041...5,130,696
Ensembl chrNW_004624868:5,126,781...5,130,320
|
|
G
|
Arid1a
|
AT-rich interaction domain 1A
|
treatment exacerbates
|
ISO
|
mRNA, protein:decreased expression:liver (human) CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver (human) human gene in mouse model associated with non-alcoholic steatohepatitis
|
RGD CTD |
PMID:22561517 PMID:22634756 PMID:22922871 PMID:25975202 PMID:26569409 PMID:26589513 PMID:29113912 PMID:29136504 More...
|
RGD:11344640 RGD:125097485 RGD:125097495 RGD:125097519 RGD:126790634 |
NCBI chrNW_004624764:10,672,673...10,759,634
Ensembl chrNW_004624764:10,672,735...10,759,634
|
|
G
|
Arid1b
|
AT-rich interaction domain 1B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22634756 |
|
NCBI chrNW_004624785:970,169...1,417,847
Ensembl chrNW_004624785:973,003...1,417,853
|
|
G
|
Arid2
|
AT-rich interaction domain 2
|
disease_progression exacerbates
|
ISO
|
CTD Direct Evidence: marker/mechanism associated with hepatitis B;protein:decreased expression:liver
|
RGD CTD |
PMID:21822264 PMID:22634756 PMID:25701229 PMID:27351279 PMID:28498550 PMID:32071245 More...
|
RGD:150340708 RGD:150340711 RGD:150340712 RGD:150429631 |
NCBI chrNW_004624816:6,329,888...6,521,535
Ensembl chrNW_004624816:6,332,612...6,521,535
|
|
G
|
Arid3a
|
AT-rich interaction domain 3A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:35179300 |
|
NCBI chrNW_004624828:7,636,211...7,666,868
Ensembl chrNW_004624828:7,635,383...7,666,416
|
|
G
|
Arrb2
|
arrestin beta 2
|
treatment
|
ISO
|
|
RGD |
PMID:33841550 |
RGD:152998960 |
NCBI chrNW_004624786:8,568,102...8,576,445
Ensembl chrNW_004624786:8,568,198...8,577,914
|
|
G
|
Asf1b
|
anti-silencing function 1B histone chaperone
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624901:1,342,855...1,354,196
Ensembl chrNW_004624901:1,342,765...1,354,165
|
|
G
|
Asl
|
argininosuccinate lyase
|
disease_progression
|
ISO
|
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
|
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chrNW_004624740:8,414,664...8,423,797
Ensembl chrNW_004624740:8,414,733...8,423,777
|
|
G
|
Asns
|
asparagine synthetase (glutamine-hydrolyzing)
|
|
ISO
|
protein:increased activity:serum (rat)
|
RGD |
PMID:10081 |
RGD:2316006 |
NCBI chrNW_004624813:4,642,420...4,661,362
Ensembl chrNW_004624813:4,641,372...4,661,778
|
|
G
|
Aspg
|
asparaginase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624734:932,877...950,509
Ensembl chrNW_004624734:931,946...950,553
|
|
G
|
Aspm
|
assembly factor for spindle microtubules
|
disease_progression
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:18676753 PMID:28284560 |
RGD:13439743 |
NCBI chrNW_004624798:3,164,145...3,223,810
Ensembl chrNW_004624798:3,165,393...3,225,181
|
|
G
|
Ass1
|
argininosuccinate synthase 1
|
disease_progression
|
ISO
|
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
|
RGD |
PMID:12359751 PMID:30901224 |
RGD:152995286 RGD:4140479 |
NCBI chrNW_004624760:5,180,095...5,221,677
Ensembl chrNW_004624760:5,180,095...5,221,732
|
|
G
|
Atg101
|
autophagy related 101
|
disease_progression
|
ISO
|
|
RGD |
PMID:35592424 |
RGD:153350091 |
NCBI chrNW_004624816:255,443...261,636
Ensembl chrNW_004624816:255,432...262,151
|
|
G
|
Atg7
|
autophagy related 7
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29191453 |
|
NCBI chrNW_004624943:231,978...480,933
Ensembl chrNW_004624943:232,618...481,290
|
|
G
|
Atm
|
ATM serine/threonine kinase
|
exacerbates
|
ISO
|
protein:increased expression:liver (human) CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:12866955 PMID:19919837 |
RGD:126781750 |
NCBI chrNW_004624784:2,933,172...3,080,131
Ensembl chrNW_004624784:2,937,499...3,078,216
|
|
G
|
Atp5pb
|
ATP synthase peripheral stalk-membrane subunit b
|
|
ISO
|
associated with hepatitis C
|
RGD |
PMID:18932288 |
RGD:14696822 |
NCBI chrNW_004624772:7,167,074...7,178,756
Ensembl chrNW_004624772:7,167,147...7,179,273
|
|
G
|
Atp5pd
|
ATP synthase peripheral stalk subunit d
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624801:4,857,689...4,863,249
Ensembl chrNW_004624801:4,857,692...4,861,430
|
|
G
|
Aurka
|
aurora kinase A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624790:143,818...162,065
Ensembl chrNW_004624790:147,149...161,344
|
|
G
|
Aurkb
|
aurora kinase B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624786:10,769,797...10,775,142
Ensembl chrNW_004624786:10,765,610...10,775,112
|
|
G
|
Axin1
|
axin 1
|
disease_progression
|
ISO
|
ClinVar Annotator: match by term: AXIN1-related condition | ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma protein:decreased expression:liver (human) associated with Hepatitis B, Chronic,DNA:SNP, haplotype:exon:(rs1805105) T>C (human)
|
OMIM ClinVar RGD |
PMID:10700176 PMID:25741868 PMID:26968103 PMID:28492532 PMID:31514071 PMID:37582359 More...
|
RGD:14402039 RGD:150530482 |
NCBI chrNW_004624913:1,139,165...1,195,477
Ensembl chrNW_004624913:1,139,165...1,195,230
|
|
G
|
Axin2
|
axin 2
|
|
ISO
|
protein:increased expression:liver:
|
RGD |
PMID:11809809 |
RGD:151356508 |
NCBI chrNW_004624870:2,803,743...2,832,489
Ensembl chrNW_004624870:2,800,873...2,832,626
|
|
G
|
Azgp1
|
alpha-2-glycoprotein 1, zinc-binding
|
disease_progression
|
ISO
|
mRNA:decreased expression:liver associated with hepatitis B;mRNA:decreased expression:liver
|
RGD |
PMID:22625427 PMID:26902423 PMID:27993894 |
RGD:153350130 RGD:153350132 RGD:153350133 |
NCBI chrNW_004624740:17,054,221...17,062,420
Ensembl chrNW_004624740:17,054,221...17,063,226
|
|
G
|
Azin1
|
antizyme inhibitor 1
|
disease_progression
|
ISO
|
RNA:increased editing:liver
|
RGD |
PMID:23291631 |
RGD:14700705 |
NCBI chrNW_004624763:19,643,980...19,667,125
Ensembl chrNW_004624763:19,643,980...19,667,125
|
|
G
|
Banf1
|
barrier to autointegration nuclear assembly factor 1
|
treatment
|
ISO
|
mRNA, protein:increased expression:liver (rat) mRNA, protein:increased expression:liver (human)
|
RGD |
PMID:29059470 |
RGD:155791679 |
NCBI chrNW_004624767:20,435,143...20,436,830
Ensembl chrNW_004624767:20,434,955...20,436,640
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
treatment
|
ISO
|
|
RGD |
PMID:33841550 |
RGD:152998960 |
NCBI chrNW_004624832:5,050,222...5,068,565
Ensembl chrNW_004624832:5,050,222...5,055,506
|
|
G
|
Bcl2
|
BCL2 apoptosis regulator
|
treatment
|
ISO
|
mRNA:increased expression:liver (mouse)
|
RGD |
PMID:28100771 PMID:33841550 |
RGD:127285675 RGD:152998960 |
NCBI chrNW_004624792:8,854,345...9,032,727
Ensembl chrNW_004624792:8,859,522...9,031,344
|
|
G
|
Bcl2l1
|
BCL2 like 1
|
treatment
|
ISO
|
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:increased expression:liver (mouse)
|
CTD RGD |
PMID:10629087 PMID:11509945 PMID:28100771 PMID:33841550 |
RGD:127285675 RGD:152998960 |
NCBI chrNW_004624741:788,445...838,513
Ensembl chrNW_004624741:789,355...839,507
|
|
G
|
Bco2
|
beta-carotene oxygenase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624784:7,324,312...7,353,733
Ensembl chrNW_004624784:7,334,472...7,353,802
|
|
G
|
Bcorl1
|
BCL6 corepressor like 1
|
disease_progression
|
ISO
|
|
RGD |
PMID:26879601 PMID:29679906 |
RGD:11556159 RGD:150340705 |
NCBI chrNW_004624797:9,211,625...9,283,435
Ensembl chrNW_004624797:9,240,209...9,282,020
|
|
G
|
Bhmt
|
betaine--homocysteine S-methyltransferase
|
disease_progression
|
ISO
|
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
|
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chrNW_004624869:3,618,895...3,639,621
Ensembl chrNW_004624869:3,617,948...3,642,860
|
|
G
|
Bhmt2
|
betaine--homocysteine S-methyltransferase 2
|
severity
|
ISO
|
mRNA:altered expression:liver tumor (human)
|
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chrNW_004624869:3,571,154...3,596,389
Ensembl chrNW_004624869:3,576,369...3,599,275
|
|
G
|
Bid
|
BH3 interacting domain death agonist
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15289866 |
|
NCBI chrNW_004624735:9,557,732...9,590,862
Ensembl chrNW_004624735:9,579,979...9,589,260
|
|
G
|
Birc3
|
baculoviral IAP repeat containing 3
|
ameliorates treatment exacerbates
|
ISO
|
human cell line in a mouse model mRNA, protein:increased expression:liver (human) associated with hepatitis B;mRNA, protein:increased expression:liver (human)
|
RGD |
PMID:22682366 PMID:22820591 PMID:30210622 PMID:30368883 PMID:33310033 |
RGD:152998937 RGD:152998984 RGD:152998986 RGD:152998988 RGD:152999010 |
NCBI chrNW_004624878:516,750...541,475
Ensembl chrNW_004624878:523,300...536,062
|
|
G
|
Birc5
|
baculoviral IAP repeat containing 5
|
disease_progression
|
ISO
|
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:increased expression:liver (human)
|
CTD RGD |
PMID:16086872 PMID:20514400 PMID:31964418 |
RGD:153344516 |
NCBI chrNW_004624801:7,727,084...7,735,946
Ensembl chrNW_004624801:7,727,093...7,735,940
|
|
G
|
Birc7
|
baculoviral IAP repeat containing 7
|
exacerbates
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chrNW_004624741:28,937,836...28,944,000
|
|
G
|
Blzf1
|
basic leucine zipper nuclear factor 1
|
disease_progression
|
ISO
|
|
RGD |
PMID:26342799 |
RGD:14398326 |
NCBI chrNW_004624826:7,300,216...7,327,081
|
|
G
|
Bmi1
|
BMI1 proto-oncogene, polycomb ring finger
|
treatment
|
ISO
|
|
RGD |
PMID:26919246 |
RGD:14928318 |
NCBI chrNW_004624796:6,277,201...6,282,830
Ensembl chrNW_004624796:6,274,561...6,282,984
|
|
G
|
Bmper
|
BMP binding endothelial regulator
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624776:19,159,906...19,462,607
Ensembl chrNW_004624776:19,160,501...19,459,227
|
|
G
|
Braf
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27222248 |
|
NCBI chrNW_004624765:20,766,368...20,951,560
Ensembl chrNW_004624765:20,773,885...20,951,736
|
|
G
|
Bsg
|
basigin (Ok blood group)
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:36574092 |
|
NCBI chrNW_004624828:7,913,297...7,920,891
Ensembl chrNW_004624828:7,913,099...7,920,804
|
|
G
|
Btg2
|
BTG anti-proliferation factor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18393292 |
|
NCBI chrNW_004624807:7,541,335...7,545,412
Ensembl chrNW_004624807:7,540,602...7,545,521
|
|
G
|
Bub1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624749:1,584,289...1,639,334
Ensembl chrNW_004624749:1,584,186...1,639,770
|
|
G
|
Bub1b
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624804:7,477,046...7,533,322
Ensembl chrNW_004624804:7,492,799...7,533,408
|
|
G
|
C3
|
complement C3
|
|
ISO
|
|
RGD |
PMID:23245919 |
RGD:11040806 |
NCBI chrNW_004624828:3,773,816...3,798,077
Ensembl chrNW_004624828:3,770,221...3,797,946
|
|
G
|
C9
|
complement C9
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19363144 PMID:28284560 |
|
NCBI chrNW_004624759:15,534,743...15,623,767
Ensembl chrNW_004624759:15,534,660...15,624,381
|
|
G
|
Ca12
|
carbonic anhydrase 12
|
disease_progression ameliorates
|
ISO
|
mRNA:altered expression:liver
|
RGD |
PMID:29900055 PMID:31934040 PMID:35362480 |
RGD:153352325 RGD:153352328 RGD:155226869 |
NCBI chrNW_004624781:9,140,753...9,195,651
Ensembl chrNW_004624781:9,140,837...9,196,400
|
|
G
|
Ca2
|
carbonic anhydrase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624744:6,168,030...6,183,407
Ensembl chrNW_004624744:6,167,606...6,183,538
|
|
G
|
Ca9
|
carbonic anhydrase 9
|
|
ISO
|
mRNA:altered expression:liver
|
RGD |
PMID:29900055 |
RGD:155226869 |
NCBI chrNW_004624868:5,110,602...5,131,167
Ensembl chrNW_004624868:5,109,846...5,116,949
|
|
G
|
Cab39
|
calcium binding protein 39
|
disease_progression
|
ISO
|
|
RGD |
PMID:28605041 |
RGD:14398832 |
NCBI chrNW_004624843:4,129,755...4,217,406
Ensembl chrNW_004624843:4,130,052...4,217,540
|
|
G
|
Cad
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
|
|
ISO
|
mRNA:increased expression:liver DNA:amplification:cds (rat)
|
RGD |
PMID:2888462 PMID:2914957 PMID:7053379 |
RGD:10755426 RGD:2303530 RGD:5132587 |
NCBI chrNW_004624738:9,318,213...9,340,765
Ensembl chrNW_004624738:9,318,232...9,340,925
|
|
G
|
Cadm1
|
cell adhesion molecule 1
|
|
ISO
|
DNA, mRNA, protein:hypermethylation, decreased expression:promoter:liver
|
RGD |
PMID:17428255 |
RGD:2289095 |
NCBI chrNW_004624784:10,595,876...10,933,024
Ensembl chrNW_004624784:10,591,824...10,932,981
|
|
G
|
Cadm2
|
cell adhesion molecule 2
|
disease_progression
|
ISO
|
mRNA, protein:decreased expression:liver
|
RGD |
PMID:24240726 |
RGD:15092075 |
NCBI chrNW_004624789:1,245,224...2,316,519
Ensembl chrNW_004624789:1,245,304...2,314,562
|
|
G
|
Calml3
|
calmodulin like 3
|
severity
|
ISO
|
protein:decreased expression:liver (human)
|
RGD |
PMID:29445139 |
RGD:151665319 |
NCBI chrNW_004624775:335,860...338,267
Ensembl chrNW_004624775:337,054...337,503
|
|
G
|
Calr
|
calreticulin
|
treatment exacerbates
|
ISO
|
human cells and recombinant gene in a mouse model protein:increased expression:liver (human)
|
RGD |
PMID:12096119 PMID:24997628 PMID:27055635 |
RGD:150521681 RGD:150521690 RGD:150521691 |
NCBI chrNW_004624901:511,295...515,208
Ensembl chrNW_004624901:511,052...516,757
|
|
G
|
Camk2n1
|
calcium/calmodulin dependent protein kinase II inhibitor 1
|
|
ISO
|
|
RGD |
PMID:23651211 |
RGD:18337283 |
NCBI chrNW_004624764:5,544,589...5,547,811
Ensembl chrNW_004624764:5,544,484...5,547,683
|
|
G
|
Cap2
|
cyclase associated actin cytoskeleton regulatory protein 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624756:8,990,151...9,174,208
Ensembl chrNW_004624756:8,989,203...9,174,283
|
|
G
|
Capn3
|
calpain 3
|
|
ISO
|
mRNA:decreased expression:skeletal muscle
|
RGD |
PMID:10806331 |
RGD:1600777 |
NCBI chrNW_004624804:9,473,075...9,512,643
Ensembl chrNW_004624804:9,473,117...9,512,353
|
|
G
|
Carm1
|
coactivator associated arginine methyltransferase 1
|
|
ISO
|
mRNA,protein:increased expression:liver:
|
RGD |
PMID:23912631 |
RGD:9586718 |
NCBI chrNW_004624828:2,833,011...2,872,281
Ensembl chrNW_004624828:2,832,769...2,871,167
|
|
G
|
Casp8
|
caspase 8
|
treatment severity
|
ISO
|
associated with hepatitis B;DNA:insertion/deletion:promoter: (rs3834129) (human)
|
OMIM RGD |
PMID:28643196 PMID:29133031 |
RGD:13782296 RGD:14695027 |
NCBI chrNW_004624899:427,064...450,931
Ensembl chrNW_004624899:424,363...451,087
|
|
G
|
Casp9
|
caspase 9
|
treatment
|
ISO
|
|
RGD |
PMID:29133031 |
RGD:13782296 |
NCBI chrNW_004624764:1,769,270...1,789,399
Ensembl chrNW_004624764:1,773,455...1,789,423
|
|
G
|
Cat
|
catalase
|
disease_progression
|
ISO
|
associated with liver cirrhosis with Hepatitis C;DNA:SNP:promoter:-262T>C (human) CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:21907168 PMID:33010264 |
RGD:27095879 |
NCBI chrNW_004624767:12,680,940...12,715,468
Ensembl chrNW_004624767:12,680,953...12,715,739
|
|
G
|
Cbfb
|
core-binding factor subunit beta
|
|
ISO
|
mRNA:decreased expression:liver
|
RGD |
PMID:17094378 |
RGD:126775147 |
NCBI chrNW_004624746:19,204,415...19,264,217
Ensembl chrNW_004624746:19,204,392...19,264,194
|
|
G
|
Cbl
|
Cbl proto-oncogene
|
disease_progression
|
ISO
|
|
RGD |
PMID:26474280 |
RGD:11536137 |
NCBI chrNW_004624784:14,577,582...14,671,816
Ensembl chrNW_004624784:14,577,515...14,667,575
|
|
G
|
Cbx2
|
chromobox 2
|
disease_progression
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004624801:8,951,659...8,961,280
Ensembl chrNW_004624801:8,951,723...8,958,352
|
|
G
|
Cbx4
|
chromobox 4
|
disease_progression
|
ISO
|
protein:increased expression:cytoplasm:
|
RGD |
PMID:23943028 PMID:24838576 |
RGD:9586738 RGD:9586739 |
NCBI chrNW_004624801:9,002,290...9,008,305
Ensembl chrNW_004624801:9,003,059...9,008,203
|
|
G
|
Cbx7
|
chromobox 7
|
|
ISO
|
mRNA:decreased expression:liver
|
RGD |
PMID:22041561 |
RGD:9587355 |
NCBI chrNW_004624752:9,133,587...9,151,216
Ensembl chrNW_004624752:9,133,569...9,151,934
|
|
G
|
Ccbe1
|
collagen and calcium binding EGF domains 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624792:4,863,978...5,146,907
Ensembl chrNW_004624792:4,867,858...5,146,839
|
|
G
|
Ccl1
|
C-C motif chemokine ligand 1
|
|
ISO
|
mRNA:increased expression:liver (mouse)
|
RGD |
PMID:26569409 |
RGD:11344640 |
NCBI chrNW_004624875:2,224,784...2,229,465
|
|
G
|
Ccl14
|
C-C motif chemokine ligand 14
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624875:3,372,982...3,376,663
|
|
G
|
Ccl5
|
C-C motif chemokine ligand 5
|
susceptibility treatment
|
ISO
|
associated with alcoholic liver cirrhosis;DNA:SNP:promoter:-403G>A(human) DNA:polymorphisms:promoter:-403G>A,-28C>G (human)
|
RGD |
PMID:21610221 PMID:22374185 PMID:28011329 |
RGD:14995306 RGD:14995333 RGD:14995338 |
NCBI chrNW_004624875:3,334,136...3,342,085
Ensembl chrNW_004624875:3,334,078...3,341,614
|
|
G
|
Ccn1
|
cellular communication network factor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17699798 |
|
NCBI chrNW_004624742:11,882,815...11,885,686
Ensembl chrNW_004624742:11,882,907...11,885,667
|
|
G
|
Ccna1
|
cyclin A1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12029619 |
|
NCBI chrNW_004624776:941,107...951,256
Ensembl chrNW_004624776:939,823...950,833
|
|
G
|
Ccnb2
|
cyclin B2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624781:12,875,215...12,905,878
Ensembl chrNW_004624781:12,874,020...12,905,932
|
|
G
|
Ccnd1
|
cyclin D1
|
susceptibility
|
ISO
|
associated with Hepatitis B, Chronic;DNA:SNP:splice-site mutation:870G>A (human) CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (mouse)
|
RGD CTD |
PMID:12029619 PMID:19919837 PMID:22649188 PMID:25822088 PMID:25851350 PMID:26189965 PMID:28100771 More...
|
RGD:127285675 RGD:14401586 |
NCBI chrNW_004624767:17,470,310...17,483,082
Ensembl chrNW_004624767:17,469,622...17,483,191
|
|
G
|
Ccnd2
|
cyclin D2
|
disease_progression susceptibility severity
|
ISO
|
associated with hepatitis B associated with Chronic Hepatitis C;DNA:SNP: :rs1049606(human) DNA:hypermethylation:CpG site
|
RGD |
PMID:22004425 PMID:31059558 PMID:33320844 |
RGD:151664743 RGD:151665109 RGD:151665169 |
NCBI chrNW_004624860:1,383,015...1,405,107
Ensembl chrNW_004624860:1,382,948...1,405,107
|
|
G
|
Ccne1
|
cyclin E1
|
ameliorates
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:12029619 PMID:17196522 PMID:22634754 PMID:28100771 PMID:29551768 |
RGD:127285675 RGD:153297807 RGD:2289277 |
NCBI chrNW_004624794:4,957,156...4,967,058
Ensembl chrNW_004624794:4,957,178...4,967,140
|
|
G
|
Ccnf
|
cyclin F
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624824:181,696...204,045
Ensembl chrNW_004624824:181,735...204,029
|
|
G
|
Ccng1
|
cyclin G1
|
severity disease_progression treatment
|
ISO
|
protein:decreased expression:liver (human) protein:increased expression:liver (human) human cells in mouse model
|
RGD |
PMID:19584283 PMID:22835824 PMID:23804702 PMID:24034575 PMID:25431954 PMID:26345095 PMID:27982046 PMID:33543294 More...
|
RGD:151356922 RGD:151356932 RGD:151356933 RGD:151356967 RGD:151356970 RGD:151356981 RGD:151361198 RGD:151361200 |
NCBI chrNW_004624733:26,366,448...26,378,062
Ensembl chrNW_004624733:26,367,200...26,376,664
|
|
G
|
Ccng2
|
cyclin G2
|
|
ISO
|
|
RGD |
PMID:27982046 |
RGD:151361200 |
NCBI chrNW_004624757:13,828,768...13,837,994
Ensembl chrNW_004624757:13,828,338...13,837,407
|
|
G
|
Cd163
|
CD163 molecule
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624860:3,976,746...4,000,349
Ensembl chrNW_004624860:3,975,747...4,000,349
|
|
G
|
Cd274
|
CD274 molecule
|
disease_progression
|
ISO
|
associated with hepatitis B associated with hepatitis B CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:21912640 PMID:22396772 PMID:30267213 |
RGD:40818240 RGD:41410800 |
NCBI chrNW_004624736:9,991,851...10,017,047
Ensembl chrNW_004624736:9,996,156...10,013,814
|
|
G
|
Cd276
|
CD276 molecule
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:16217749 |
|
NCBI chrNW_004624781:691,348...703,202
|
|
G
|
Cd34
|
CD34 molecule
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624807:3,936,043...3,958,274
Ensembl chrNW_004624807:3,936,028...3,957,249
|
|
G
|
Cd40lg
|
CD40 ligand
|
|
ISO
|
|
RGD |
PMID:19016771 |
RGD:2313413 |
NCBI chrNW_004624808:10,472,028...10,484,407
Ensembl chrNW_004624808:10,472,572...10,484,338
|
|
G
|
Cd5l
|
CD5 molecule like
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624794:3,060,436...3,071,570
Ensembl chrNW_004624794:3,060,365...3,072,801
|
|
G
|
Cd68
|
CD68 molecule
|
severity
|
ISO
|
protein:increased expression:liver (human)
|
RGD |
PMID:28656201 |
RGD:40924686 |
NCBI chrNW_004624786:10,195,337...10,197,963
|
|
G
|
Cdc20
|
cell division cycle 20
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624892:2,675,980...2,679,709
Ensembl chrNW_004624892:2,675,754...2,679,793
|
|
G
|
Cdc25c
|
cell division cycle 25C
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624743:31,099,320...31,123,808
Ensembl chrNW_004624743:31,099,268...31,124,262
|
|
G
|
Cdc27
|
cell division cycle 27
|
|
ISO
|
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
|
ClinVar |
|
|
NCBI chrNW_004624849:2,026,433...2,105,626
Ensembl chrNW_004624849:2,026,425...2,092,857
|
|
G
|
Cdc45
|
cell division cycle 45
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624747:132,731...161,590
Ensembl chrNW_004624747:132,835...161,553
|
|
G
|
Cdc6
|
cell division cycle 6
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624795:2,980,334...2,992,579
Ensembl chrNW_004624795:2,980,185...2,992,330
|
|
G
|
Cdca2
|
cell division cycle associated 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624758:20,490,902...20,537,171
Ensembl chrNW_004624758:20,491,118...20,538,653
|
|
G
|
Cdca3
|
cell division cycle associated 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624860:3,516,244...3,519,107
Ensembl chrNW_004624860:3,515,411...3,518,828
|
|
G
|
Cdca5
|
cell division cycle associated 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624767:21,321,286...21,327,780
|
|
G
|
Cdca8
|
cell division cycle associated 8
|
disease_progression
|
ISO
|
mRNA:increased expression:liver (human) CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:28284560 PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004624764:20,418,342...20,433,763
Ensembl chrNW_004624764:20,418,585...20,434,026
|
|
G
|
Cdh1
|
cadherin 1
|
severity
|
ISO
|
mRNA:increased expression:liver protein:decreased expression:liver DNA:hypermethylation
|
RGD |
PMID:17295234 PMID:18837082 PMID:24840851 PMID:30697077 |
RGD:14402045 RGD:14402046 RGD:14402047 RGD:2289638 |
NCBI chrNW_004624746:17,480,472...17,557,722
Ensembl chrNW_004624746:17,483,469...17,557,581
|
|
G
|
Cdh13
|
cadherin 13
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18425332 PMID:18553387 PMID:28284560 |
|
NCBI chrNW_004624746:3,696,608...4,759,693
Ensembl chrNW_004624746:3,698,196...4,759,442
|
|
G
|
Cdk1
|
cyclin dependent kinase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human)
|
CTD RGD |
PMID:19136513 PMID:28284560 |
RGD:2316317 |
NCBI chrNW_004624791:2,891,239...2,915,001
|
|
G
|
Cdk12
|
cyclin dependent kinase 12
|
exacerbates
|
ISO
|
mRNA, protein:increased expression:liver (human)
|
RGD |
PMID:31519701 |
RGD:151361172 |
NCBI chrNW_004624795:3,490,081...3,564,144
Ensembl chrNW_004624795:3,512,429...3,562,515
|
|
G
|
Cdk13
|
cyclin dependent kinase 13
|
onset
|
ISO
|
DNA:amplification: :
|
RGD |
PMID:22912832 |
RGD:155641228 |
NCBI chrNW_004624740:21,100,780...21,202,147
Ensembl chrNW_004624740:21,105,212...21,202,111
|
|
G
|
Cdk14
|
cyclin dependent kinase 14
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22922871 |
|
NCBI chrNW_004624809:2,067,985...2,688,847
Ensembl chrNW_004624809:2,155,554...2,688,759
|
|
G
|
Cdk4
|
cyclin dependent kinase 4
|
treatment
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:26189965 PMID:33841550 |
RGD:152998960 |
NCBI chrNW_004624802:10,191,679...10,194,585
Ensembl chrNW_004624802:10,191,014...10,194,275
|
|
G
|
Cdkn1a
|
cyclin dependent kinase inhibitor 1A
|
|
ISO
|
OMIM:114550
|
MouseDO |
|
|
NCBI chrNW_004624754:21,109,074...21,115,869
Ensembl chrNW_004624754:21,108,874...21,115,885
|
|
G
|
Cdkn1b
|
cyclin dependent kinase inhibitor 1B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20698225 |
|
NCBI chrNW_004624752:25,202,474...25,207,107
Ensembl chrNW_004624752:25,203,474...25,207,114
|
|
G
|
Cdkn1c
|
cyclin dependent kinase inhibitor 1C
|
severity
|
ISO
|
protein:decreased expression:liver (human)
|
RGD |
PMID:26606000 |
RGD:11354707 |
NCBI chrNW_004624767:15,642,991...15,645,648
Ensembl chrNW_004624767:15,642,012...15,645,664
|
|
G
|
Cdkn2b
|
cyclin dependent kinase inhibitor 2B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:33010264 |
|
NCBI chrNW_004624736:25,929,314...25,933,318
Ensembl chrNW_004624736:25,926,668...25,933,440
|
|
G
|
Cdkn2c
|
cyclin dependent kinase inhibitor 2C
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624859:2,092,622...2,097,628
Ensembl chrNW_004624859:2,091,734...2,097,659
|
|
G
|
Cdkn3
|
cyclin dependent kinase inhibitor 3
|
severity treatment
|
ISO
|
protein:decreased expression:liver CTD Direct Evidence: marker/mechanism associated with alcoholism; protein:increased expression:liver mRNA:increased expression:liver
|
RGD CTD |
PMID:22390936 PMID:23292002 PMID:27314282 PMID:28284560 |
RGD:15090800 RGD:15090801 RGD:15090802 |
NCBI chrNW_004624731:14,838,555...14,853,588
Ensembl chrNW_004624731:14,838,561...14,852,554
|
|
G
|
Cdt1
|
chromatin licensing and DNA replication factor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624746:808,463...813,464
Ensembl chrNW_004624746:809,252...812,993
|
|
G
|
Cebpa
|
CCAAT enhancer binding protein alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16288022 PMID:21785164 |
|
NCBI chrNW_004624794:9,809,007...9,813,418
|
|
G
|
Cebpb
|
CCAAT enhancer binding protein beta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (human)
|
CTD RGD |
PMID:14563831 PMID:30659195 |
RGD:40903042 |
NCBI chrNW_004624790:5,367,808...5,369,686
Ensembl chrNW_004624790:5,368,349...5,369,377
|
|
G
|
Cebpd
|
CCAAT enhancer binding protein delta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:14563831 |
|
NCBI chrNW_004624735:7,721,564...7,722,823
Ensembl chrNW_004624735:7,721,633...7,722,445
|
|
G
|
Celsr3
|
cadherin EGF LAG seven-pass G-type receptor 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624730:2,650,096...2,675,930
Ensembl chrNW_004624730:2,651,756...2,675,923
|
|
G
|
Cenpa
|
centromere protein A
|
|
ISO
|
protein:increased expression:liver (human) CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:21956590 PMID:28284560 |
RGD:36947377 |
NCBI chrNW_004624738:8,899,260...8,906,379
Ensembl chrNW_004624738:8,899,362...8,906,373
|
|
G
|
Cenpe
|
centromere protein E
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624830:4,930,533...4,986,437
Ensembl chrNW_004624830:4,930,555...4,986,076
|
|
G
|
Cenpf
|
centromere protein F
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624771:19,657,489...19,702,506
Ensembl chrNW_004624771:19,656,981...19,702,625
|
|
G
|
Cenpm
|
centromere protein M
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624752:6,781,504...6,790,520
Ensembl chrNW_004624752:6,781,529...6,790,518
|
|
G
|
Cenpu
|
centromere protein U
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624769:15,450,423...15,491,393
|
|
G
|
Cenpw
|
centromere protein W
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624753:888,495...896,617
Ensembl chrNW_004624753:887,689...896,931
|
|
G
|
Cep131
|
centrosomal protein 131
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624801:10,212,489...10,251,015
Ensembl chrNW_004624801:10,226,629...10,248,829
|
|
G
|
Cep164
|
centrosomal protein 164
|
susceptibility
|
ISO
|
associated with Chronic Hepatitis C;DNA:SNP: :rs573455 (human)
|
RGD |
PMID:22004425 |
RGD:151665169 |
NCBI chrNW_004624784:12,754,685...12,837,440
Ensembl chrNW_004624784:12,773,870...12,836,107
|
|
G
|
Cep55
|
centrosomal protein 55
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624737:4,718,904...4,741,317
Ensembl chrNW_004624737:4,718,883...4,740,489
|
|
G
|
Cetp
|
cholesteryl ester transfer protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624746:29,035,282...29,053,867
|
|
G
|
Cfp
|
complement factor properdin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624978:180,352...194,467
Ensembl chrNW_004624978:184,286...190,970
|
|
G
|
Chaf1b
|
chromatin assembly factor 1 subunit B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624745:27,094,302...27,117,957
Ensembl chrNW_004624745:27,095,361...27,117,669
|
|
G
|
Chd4
|
chromodomain helicase DNA binding protein 4
|
exacerbates
|
ISO
|
mRNA:increased expression:liver (human) protein:increased expression:liver (human)
|
RGD |
PMID:26095183 PMID:28486105 PMID:32070428 |
RGD:11571740 RGD:153323299 RGD:153323308 |
NCBI chrNW_004624860:3,285,086...3,318,939
Ensembl chrNW_004624860:3,283,837...3,318,985
|
|
G
|
Chd5
|
chromodomain helicase DNA binding protein 5
|
|
ISO
|
mRNA:decreased expression:liver
|
RGD |
PMID:26517514 |
RGD:11537550 |
NCBI chrNW_004624818:5,203,200...5,251,057
Ensembl chrNW_004624818:5,203,304...5,249,033
|
|
G
|
Ckap2l
|
cytoskeleton associated protein 2 like
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624749:12,755,752...12,786,425
Ensembl chrNW_004624749:12,756,817...12,786,361
|
|
G
|
Ckap4
|
cytoskeleton associated protein 4
|
disease_progression
|
ISO
|
associated with tumor vascularization; mRNA,protein:increased expression:liver tumor (human)
|
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chrNW_004624750:3,067,167...3,079,095
|
|
G
|
Cldn1
|
claudin 1
|
severity
|
ISO
|
associated with liver cirrhosis;protein:increased expression:liver (human) protein:decreased expression:liver (human)
|
RGD |
PMID:17270214 PMID:24696415 PMID:24815833 |
RGD:26884345 RGD:26884348 RGD:26884352 |
NCBI chrNW_004624730:66,885,674...66,902,345
Ensembl chrNW_004624730:66,885,319...66,903,079
|
|
G
|
Clec4g
|
C-type lectin domain family 4 member G
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624828:775,114...778,526
Ensembl chrNW_004624828:773,569...778,615
|
|
G
|
Clptm1l
|
CLPTM1 like
|
susceptibility disease_progression
|
ISO
|
DNA:SNPs::rs401681(human) DNA:SNP: :rs401681(human)
|
RGD |
PMID:25339005 PMID:29042796 |
RGD:150530496 RGD:150537100 |
NCBI chrNW_004624751:652,857...669,400
Ensembl chrNW_004624751:652,767...669,587
|
|
G
|
Cltrn
|
collectrin, amino acid transport regulator
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624829:412,797...447,076
Ensembl chrNW_004624829:412,532...446,938
|
|
G
|
Cndp1
|
carnosine dipeptidase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624806:6,113,052...6,169,943
Ensembl chrNW_004624806:6,113,227...6,169,745
|
|
G
|
Cntnap4
|
contactin associated protein family member 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624746:10,376,304...10,649,868
Ensembl chrNW_004624746:10,378,704...10,650,691
|
|
G
|
Col15a1
|
collagen type XV alpha 1 chain
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624825:1,939,685...2,041,575
|
|
G
|
Col18a1
|
collagen type XVIII alpha 1 chain
|
severity
|
ISO
|
Protein:increased expression
|
RGD |
PMID:15739185 |
RGD:1600906 |
NCBI chrNW_004624745:30,754,654...30,792,352
Ensembl chrNW_004624745:30,754,820...30,791,426
|
|
G
|
Colec10
|
collectin subfamily member 10
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624763:17,302,075...17,350,682
Ensembl chrNW_004624763:17,301,993...17,352,559
|
|
G
|
Comt
|
catechol-O-methyltransferase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15341023 |
|
NCBI chrNW_004624747:569,127...588,479
Ensembl chrNW_004624747:581,832...588,333
|
|
G
|
Cops5
|
COP9 signalosome subunit 5
|
severity
|
ISO
|
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human)
|
CTD RGD |
PMID:20698225 PMID:26606000 |
RGD:11354707 |
NCBI chrNW_004624744:24,287,278...24,308,171
Ensembl chrNW_004624744:24,287,443...24,308,024
|
|
G
|
Cp
|
ceruloplasmin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19229483 |
|
NCBI chrNW_004624730:26,458,554...26,510,796
Ensembl chrNW_004624730:26,462,550...26,511,078
|
|
G
|
Cpeb3
|
cytoplasmic polyadenylation element binding protein 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624737:3,352,064...3,570,317
Ensembl chrNW_004624737:3,355,360...3,542,731
|
|
G
|
Cps1
|
carbamoyl-phosphate synthase 1
|
disease_progression
|
ISO
|
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
|
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chrNW_004624765:5,527,029...5,652,343
Ensembl chrNW_004624765:5,528,112...5,651,415
|
|
G
|
Crebbp
|
CREB binding protein
|
|
ISO
|
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: LIVER CELL CARCINOMA
|
ClinVar |
PMID:21390126 PMID:21680795 PMID:21796119 PMID:22832583 PMID:23334668 PMID:23685749 PMID:23778141 PMID:25741868 PMID:26087898 PMID:26619011 PMID:27257180 PMID:28492532 PMID:28970362 PMID:29551561 PMID:33560380 More...
|
|
NCBI chrNW_004624824:1,516,481...1,655,364
Ensembl chrNW_004624824:1,517,966...1,655,329
|
|
G
|
Crhbp
|
corticotropin releasing hormone binding protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624869:1,412,541...1,423,891
Ensembl chrNW_004624869:1,412,499...1,423,932
|
|
G
|
Crp
|
C-reactive protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19363144 |
|
NCBI chrNW_004624794:1,531,555...1,533,804
Ensembl chrNW_004624794:1,531,571...1,533,804
|
|
G
|
Csf1r
|
colony stimulating factor 1 receptor
|
exacerbates severity
|
ISO
|
DNA:hypomethylation mRNA:increased expression:liver (human) DNA:hypomethylation:promoter (human) protein:increased expression: liver (human) protein:increased expression:liver (human)
|
RGD |
PMID:11412385 PMID:14969845 PMID:20551429 PMID:32724427 PMID:32760707 |
RGD:150524279 RGD:150524282 RGD:150524286 RGD:150524301 RGD:150524302 |
NCBI chrNW_004624774:9,363,156...9,391,939
Ensembl chrNW_004624774:9,363,908...9,391,986
|
|
G
|
Csf2
|
colony stimulating factor 2
|
treatment
|
ISO
|
|
RGD |
PMID:12731087 |
RGD:10450243 |
NCBI chrNW_004624733:40,039,127...40,041,294
Ensembl chrNW_004624733:40,039,414...40,041,294
|
|
G
|
Csk
|
C-terminal Src kinase
|
|
ISO
|
protein:decreased expression:liver
|
RGD |
PMID:9918913 |
RGD:5134372 |
NCBI chrNW_004624894:12,621...29,400
Ensembl chrNW_004624894:24,203...29,668
|
|
G
|
Csmd1
|
CUB and Sushi multiple domains 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624861:1,731,662...3,244,884
Ensembl chrNW_004624861:1,733,220...3,244,830
|
|
G
|
Cspg4
|
chondroitin sulfate proteoglycan 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624894:564,252...595,048
Ensembl chrNW_004624894:561,683...594,878
|
|
G
|
Csrnp1
|
cysteine and serine rich nuclear protein 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624731:1,829,158...1,841,216
Ensembl chrNW_004624731:1,829,105...1,841,216
|
|
G
|
Ctla4
|
cytotoxic T-lymphocyte associated protein 4
|
susceptibility
|
ISO
|
protein:increased expression:CD4+ and CD8+ T cells: DNA:SNPs: :rs231775,rs231725(human)
|
RGD |
PMID:23432218 PMID:28648905 |
RGD:14398741 RGD:14398742 |
NCBI chrNW_004624765:12,449,205...12,454,324
Ensembl chrNW_004624765:12,449,205...12,454,324
|
|
G
|
Ctnnb1
|
catenin beta 1
|
severity susceptibility exacerbates
|
ISO
|
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar Annotator: match by term: AXIN1-related condition | ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma | ClinVar Annotator: match by term: LIVER CELL CARCINOMA DNA:Mutations:exon: associated with hepatitis B;DNA:SNPs: :rs3864004,rs11564475(human) associated with Hepatitis B, Chronic,DNA:SNP, haplotype: :rs3864004 (human) DNA:missense mutations:exon 3:multiple (human)
|
OMIM ClinVar RGD |
PMID:9065402 PMID:9065403 PMID:9294210 PMID:9500465 PMID:9927029 PMID:10027390 PMID:10192393 PMID:10391090 PMID:10398436 PMID:10435629 PMID:10655994 PMID:10666372 PMID:11351304 PMID:11930117 PMID:11950921 PMID:12124804 PMID:15133491 PMID:19101982 PMID:19234609 PMID:21903672 PMID:23033978 PMID:23265383 PMID:24614104 PMID:24728327 PMID:24788118 PMID:25157968 PMID:25326635 PMID:25326669 PMID:25741868 PMID:26350204 PMID:26502894 PMID:26619011 PMID:26822237 PMID:26968103 PMID:27276713 PMID:27915094 PMID:27959697 PMID:28328801 PMID:28333917 PMID:28492532 PMID:28575650 PMID:29682453 PMID:30640974 PMID:31526516 More...
|
RGD:14402039 RGD:14402040 RGD:14402052 RGD:150429592 |
NCBI chrNW_004624730:77,876,361...77,887,228
Ensembl chrNW_004624730:77,875,257...77,887,234
|
|
G
|
Ctsb
|
cathepsin B
|
|
ISO
|
|
RGD |
PMID:15641152 |
RGD:2315605 |
NCBI chrNW_004624758:25,366,120...25,384,554
Ensembl chrNW_004624758:25,366,840...25,373,954
|
|
G
|
Ctsd
|
cathepsin D
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624767:14,661,058...14,671,116
Ensembl chrNW_004624767:14,660,936...14,671,671
|
|
G
|
CUNH14orf180
|
chromosome unknown C14orf180 homolog
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624734:636,582...643,656
|
|
G
|
Cux1
|
cut like homeobox 1
|
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:30561038 |
RGD:152985541 |
NCBI chrNW_004624740:15,289,616...15,664,090
Ensembl chrNW_004624740:15,287,421...15,664,077
|
|
G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
disease_progression treatment
|
ISO
|
|
RGD |
PMID:27245433 PMID:28592115 PMID:28638480 |
RGD:27095889 RGD:27095898 RGD:27095899 |
NCBI chrNW_004624757:14,989,241...14,991,650
Ensembl chrNW_004624757:14,989,084...14,991,910
|
|
G
|
Cxcl11
|
C-X-C motif chemokine ligand 11
|
|
ISO
|
mRNA:increased expression:liver (mouse)
|
RGD |
PMID:26569409 |
RGD:11344640 |
NCBI chrNW_004624757:14,952,966...14,954,343
Ensembl chrNW_004624757:14,952,851...14,954,905
|
|
G
|
Cxcl12
|
C-X-C motif chemokine ligand 12
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19363144 PMID:28284560 |
|
NCBI chrNW_004624922:1,261,228...1,273,755
Ensembl chrNW_004624922:1,261,228...1,273,758
|
|
G
|
Cxcl14
|
C-X-C motif chemokine ligand 14
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624733:11,455,166...11,463,086
Ensembl chrNW_004624733:11,455,047...11,463,176
|
|
G
|
Cxcl8
|
C-X-C motif chemokine ligand 8
|
disease_progression susceptibility
|
ISO
|
protein:increased expression:liver (human) CTD Direct Evidence: marker/mechanism|therapeutic mRNA:increased expression:liver (human) DNA:SNPs, haplotype:multiple
|
RGD CTD |
PMID:12432545 PMID:24381110 PMID:26078356 PMID:30523154 PMID:35776891 |
RGD:11526468 RGD:26884364 RGD:26884366 |
NCBI chrNW_004624730:1,744,097...1,747,206
Ensembl chrNW_004624730:1,743,916...1,747,293
|
|
G
|
Cxcr4
|
C-X-C motif chemokine receptor 4
|
treatment severity
|
ISO
|
human cells in mouse model protein:increased expression:liver (human)
|
RGD |
PMID:30034941 PMID:33574707 |
RGD:151665327 RGD:151665331 |
NCBI chrNW_004624732:35,473,740...35,477,482
Ensembl chrNW_004624732:35,472,760...35,477,528
|
|
G
|
Cyld
|
CYLD lysine 63 deubiquitinase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21109933 |
|
NCBI chrNW_004624757:5,895,912...5,953,485
|
|
G
|
Dab2ip
|
DAB2 interacting protein
|
severity
|
ISO
|
mRNA:decreased expression:liver (human) protein:decreased expression:liver (human)
|
RGD |
PMID:22168621 PMID:31176165 |
RGD:151665110 RGD:151665148 |
NCBI chrNW_004624760:13,472,500...13,658,070
Ensembl chrNW_004624760:13,472,672...13,657,930
|
|
G
|
Dbh
|
dopamine beta-hydroxylase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624760:2,016,066...2,030,240
Ensembl chrNW_004624760:2,015,474...2,029,939
|
|
G
|
Dcn
|
decorin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624750:15,466,938...15,517,475
Ensembl chrNW_004624750:15,470,968...15,516,365
|
|
G
|
Ddr1
|
discoidin domain receptor tyrosine kinase 1
|
severity
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:33173221 |
RGD:151347691 |
NCBI chrNW_004624754:24,881,439...24,905,633
Ensembl chrNW_004624754:24,880,496...24,896,995
|
|
G
|
Ddr2
|
discoidin domain receptor tyrosine kinase 2
|
treatment disease_progression
|
ISO
|
|
RGD |
PMID:26362312 PMID:33969575 |
RGD:11086753 RGD:150429748 |
NCBI chrNW_004624826:1,225,217...1,255,889
Ensembl chrNW_004624826:1,173,621...1,249,692
|
|
G
|
Ddx3x
|
DEAD-box helicase 3 X-linked
|
sexual_dimorphism exacerbates
|
ISO
|
associated with hepatitis B; mRNA,protein:decreased expression:liver (human)
|
RGD |
PMID:16301996 PMID:30297359 |
RGD:151356499 RGD:151356660 |
NCBI chrNW_004624762:14,290,267...14,305,437
Ensembl chrNW_004624762:14,290,267...14,305,633
|
|
G
|
Depdc1
|
DEP domain containing 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624742:27,240,906...27,288,872
Ensembl chrNW_004624742:27,240,342...27,258,681
|
|
G
|
Depdc1b
|
DEP domain containing 1B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624815:9,289,221...9,372,580
Ensembl chrNW_004624815:9,289,292...9,371,716
|
|
G
|
Depdc5
|
DEP domain containing 5, GATOR1 subcomplex subunit
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21725309 |
|
NCBI chrNW_004624747:8,169,035...8,310,945
Ensembl chrNW_004624747:8,168,321...8,310,457
|
|
G
|
Dhfr
|
dihydrofolate reductase
|
|
ISO
|
ClinVar Annotator: match by term: Hepatocellular cancer
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004624743:1,446,643...1,462,319
Ensembl chrNW_004624743:1,446,643...1,461,863
|
|
G
|
Dicer1
|
dicer 1, ribonuclease III
|
susceptibility
|
ISO
|
associated with hepatitis B; DNA:SNP: :rs1057035 T>C (human)
|
RGD |
PMID:23868705 |
RGD:149735346 |
NCBI chrNW_004624734:7,604,049...7,681,481
Ensembl chrNW_004624734:7,608,273...7,651,819
|
|
G
|
Dipk2b
|
divergent protein kinase domain 2B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624887:1,321,247...1,361,036
Ensembl chrNW_004624887:1,326,336...1,361,124
|
|
G
|
Dlgap5
|
DLG associated protein 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624731:14,264,378...14,298,170
Ensembl chrNW_004624731:14,264,298...14,299,646
|
|
G
|
Dlk1
|
delta like non-canonical Notch ligand 1
|
|
ISO
|
mRNA:increased expression:liver (mouse)
|
RGD |
PMID:26569409 |
RGD:11344640 |
NCBI chrNW_004624734:3,363,084...3,372,790
Ensembl chrNW_004624734:3,363,001...3,372,694
|
|
G
|
Dmgdh
|
dimethylglycine dehydrogenase
|
disease_progression
|
ISO
|
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
|
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chrNW_004624869:3,498,851...3,576,341
Ensembl chrNW_004624869:3,500,293...3,576,245
|
|
G
|
Dnajc6
|
DnaJ heat shock protein family (Hsp40) member C6
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624742:29,397,811...29,525,886
Ensembl chrNW_004624742:29,398,544...29,485,165
|
|
G
|
Dnase1l3
|
deoxyribonuclease 1L3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624821:845,631...871,156
Ensembl chrNW_004624821:849,434...871,609
|
|
G
|
Dnmt1
|
DNA methyltransferase 1
|
|
ISO
|
mRNA, protein:increased expression:liver
|
RGD |
PMID:11844796 |
RGD:2289670 |
NCBI chrNW_004624828:2,316,042...2,358,866
Ensembl chrNW_004624828:2,315,251...2,358,711
|
|
G
|
Dnmt3a
|
DNA methyltransferase 3 alpha
|
|
ISO
|
protein:increased expression:liver: mRNA, protein:increased expression:liver
|
RGD |
PMID:11844796 PMID:15885882 |
RGD:2289670 RGD:9588598 |
NCBI chrNW_004624738:7,481,084...7,581,332
Ensembl chrNW_004624738:7,485,842...7,581,056
|
|
G
|
Dnmt3b
|
DNA methyltransferase 3 beta
|
|
ISO
|
mRNA:increased expression:liver: mRNA, protein:increased expression:liver
|
RGD |
PMID:11844796 PMID:15885882 |
RGD:2289670 RGD:9588598 |
NCBI chrNW_004624842:6,450,972...6,505,929
Ensembl chrNW_004624842:6,450,852...6,475,785
|
|
G
|
Dsn1
|
DSN1 component of MIS12 kinetochore complex
|
disease_progression
|
ISO
|
|
RGD |
PMID:30136646 |
RGD:27372884 |
NCBI chrNW_004624842:2,738,739...2,762,968
Ensembl chrNW_004624842:2,738,734...2,760,783
|
|
G
|
Dtl
|
denticleless E3 ubiquitin protein ligase homolog
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624771:17,612,264...17,660,772
Ensembl chrNW_004624771:17,612,284...17,662,405
|
|
G
|
Dynlrb1
|
dynein light chain roadblock-type 1
|
|
ISO
|
|
RGD |
PMID:11750132 |
RGD:13208527 |
NCBI chrNW_004624842:4,817,469...4,837,843
Ensembl chrNW_004624842:4,817,469...4,837,824
|
|
G
|
Dynlrb2
|
dynein light chain roadblock-type 2
|
|
ISO
|
|
RGD |
PMID:11750132 |
RGD:13208527 |
NCBI chrNW_004624746:6,805,245...6,814,227
Ensembl chrNW_004624746:6,804,890...6,814,724
|
|
G
|
E2f1
|
E2F transcription factor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12029619 PMID:15565109 PMID:28284560 |
|
NCBI chrNW_004624842:5,602,432...5,612,951
Ensembl chrNW_004624842:5,602,432...5,612,951
|
|
G
|
E2f8
|
E2F transcription factor 8
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624766:10,652,749...10,670,886
Ensembl chrNW_004624766:10,652,745...10,669,909
|
|
G
|
Eaf2
|
ELL associated factor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20564326 |
|
NCBI chrNW_004624912:112,793...168,553
Ensembl chrNW_004624912:112,843...168,553
|
|
G
|
Ecm1
|
extracellular matrix protein 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624772:18,234,537...18,239,896
Ensembl chrNW_004624772:18,233,727...18,240,601
|
|
G
|
Ect2
|
epithelial cell transforming 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624730:50,773,465...50,841,427
Ensembl chrNW_004624730:50,773,566...50,840,510
|
|
G
|
Eef2
|
eukaryotic translation elongation factor 2
|
exacerbates
|
ISO
|
protein:increased expression, increased phosphorylation:liver (human)
|
RGD |
PMID:28060762 |
RGD:153298915 |
NCBI chrNW_004624828:5,601,906...5,609,978
Ensembl chrNW_004624828:5,601,444...5,611,405
|
|
G
|
Efemp1
|
EGF containing fibulin extracellular matrix protein 1
|
disease_progression
|
ISO
|
protein:decreased expression:liver:
|
RGD |
PMID:23936443 |
RGD:10401793 |
NCBI chrNW_004624833:5,654,805...5,722,185
Ensembl chrNW_004624833:5,654,016...5,723,519
|
|
G
|
Eftud2
|
elongation factor Tu GTP binding domain containing 2
|
ameliorates severity
|
ISO
|
|
RGD |
PMID:34282556 |
RGD:155791664 |
NCBI chrNW_004624795:407,228...435,578
Ensembl chrNW_004624795:407,598...438,734
|
|
G
|
Egfr
|
epidermal growth factor receptor
|
disease_progression
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:9029167 PMID:11355950 |
RGD:126781769 |
NCBI chrNW_004624740:584,133...713,205
Ensembl chrNW_004624740:589,606...713,271
|
|
G
|
Egr1
|
early growth response 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624743:31,247,855...31,251,675
Ensembl chrNW_004624743:31,247,516...31,252,205
|
|
G
|
Egr2
|
early growth response 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624791:953,009...959,656
Ensembl chrNW_004624791:955,161...959,791
|
|
G
|
Ehd3
|
EH domain containing 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624738:13,033,491...13,062,795
Ensembl chrNW_004624738:13,032,604...13,062,795
|
|
G
|
Eif3h
|
eukaryotic translation initiation factor 3 subunit H
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:14578863 |
|
NCBI chrNW_004624763:14,938,624...15,027,001
Ensembl chrNW_004624763:14,935,271...15,027,010
|
|
G
|
Enah
|
ENAH actin regulator
|
disease_progression
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:35030977 |
RGD:155791678 |
NCBI chrNW_004624835:6,292,808...6,442,349
|
|
G
|
Eng
|
endoglin
|
|
ISO
|
protein:increased expression:liver (rat)
|
RGD |
PMID:20368095 |
RGD:7257538 |
NCBI chrNW_004624760:7,703,979...7,735,636
Ensembl chrNW_004624760:7,703,820...7,734,457
|
|
G
|
Eno1
|
enolase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624818:3,223,384...3,235,128
Ensembl chrNW_004624818:3,223,308...3,238,419
|
|
G
|
Epas1
|
endothelial PAS domain protein 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:26735578 |
|
NCBI chrNW_004624738:27,747,770...27,831,213
Ensembl chrNW_004624738:27,747,696...27,834,054
|
|
G
|
Epcam
|
epithelial cell adhesion molecule
|
severity
|
ISO
|
protein:increased expression:liver
|
RGD |
PMID:24616575 |
RGD:14695007 |
NCBI chrNW_004624738:28,755,039...28,770,160
Ensembl chrNW_004624738:28,754,602...28,770,758
|
|
G
|
Ephb1
|
EPH receptor B1
|
|
ISO
|
protein:increased phosphorylation:liver (mouse)
|
RGD |
PMID:28100771 |
RGD:127285675 |
NCBI chrNW_004624730:11,120,018...11,564,972
Ensembl chrNW_004624730:11,119,909...11,565,293
|
|
G
|
Ephx1
|
epoxide hydrolase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:7892276 |
|
NCBI chrNW_004624835:6,161,930...6,181,016
Ensembl chrNW_004624835:6,162,111...6,168,714
|
|
G
|
Eps8l3
|
EPS8 signaling adaptor L3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624772:5,502,020...5,515,704
|
|
G
|
Erbb3
|
erb-b2 receptor tyrosine kinase 3
|
disease_progression
|
ISO
|
|
RGD |
PMID:11355950 |
RGD:126781769 |
NCBI chrNW_004624802:11,906,279...11,925,530
Ensembl chrNW_004624802:11,905,271...11,925,707
|
|
G
|
Erbb4
|
erb-b2 receptor tyrosine kinase 4
|
|
ISO
|
DNA:insertion/deletion:3'UTR:rs6147150 (human)
|
RGD |
PMID:22294845 |
RGD:126781763 |
NCBI chrNW_004624765:3,612,781...4,742,219
Ensembl chrNW_004624765:3,613,379...4,734,585
|
|
G
|
Ercc1
|
ERCC excision repair 1, endonuclease non-catalytic subunit
|
|
ISO
|
mRNA, protein:increased expression:liver (human)
|
RGD |
PMID:15922480 |
RGD:155598683 |
NCBI chrNW_004624907:2,288,380...2,298,909
Ensembl chrNW_004624907:2,288,423...2,298,373
|
|
G
|
Ercc2
|
ERCC excision repair 2, TFIIH core complex helicase subunit
|
susceptibility disease_progression
|
ISO
|
DNA:SNPs:exon 23: p.K751Q (human) DNA:SNP:cd: 312A>G (human) DNA:SNPs:exon 23: p.K751Q (human) DNA:SNPs:exon 23: p.K751Q (rs13181) (human)
|
RGD |
PMID:19919686 PMID:25531380 PMID:28598207 PMID:28927037 |
RGD:150530503 RGD:25671459 RGD:25671460 RGD:25671461 |
NCBI chrNW_004624907:2,249,323...2,263,999
Ensembl chrNW_004624907:2,250,133...2,263,947
|
|
G
|
Ereg
|
epiregulin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:35776891 |
|
NCBI chrNW_004624730:1,339,017...1,353,869
Ensembl chrNW_004624730:1,339,518...1,353,429
|
|
G
|
Ern1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ISO
|
DNA:hypomethylation: CpG islands:
|
RGD |
PMID:20165882 |
RGD:14694974 |
NCBI chrNW_004624849:1,521,996...1,625,878
Ensembl chrNW_004624849:1,525,235...1,625,893
|
|
G
|
Erp29
|
endoplasmic reticulum protein 29
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624747:20,167,197...20,174,914
Ensembl chrNW_004624747:20,166,371...20,175,012
|
|
G
|
Esm1
|
endothelial cell specific molecule 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624759:4,334,532...4,343,078
Ensembl chrNW_004624759:4,334,206...4,359,232
|
|
G
|
Esr1
|
estrogen receptor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19363144 PMID:28284560 |
|
NCBI chrNW_004624785:6,164,507...6,601,302
Ensembl chrNW_004624785:6,164,379...6,601,326
|
|
G
|
Etfa
|
electron transfer flavoprotein subunit alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624894:1,874,859...1,935,587
Ensembl chrNW_004624894:1,874,695...1,936,120
|
|
G
|
Exo1
|
exonuclease 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624771:12,215,957...12,230,908
|
|
G
|
Ezh2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
susceptibility
|
ISO
|
CTD Direct Evidence: marker/mechanism DNA:SNPs: :multiple mRNA:increased expression:liver mRNA:increased expression:liver (human)
|
RGD CTD |
PMID:24040354 PMID:24211739 PMID:25226601 PMID:26517514 PMID:28284560 PMID:34545456 More...
|
RGD:10755339 RGD:11537550 RGD:126779595 RGD:126779608 |
NCBI chrNW_004624800:6,781,848...6,874,221
Ensembl chrNW_004624800:6,802,901...6,874,196
|
|
G
|
F2
|
coagulation factor II, thrombin
|
severity
|
ISO
|
CTD Direct Evidence: marker/mechanism associated with liver cirrhosis;protein:altered expression, altered processing:liver (human)
|
CTD RGD |
PMID:2821104 PMID:7620113 |
RGD:14975114 |
NCBI chrNW_004624767:1,876,974...1,887,720
Ensembl chrNW_004624767:1,877,024...1,887,958
|
|
G
|
Fabp5
|
fatty acid binding protein 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624744:10,129,515...10,133,700
|
|
G
|
Fam180a
|
family with sequence similarity 180 member A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624765:16,007,155...16,019,066
Ensembl chrNW_004624765:16,006,739...16,018,976
|
|
G
|
Fam83d
|
family with sequence similarity 83 member D
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624842:757,708...782,524
Ensembl chrNW_004624842:758,273...782,524
|
|
G
|
Fancd2
|
FA complementation group D2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624731:4,577,663...4,671,086
Ensembl chrNW_004624731:4,611,963...4,671,765
|
|
G
|
Fanci
|
FA complementation group I
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624768:16,427,060...16,493,850
|
|
G
|
Fas
|
Fas cell surface death receptor
|
treatment
|
ISO
|
protein:increased expression:liver:
|
RGD |
PMID:11274632 PMID:29634416 PMID:30737368 |
RGD:13792608 RGD:14700677 RGD:14700700 |
NCBI chrNW_004624791:15,290,022...15,315,848
Ensembl chrNW_004624791:15,289,348...15,315,848
|
|
G
|
Faslg
|
Fas ligand
|
|
ISO
|
protein:increased expression:liver:
|
RGD |
PMID:11274632 |
RGD:14700677 |
NCBI chrNW_004624771:9,031,978...9,038,760
Ensembl chrNW_004624771:9,032,016...9,038,825
|
|
G
|
Fasn
|
fatty acid synthase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:14563831 PMID:15543204 PMID:21147110 |
|
NCBI chrNW_004624801:10,910,022...10,926,505
Ensembl chrNW_004624801:10,909,647...10,927,547
|
|
G
|
Fat1
|
FAT atypical cadherin 1
|
disease_progression
|
ISO
|
mRNA,protein:increased expression:liver (human)
|
RGD |
PMID:24590895 |
RGD:151347630 |
NCBI chrNW_004624769:17,801,796...17,924,685
Ensembl chrNW_004624769:17,801,894...17,925,191
|
|
G
|
Fate1
|
fetal and adult testis expressed 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15580283 |
|
NCBI chrNW_004624883:3,030,776...3,033,912
|
|
G
|
Fbp1
|
fructose-bisphosphatase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22039417 |
|
NCBI chrNW_004624753:16,019,546...16,048,096
Ensembl chrNW_004624753:16,016,022...16,048,104
|
|
G
|
Fbxl18
|
F-box and leucine rich repeat protein 18
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624740:28,098,394...28,126,181
Ensembl chrNW_004624740:28,098,310...28,126,454
|
|
G
|
Fbxo11
|
F-box protein 11
|
exacerbates ameliorates
|
ISO
|
protein:increased expression:liver (human) mRNA:increased expression:liver (human)
|
RGD |
PMID:29518611 PMID:29603830 PMID:32657545 |
RGD:152025259 RGD:152025263 RGD:152025266 |
NCBI chrNW_004624738:29,108,759...29,190,725
Ensembl chrNW_004624738:29,108,809...29,191,368
|
|
G
|
Fcn3
|
ficolin 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624764:11,265,740...11,269,588
Ensembl chrNW_004624764:11,265,505...11,269,650
|
|
G
|
Fdft1
|
farnesyl-diphosphate farnesyltransferase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21147110 |
|
NCBI chrNW_004624758:25,340,142...25,363,669
Ensembl chrNW_004624758:25,340,074...25,366,299
|
|
G
|
Fes
|
FES proto-oncogene, tyrosine kinase
|
exacerbates
|
ISO
|
DNA:hypermethylation:promoter (human)
|
RGD |
PMID:31038805 |
RGD:153323297 |
NCBI chrNW_004624768:17,360,602...17,372,563
Ensembl chrNW_004624768:17,359,196...17,372,712
|
|
G
|
Fgf19
|
fibroblast growth factor 19
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25822088 |
|
NCBI chrNW_004624767:17,434,501...17,439,351
Ensembl chrNW_004624767:17,432,358...17,438,173
|
|
G
|
Fgf3
|
fibroblast growth factor 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25822088 |
|
NCBI chrNW_004624767:17,353,989...17,360,857
Ensembl chrNW_004624767:17,353,989...17,360,705
|
|
G
|
Fgf4
|
fibroblast growth factor 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25822088 |
|
NCBI chrNW_004624767:17,381,387...17,385,698
Ensembl chrNW_004624767:17,381,791...17,383,468
|
|
G
|
Fgfr1
|
fibroblast growth factor receptor 1
|
treatment
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:16452204 PMID:20155451 PMID:21573021 PMID:36029209 |
RGD:25330358 RGD:25440476 RGD:25440478 |
NCBI chrNW_004624780:5,161,245...5,212,641
Ensembl chrNW_004624780:5,161,073...5,213,870
|
|
G
|
Fgfr2
|
fibroblast growth factor receptor 2
|
severity
|
ISO
|
associated with hepatitis B;DNA:SNPs: promoter, intron:rs308379, rs1219648 (human)
|
RGD |
PMID:30952770 |
RGD:38501096 |
NCBI chrNW_004624737:25,052,698...25,158,346
Ensembl chrNW_004624737:25,052,606...25,158,529
|
|
G
|
Fgfr4
|
fibroblast growth factor receptor 4
|
treatment
|
ISO
|
|
RGD |
PMID:32677805 |
RGD:150520166 |
NCBI chrNW_004624733:12,964,893...12,979,198
Ensembl chrNW_004624733:12,964,746...12,976,732
|
|
G
|
Fh
|
fumarate hydratase
|
|
ISO
|
ClinVar Annotator: match by term: Hepatocellular carcinoma
|
ClinVar |
PMID:10896297 PMID:15221078 PMID:16876016 PMID:17182618 PMID:18313410 PMID:19151755 PMID:20301679 PMID:21445611 PMID:25637381 PMID:25741868 PMID:28492532 PMID:28747166 More...
|
|
NCBI chrNW_004624771:11,861,537...11,886,154
Ensembl chrNW_004624771:11,856,884...11,887,066
|
|
G
|
Fhit
|
fragile histidine triad diadenosine triphosphatase
|
|
ISO
|
|
RGD |
PMID:12112319 |
RGD:632723 |
NCBI chrNW_004624822:6,621,609...8,069,590
Ensembl chrNW_004624822:6,621,909...7,380,047
|
|
G
|
Flt3
|
fms related receptor tyrosine kinase 3
|
ameliorates
|
ISO
|
human cells in mouse model
|
RGD |
PMID:27511526 |
RGD:149735514 |
NCBI chrNW_004624776:10,407,083...10,516,350
Ensembl chrNW_004624776:10,435,850...10,517,066
|
|
G
|
Flvcr1
|
FLVCR choline and heme transporter 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624771:18,239,437...18,270,408
|
|
G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:9029167 PMID:28284560 |
|
NCBI chrNW_004624734:26,424,053...26,427,431
Ensembl chrNW_004624734:26,423,079...26,427,732
|
|
G
|
Fosb
|
FosB proto-oncogene, AP-1 transcription factor subunit
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624907:2,332,746...2,338,825
Ensembl chrNW_004624907:2,328,691...2,339,099
|
|
G
|
Fosl2
|
FOS like 2, AP-1 transcription factor subunit
|
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:30086463 PMID:32048611 |
RGD:153344517 RGD:153344521 |
NCBI chrNW_004624738:10,370,479...10,391,623
Ensembl chrNW_004624738:10,370,103...10,391,623
|
|
G
|
Foxa1
|
forkhead box A1
|
susceptibility sexual_dimorphism disease_progression
|
ISO
|
DNA:VNTR, SNPs, haplotypes:multiple: protein:decreased expression:liver
|
RGD |
PMID:25965836 PMID:29208003 PMID:31400761 |
RGD:11054501 RGD:151665752 RGD:151665820 |
NCBI chrNW_004624955:234,289...239,541
Ensembl chrNW_004624955:231,506...239,508
|
|
G
|
Foxm1
|
forkhead box M1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism OMIM:114550
|
CTD MouseDO |
PMID:15082532 PMID:17173139 PMID:28284560 |
|
NCBI chrNW_004624860:206,367...222,035
Ensembl chrNW_004624860:207,242...219,959
|
|
G
|
Foxo1
|
forkhead box O1
|
|
ISO
|
mRNA:decreased expression:liver
|
RGD |
PMID:28972178 |
RGD:14401599 |
NCBI chrNW_004624748:1,413,754...1,529,646
Ensembl chrNW_004624748:1,413,983...1,529,992
|
|
G
|
Foxp1
|
forkhead box P1
|
treatment
|
ISO
|
|
RGD |
PMID:25156538 |
RGD:9587823 |
NCBI chrNW_004624773:5,543,529...6,076,522
Ensembl chrNW_004624773:5,543,536...5,883,131
|
|
G
|
Foxp3
|
forkhead box P3
|
|
ISO
|
protein:increased expression:liver
|
RGD |
PMID:21086571 |
RGD:38548919 |
NCBI chrNW_004624893:995,145...1,008,492
Ensembl chrNW_004624893:995,182...1,008,679
|
|
G
|
Fst
|
follistatin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12203361 PMID:19363144 |
|
NCBI chrNW_004624759:5,799,127...5,804,802
Ensembl chrNW_004624759:5,798,067...5,805,254
|
|
G
|
Fth1
|
ferritin heavy chain 1
|
|
ISO
|
mRNA:increased expression:liver (rat)
|
RGD |
PMID:9054589 |
RGD:632698 |
NCBI chrNW_004624926:469,870...471,142
|
|
G
|
Fubp1
|
far upstream element binding protein 1
|
ameliorates exacerbates
|
ISO
|
human cell line in a mouse model mRNA:increased expression:liver (human) associated with Chronic Hepatitis C;mRNA:increased expression:liver (human)
|
RGD |
PMID:19637194 PMID:25995247 PMID:31587040 |
RGD:151361188 RGD:151361194 RGD:151361196 |
NCBI chrNW_004624742:19,279,544...19,313,139
|
|
G
|
G6pc1
|
glucose-6-phosphatase catalytic subunit 1
|
treatment
|
ISO
|
associated with Glycogen Storage Disease IA, human gene in a mouse model
|
RGD |
PMID:28096054 |
RGD:14695537 |
NCBI chrNW_004624795:1,331,592...1,339,575
Ensembl chrNW_004624795:1,331,601...1,339,580
|
|
G
|
G6pd
|
glucose-6-phosphate dehydrogenase
|
disease_progression
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:25473368 PMID:35693827 |
RGD:10449118 RGD:153344586 |
NCBI chrNW_004624946:989,376...1,001,787
Ensembl chrNW_004624946:986,107...1,001,955
|
|
G
|
Gabrd
|
gamma-aminobutyric acid type A receptor subunit delta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624818:7,856,797...7,864,552
Ensembl chrNW_004624818:7,856,797...7,864,540
|
|
G
|
Gapdh
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16767786 PMID:21472284 |
|
NCBI chrNW_004624860:3,257,805...3,261,736
Ensembl chrNW_004624860:3,257,853...3,261,735
|
|
G
|
Gc
|
GC vitamin D binding protein
|
susceptibility
|
ISO
|
associated with Hepatitis B, Chronic;DNA:SNP: :rs7041(human) protein:increased expression:liver
|
RGD |
PMID:21683810 PMID:25541958 |
RGD:14402025 RGD:5509919 |
NCBI chrNW_004624890:3,274,239...3,318,281
Ensembl chrNW_004624890:3,226,900...3,318,316
|
|
G
|
Gdf15
|
growth differentiation factor 15
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20512989 |
|
NCBI chrNW_004624908:1,633,927...1,636,242
Ensembl chrNW_004624908:1,634,174...1,636,242
|
|
G
|
Ggt1
|
gamma-glutamyltransferase 1
|
disease_progression
|
ISO
|
RNA,protein:increased expression, activity:liver: HBV associated
|
RGD |
PMID:10572675 PMID:11940314 PMID:27793641 |
RGD:14701040 RGD:14701041 RGD:14701048 |
NCBI chrNW_004624747:10,030,034...10,048,554
|
|
G
|
Ghr
|
growth hormone receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624759:12,282,295...12,570,106
Ensembl chrNW_004624759:12,285,594...12,570,906
|
|
G
|
Gins1
|
GINS complex subunit 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624939:177,496...212,804
Ensembl chrNW_004624939:176,929...205,642
|
|
G
|
Gjb1
|
gap junction protein beta 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17978847 |
|
NCBI chrNW_004624903:1,511,347...1,519,265
Ensembl chrNW_004624903:1,517,324...1,519,265
|
|
G
|
Gjb2
|
gap junction protein beta 2
|
|
ISO
|
DNA, mRNA:promoter hypermethylation, decreased expression:liver
|
RGD |
PMID:17295234 |
RGD:2289638 |
NCBI chrNW_004624776:17,517,824...17,522,683
Ensembl chrNW_004624776:17,518,284...17,522,936
|
|
G
|
Gli1
|
GLI family zinc finger 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:26189965 |
|
NCBI chrNW_004624802:10,483,279...10,494,539
Ensembl chrNW_004624802:10,483,219...10,498,609
|
|
G
|
Glul
|
glutamate-ammonia ligase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19363144 |
|
NCBI chrNW_004624771:2,608,779...2,618,130
|
|
G
|
Gmnn
|
geminin DNA replication inhibitor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624756:2,268,304...2,335,021
Ensembl chrNW_004624756:2,268,304...2,278,129
|
|
G
|
Gmps
|
guanine monophosphate synthase
|
|
ISO
|
protein:increased activity:hepatoma (rat)
|
RGD |
PMID:6861338 |
RGD:5135537 |
NCBI chrNW_004624730:33,459,059...33,535,593
Ensembl chrNW_004624730:33,460,566...33,535,593
|
|
G
|
Gnao1
|
G protein subunit alpha o1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624757:178,616...346,443
|
|
G
|
Gnas
|
GNAS complex locus
|
|
ISO
|
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
|
ClinVar |
PMID:1517386 PMID:1594625 PMID:1944469 PMID:2549426 PMID:3720010 PMID:7739708 PMID:8766942 PMID:9626141 PMID:11093740 PMID:12727968 PMID:12970318 PMID:15126527 PMID:15952988 PMID:16507630 PMID:21835143 PMID:23403822 PMID:23536913 PMID:23843956 PMID:24855271 PMID:25157968 PMID:25719192 PMID:25741868 PMID:26619011 PMID:27398169 PMID:30702195 More...
|
|
NCBI chrNW_004624741:25,138,678...25,197,194
Ensembl chrNW_004624741:25,183,329...25,196,880
|
|
G
|
Gnaz
|
G protein subunit alpha z
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624747:9,425,720...9,479,571
Ensembl chrNW_004624747:9,425,775...9,480,162
|
|
G
|
Golm1
|
golgi membrane protein 1
|
severity
|
ISO
|
protein:increased expression:serum mRNA, protein:increased expression:liver
|
RGD |
PMID:21140449 PMID:21443671 |
RGD:401827118 RGD:401827119 |
NCBI chrNW_004624809:9,485,832...9,555,889
Ensembl chrNW_004624809:9,486,724...9,534,333
|
|
G
|
Gpc1
|
glypican 1
|
disease_progression
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004624847:4,832,610...4,853,849
Ensembl chrNW_004624847:4,832,488...4,853,851
|
|
G
|
Gpc3
|
glypican 3
|
severity disease_progression exacerbates treatment
|
ISO
|
protein:increased expression:liver protein:increased expression:blood serum (human) mRNA,protein:increased expression:peripheral blood mononuclear cell,blood serum, liver (human) mRNA:increased expression:Peripheral Blood (human) protein:increased expression:liver (human) CTD Direct Evidence: marker/mechanism protein:increased expression:serum
|
RGD CTD |
PMID:16698587 PMID:19496787 PMID:21438004 PMID:22883669 PMID:23558072 PMID:25449037 PMID:27286460 PMID:28284560 PMID:28801286 More...
|
RGD:14695019 RGD:14695020 RGD:243065125 RGD:243065131 RGD:243065134 RGD:243065135 RGD:243065139 |
NCBI chrNW_004624797:13,234,741...13,678,542
Ensembl chrNW_004624797:13,230,932...13,678,742
|
|
G
|
Gpm6a
|
glycoprotein M6A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624769:6,763,158...7,082,764
Ensembl chrNW_004624769:6,762,743...6,904,757
|
|
G
|
Gpr158
|
G protein-coupled receptor 158
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624796:3,299,535...3,806,346
Ensembl chrNW_004624796:3,302,496...3,806,219
|
|
G
|
Gpr182
|
G protein-coupled receptor 182
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624802:10,936,114...10,939,614
Ensembl chrNW_004624802:10,936,619...10,939,603
|
|
G
|
Gpx1
|
glutathione peroxidase 1
|
severity no_association susceptibility
|
ISO
|
associated with hepatitis C;DNA:missense mutation:CDS:p.P198L (rs1050450) (human) DNA:missense mutation:CDS:p.P198L (human) associated with alcoholic liver cirrhosis;DNA:missense mutation:CDS:p.P198L (human)
|
RGD |
PMID:16510607 PMID:19929244 PMID:25894370 PMID:26990426 |
RGD:11533013 RGD:151708729 RGD:152995483 RGD:152998906 |
NCBI chrNW_004624730:3,313,773...3,314,870
Ensembl chrNW_004624730:3,313,972...3,314,626
|
|
G
|
Gpx3
|
glutathione peroxidase 3
|
severity disease_progression
|
ISO
|
mRNA,protein:decreased expression:liver, blood plasma (human) DNA:hypermethylation
|
RGD |
PMID:25333265 PMID:25445749 PMID:27570561 |
RGD:151665355 RGD:151665509 RGD:401827855 |
NCBI chrNW_004624733:40,957,895...40,963,469
Ensembl chrNW_004624733:40,957,999...40,962,993
|
|
G
|
Grb7
|
growth factor receptor bound protein 7
|
exacerbates
|
ISO
|
protein:increased expression:liver (human)
|
RGD |
PMID:17634422 |
RGD:151347655 |
NCBI chrNW_004624795:3,359,119...3,366,802
Ensembl chrNW_004624795:3,357,469...3,365,425
|
|
G
|
Gtse1
|
G2 and S-phase expressed 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624752:3,554,960...3,580,180
Ensembl chrNW_004624752:3,555,283...3,572,409
|
|
G
|
Gys2
|
glycogen synthase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624752:17,090,741...17,145,823
Ensembl chrNW_004624752:17,090,563...17,143,493
|
|
G
|
Hamp
|
hepcidin antimicrobial peptide
|
|
ISO
|
DNA:hypermethylation,hypomethylation:promoter CTD Direct Evidence: marker/mechanism mRNA:decreased expression:liver (human)
|
RGD CTD |
PMID:28284560 PMID:29235098 |
RGD:15042879 |
NCBI chrNW_004624794:8,257,760...8,259,243
Ensembl chrNW_004624794:8,257,760...8,259,264
|
|
G
|
Hao2
|
hydroxyacid oxidase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624772:14,981,777...15,022,699
Ensembl chrNW_004624772:14,981,666...15,023,173
|
|
G
|
Havcr1
|
hepatitis A virus cellular receptor 1
|
disease_progression
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004624733:32,284,793...32,310,980
|
|
G
|
Havcr2
|
hepatitis A virus cellular receptor 2
|
disease_progression
|
ISO
|
associated with hepatitis B;DNA:SNP: : ���1516 G>T (human)
|
RGD |
PMID:27034168 |
RGD:40818257 |
NCBI chrNW_004624733:32,521,318...32,527,499
|
|
G
|
Hdac2
|
histone deacetylase 2
|
disease_progression
|
ISO
|
mRNA:increased expression:liver:
|
RGD |
PMID:24448241 |
RGD:9590206 |
NCBI chrNW_004624856:4,834,197...4,861,546
Ensembl chrNW_004624856:4,834,217...4,861,592
|
|
G
|
Hdac4
|
histone deacetylase 4
|
|
ISO
|
mRNA:increased expression:liver:
|
RGD |
PMID:21837748 |
RGD:9681451 |
NCBI chrNW_004624847:3,846,196...4,101,537
Ensembl chrNW_004624847:3,845,858...4,101,487
|
|
G
|
Herc5
|
HECT and RLD domain containing E3 ubiquitin protein ligase 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28919514 |
|
NCBI chrNW_004624757:16,108,509...16,151,654
Ensembl chrNW_004624757:16,028,668...16,152,628
|
|
G
|
Hfe
|
homeostatic iron regulator
|
disease_progression
|
ISO
|
associated with Liver Cirrhosis;DNA:missense mutation:cds:p.C282Y (human)
|
RGD |
PMID:20019189 PMID:29642405 |
RGD:14746967 RGD:2317357 |
NCBI chrNW_004624756:821,738...831,482
Ensembl chrNW_004624756:823,947...831,376
|
|
G
|
Hgf
|
hepatocyte growth factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:9932610 PMID:11896611 |
|
NCBI chrNW_004624739:30,233,589...30,307,508
Ensembl chrNW_004624739:30,236,146...30,307,356
|
|
G
|
Hgfac
|
HGF activator
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19363144 |
|
NCBI chrNW_004624755:24,483,358...24,488,505
Ensembl chrNW_004624755:24,483,431...24,488,450
|
|
G
|
Hhip
|
hedgehog interacting protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18559595 |
|
NCBI chrNW_004624853:3,649,974...3,739,344
Ensembl chrNW_004624853:3,649,967...3,735,834
|
|
G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
treatment disease_progression
|
ISO
|
protein:increased expression:liver (human)
|
RGD |
PMID:19335982 PMID:26078356 PMID:31321740 |
RGD:11526468 RGD:155882550 RGD:9068886 |
NCBI chrNW_004624734:39,414,458...39,471,705
Ensembl chrNW_004624734:39,411,824...39,471,705
|
|
G
|
Hilpda
|
hypoxia inducible lipid droplet associated
|
disease_progression
|
ISO
|
mRNA:increased expression:liver (human) human cells in mouse model mRNA, protein:increased expression:liver (human)
|
RGD |
PMID:30205391 PMID:31142329 PMID:35693827 |
RGD:153344574 RGD:153344577 RGD:153344586 |
NCBI chrNW_004624783:7,536,257...7,538,380
Ensembl chrNW_004624783:7,536,167...7,538,418
|
|
G
|
Hjurp
|
Holliday junction recognition protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624847:166,511...179,881
|
|
G
|
Hmgb2
|
high mobility group box 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20851854 |
|
NCBI chrNW_004624769:4,834,998...4,837,111
|
|
G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:9207284 PMID:21147110 |
|
NCBI chrNW_004624951:681,559...711,476
Ensembl chrNW_004624951:682,178...711,474
|
|
G
|
Hmgcs2
|
3-hydroxy-3-methylglutaryl-CoA synthase 2
|
disease_progression
|
ISO
|
|
RGD |
PMID:28867541 |
RGD:14975299 |
NCBI chrNW_004624772:15,432,612...15,464,343
Ensembl chrNW_004624772:15,432,198...15,467,797
|
|
G
|
Hmmr
|
hyaluronan mediated motility receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624733:26,319,635...26,351,576
Ensembl chrNW_004624733:26,319,678...26,351,234
|
|
G
|
Hnf1a
|
HNF1 homeobox A
|
treatment
|
ISO
|
human cell line in mouse model
|
RGD |
PMID:29466992 |
RGD:14700664 |
NCBI chrNW_004624747:12,717,713...12,746,040
Ensembl chrNW_004624747:12,717,707...12,746,724
|
|
G
|
Hnf4a
|
hepatocyte nuclear factor 4 alpha
|
|
ISO
|
protein:decreased expression:liver:
|
RGD |
PMID:20876809 |
RGD:12904747 |
NCBI chrNW_004624790:10,039,344...10,065,167
Ensembl chrNW_004624790:10,038,999...10,100,649
|
|
G
|
Hnrnpa1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
ISO
|
protein:increased expression:liver (human)
|
RGD |
PMID:23633480 |
RGD:9685423 |
NCBI chrNW_004624904:2,314,197...2,320,900
Ensembl chrNW_004624904:2,314,249...2,318,791
|
|
G
|
Hnrnpa2b1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
ISO
|
mRNA:increased expression:liver (rat) protein:increased expression:liver (human)
|
RGD |
PMID:20604928 PMID:23633480 |
RGD:9685422 RGD:9685423 |
NCBI chrNW_004624739:4,343,164...4,353,123
Ensembl chrNW_004624739:4,343,246...4,352,066
|
|
G
|
Hnrnpab
|
heterogeneous nuclear ribonucleoprotein A/B
|
severity
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:24638979 |
RGD:10059322 |
NCBI chrNW_004624733:41,387,068...41,403,701
Ensembl chrNW_004624733:41,398,123...41,403,617
|
|
G
|
Hnrnpd
|
heterogeneous nuclear ribonucleoprotein D
|
|
ISO
|
protein:increased expression:liver (rat) protein:increased expression:liver (human)
|
RGD |
PMID:20102719 PMID:22318685 |
RGD:10042969 RGD:10042977 |
NCBI chrNW_004624757:8,532,373...8,549,840
Ensembl chrNW_004624757:8,531,601...8,549,835
|
|
G
|
Hnrnph1
|
heterogeneous nuclear ribonucleoprotein H1
|
|
ISO
|
protein:increased expression:liver (human)
|
RGD |
PMID:23633480 |
RGD:9685423 |
NCBI chrNW_004624733:42,538,286...42,547,911
Ensembl chrNW_004624733:42,538,159...42,548,249
|
|
G
|
Hnrnpl
|
heterogeneous nuclear ribonucleoprotein L
|
|
ISO
|
associated with Hepatitis B
|
RGD |
PMID:24125732 |
RGD:9999429 |
NCBI chrNW_004624794:12,206,278...12,220,679
Ensembl chrNW_004624794:12,206,252...12,218,173
|
|
G
|
Hoxa10
|
homeobox A10
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624739:3,425,468...3,435,218
Ensembl chrNW_004624739:3,425,468...3,433,967
|
|
G
|
Hoxa13
|
homeobox A13
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624739:3,405,860...3,410,426
Ensembl chrNW_004624739:3,406,436...3,410,851
|
|
G
|
Hoxd9
|
homeobox D9
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624787:13,263,020...13,265,538
Ensembl chrNW_004624787:13,249,946...13,265,627
|
|
G
|
Hprt1
|
hypoxanthine phosphoribosyltransferase 1
|
|
ISO
|
protein:increased activity:hepatoma (rat)
|
RGD |
PMID:6327016 |
RGD:5135035 |
NCBI chrNW_004624797:14,148,580...14,184,471
|
|
G
|
Hras
|
HRas proto-oncogene, GTPase
|
treatment
|
ISO
|
human cells in a mouse model ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
|
RGD ClinVar |
PMID:10791191 PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20660566 PMID:20859122 PMID:20937837 PMID:20979192 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26619011 PMID:26778095 PMID:27195699 PMID:27283355 PMID:27444071 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:30191474 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32371413 PMID:32732226 PMID:33027564 PMID:33372952 PMID:34008892 PMID:34958143 PMID:168335863 More...
|
RGD:14688055 |
NCBI chrNW_004624766:21,907,423...21,913,414
Ensembl chrNW_004624766:21,911,241...21,913,653
|
|
G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 PMID:29698666 |
|
NCBI chrNW_004624760:9,986,529...9,991,261
Ensembl chrNW_004624760:9,986,656...9,995,252
|
|
G
|
Hspa9
|
heat shock protein family A (Hsp70) member 9
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624743:31,324,085...31,345,681
Ensembl chrNW_004624743:31,324,085...31,345,695
|
|
G
|
Hspb1
|
heat shock protein family B (small) member 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624740:14,940,161...14,941,561
Ensembl chrNW_004624740:14,939,445...14,941,819
|
|
G
|
Htatip2
|
HIV-1 Tat interactive protein 2
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:16799960 |
|
NCBI chrNW_004624766:11,650,643...11,667,338
Ensembl chrNW_004624766:11,649,834...11,669,418
|
|
G
|
Htra1
|
HtrA serine peptidase 1
|
exacerbates disease_progression
|
ISO
|
protein:decreased expression:liver (human) mRNA:decreased expression:liver (human)
|
RGD |
PMID:20943460 PMID:26403966 |
RGD:152985524 RGD:152985529 |
NCBI chrNW_004624737:24,217,260...24,267,836
Ensembl chrNW_004624737:24,216,525...24,267,827
|
|
G
|
Icam1
|
intercellular adhesion molecule 1
|
severity
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:26109813 |
RGD:11056752 |
NCBI chrNW_004624828:2,432,584...2,451,997
Ensembl chrNW_004624828:2,432,550...2,453,071
|
|
G
|
Idh1
|
isocitrate dehydrogenase (NADP(+)) 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624765:7,806,560...7,825,520
|
|
G
|
Idh2
|
isocitrate dehydrogenase (NADP(+)) 2
|
disease_progression
|
ISO
|
|
RGD |
PMID:24716838 |
RGD:14985249 |
NCBI chrNW_004624768:17,094,649...17,111,333
Ensembl chrNW_004624768:17,094,655...17,111,397
|
|
G
|
Ier2
|
immediate early response 2
|
|
ISO
|
human cells in mouse model
|
RGD |
PMID:32009420 |
RGD:153323326 |
NCBI chrNW_004624901:684,313...686,488
Ensembl chrNW_004624901:684,966...685,652
|
|
G
|
Ifng
|
interferon gamma
|
|
ISO
|
mRNA:increased expression:liver (mouse)
|
RGD |
PMID:26569409 |
RGD:11344640 |
NCBI chrNW_004624802:163,261...166,534
Ensembl chrNW_004624802:163,261...166,534
|
|
G
|
Igbp1
|
immunoglobulin binding protein 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21339737 |
|
NCBI chrNW_004624903:71,212...94,470
|
|
G
|
Igf1
|
insulin like growth factor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624750:5,881,065...5,954,799
Ensembl chrNW_004624750:5,881,091...5,952,300
|
|
G
|
Igf1r
|
insulin like growth factor 1 receptor
|
susceptibility
|
ISO
|
DNA:SNPs, haplotype: : CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:17441810 PMID:23958494 PMID:24758241 |
RGD:14985227 |
NCBI chrNW_004624768:5,396,027...5,688,435
Ensembl chrNW_004624768:5,396,156...5,681,809
|
|
G
|
Igf2
|
insulin like growth factor 2
|
susceptibility
|
ISO
|
CTD Direct Evidence: marker/mechanism associated with hepatitis B;DNA:SNPs:intron, 3'utr:+2482A>C, +820A>G (human)
|
CTD RGD |
PMID:12532445 PMID:16092956 PMID:16750516 PMID:17554210 |
RGD:14401723 RGD:2311523 |
NCBI chrNW_004624767:14,969,977...14,997,577
Ensembl chrNW_004624767:14,969,866...14,979,026
|
|
G
|
Igf2bp1
|
insulin like growth factor 2 mRNA binding protein 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624795:5,352,932...5,391,617
Ensembl chrNW_004624795:5,353,005...5,385,521
|
|
G
|
Igf2bp3
|
insulin like growth factor 2 mRNA binding protein 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624739:7,154,893...7,319,724
Ensembl chrNW_004624739:7,158,020...7,319,720
|
|
G
|
Igf2r
|
insulin like growth factor 2 receptor
|
disease_progression treatment no_association
|
ISO
|
ClinVar Annotator: match by term: Hepatocellular carcinoma DNA:loss of heterozygosity:liver DNA:loss of heterozygosity,mutations:liver:
|
OMIM ClinVar RGD |
PMID:9722161 PMID:10347113 PMID:18322954 PMID:25741868 PMID:30720132 |
RGD:14985219 RGD:14985220 RGD:14985221 |
NCBI chrNW_004624855:2,752,676...2,887,327
Ensembl chrNW_004624855:2,753,994...2,887,151
|
|
G
|
Igfals
|
insulin like growth factor binding protein acid labile subunit
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624913:460,862...464,457
Ensembl chrNW_004624913:458,844...465,193
|
|
G
|
Ikbkg
|
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
|
treatment
|
ISO
|
protein:decreased expression:liver (human)
|
RGD |
PMID:17292824 PMID:22176836 PMID:22922425 PMID:24971483 PMID:25173965 PMID:29551768 More...
|
RGD:11079569 RGD:153297807 RGD:153297813 RGD:153305943 RGD:153305945 RGD:153305947 |
NCBI chrNW_004624946:997,571...1,015,748
Ensembl chrNW_004624946:996,814...1,013,379
|
|
G
|
Ikzf1
|
IKAROS family zinc finger 1
|
ameliorates
|
ISO
|
protein:increased expression:liver (human)
|
RGD |
PMID:25301737 |
RGD:150540326 |
NCBI chrNW_004624740:3,785,342...3,875,892
Ensembl chrNW_004624740:3,785,209...3,875,841
|
|
G
|
Il10
|
interleukin 10
|
treatment
|
ISO
|
|
RGD |
PMID:23822114 PMID:26890368 |
RGD:14975171 RGD:7365006 |
NCBI chrNW_004624807:4,687,249...4,691,658
Ensembl chrNW_004624807:4,687,176...4,691,732
|
|
G
|
Il12a
|
interleukin 12A
|
susceptibility
|
ISO
|
associated with hepatitis C;DNA:SNP:3'UTR: rs568408( G>A)(human) associated with hepatitis B; DNA:SNP, haplotype:3′UTR :rs568408(human)
|
RGD |
PMID:20521253 PMID:26631030 PMID:27819525 |
RGD:25440490 RGD:25440491 RGD:25440501 |
NCBI chrNW_004624730:37,787,772...37,794,871
Ensembl chrNW_004624730:37,787,909...37,794,940
|
|
G
|
Il15ra
|
interleukin 15 receptor subunit alpha
|
disease_progression
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004624775:846,063...877,894
Ensembl chrNW_004624775:847,677...877,604
|
|
G
|
Il18
|
interleukin 18
|
susceptibility severity disease_progression
|
ISO
|
DNA:SNP:promoter:-137G>C(rs187238)(human) associated with hepatitis C;DNA:SNPs, haplotype:promoter:-607C>A, -137G>C(human) associated with hepatitis B, chronic;DNA:SNP:promoter:-607C>A(human)
|
RGD |
PMID:26893476 PMID:27429592 PMID:27470888 PMID:29341496 |
RGD:11538094 RGD:14695526 RGD:14695540 RGD:14696663 |
NCBI chrNW_004624784:7,294,286...7,312,959
Ensembl chrNW_004624784:7,294,183...7,304,687
|
|
G
|
Il18r1
|
interleukin 18 receptor 1
|
|
ISO
|
mRNA:decreased expression:liver
|
RGD |
PMID:26893476 |
RGD:11538094 |
NCBI chrNW_004624749:6,875,934...6,909,702
Ensembl chrNW_004624749:6,875,750...6,909,734
|
|
G
|
Il1b
|
interleukin 1 beta
|
susceptibility
|
ISO
|
DNA:polymorphism:promoter:-31T>C (human)
|
RGD |
PMID:21653279 |
RGD:7401222 |
NCBI chrNW_004624749:12,852,128...12,858,478
Ensembl chrNW_004624749:12,852,021...12,858,760
|
|
G
|
Il1rap
|
interleukin 1 receptor accessory protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624730:66,491,230...66,625,642
|
|
G
|
Il1rn
|
interleukin 1 receptor antagonist
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624749:13,210,365...13,224,471
Ensembl chrNW_004624749:13,210,476...13,225,890
|
|
G
|
Il2
|
interleukin 2
|
treatment
|
ISO
|
|
RGD |
PMID:9449371 PMID:10933975 |
RGD:14747035 RGD:8693323 |
NCBI chrNW_004624777:2,885,537...2,890,453
Ensembl chrNW_004624777:2,885,535...2,890,453
|
|
G
|
Il21
|
interleukin 21
|
|
ISO
|
associated with hepatitis B;DNA:SNPS, haplotype:(rs13143866, rs2221903, rs907715) (human)
|
RGD |
PMID:25892873 |
RGD:127285359 |
NCBI chrNW_004624777:3,054,368...3,061,304
Ensembl chrNW_004624777:3,054,368...3,061,304
|
|
G
|
Il6
|
interleukin 6
|
treatment disease_progression
|
ISO
|
DNA:SNP: :rs2069852 (human) CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:liver, blood serum (mouse)
|
RGD CTD |
PMID:17615358 PMID:20818158 PMID:26297436 PMID:26569409 PMID:27022031 PMID:27368337 PMID:29486150 More...
|
RGD:11344640 RGD:127285672 RGD:14975289 |
NCBI chrNW_004624739:7,957,709...7,963,414
Ensembl chrNW_004624739:7,957,674...7,962,318
|
|
G
|
Il6st
|
interleukin 6 cytokine family signal transducer
|
|
ISO
|
|
RGD |
PMID:15780071 |
RGD:1626706 |
NCBI chrNW_004624759:3,258,324...3,315,265
Ensembl chrNW_004624759:3,276,741...3,312,601
|
|
G
|
Ing3
|
inhibitor of growth family member 3
|
treatment
|
ISO
|
|
RGD |
PMID:25156538 |
RGD:9587823 |
NCBI chrNW_004624783:15,094,631...15,126,699
Ensembl chrNW_004624783:15,094,764...15,126,693
|
|
G
|
Inmt
|
indolethylamine N-methyltransferase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624783:17,712...22,867
Ensembl chrNW_004624783:17,084...20,921
|
|
G
|
Inpp4b
|
inositol polyphosphate-4-phosphatase type II B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29415082 |
|
NCBI chrNW_004624853:1,350,577...2,147,616
Ensembl chrNW_004624853:1,355,384...1,868,812
|
|
G
|
Ins
|
insulin
|
|
ISO
|
associated with Chronic Hepatitis C;mRNA:decreased expression:liver (human)
|
RGD |
PMID:33132693 |
RGD:150340613 |
NCBI chrNW_004624767:14,999,088...15,000,035
Ensembl chrNW_004624767:14,999,088...15,000,035
|
|
G
|
Insr
|
insulin receptor
|
|
ISO
|
human cells in a mouse model mRNA, protein:increased expression:liver (human, rat)
|
RGD |
PMID:23633480 PMID:29610518 |
RGD:14700930 RGD:9685423 |
NCBI chrNW_004624828:345,135...485,856
Ensembl chrNW_004624828:345,135...486,184
|
|
G
|
Iqgap1
|
IQ motif containing GTPase activating protein 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20977743 |
|
NCBI chrNW_004624768:17,703,113...17,797,922
Ensembl chrNW_004624768:17,702,728...17,799,022
|
|
G
|
Iqgap2
|
IQ motif containing GTPase activating protein 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism OMIM:114550
|
CTD MouseDO |
PMID:20977743 |
|
NCBI chrNW_004624869:888,868...1,172,747
Ensembl chrNW_004624869:889,091...1,171,983
|
|
G
|
Iqgap3
|
IQ motif containing GTPase activating protein 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624885:1,730,079...1,765,250
Ensembl chrNW_004624885:1,730,771...1,765,180
|
|
G
|
Irf2
|
interferon regulatory factor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22561517 |
|
NCBI chrNW_004624769:15,167,228...15,251,689
Ensembl chrNW_004624769:15,164,744...15,251,745
|
|
G
|
Irs1
|
insulin receptor substrate 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:1311924 PMID:23958494 |
|
NCBI chrNW_004624843:1,113,075...1,178,859
Ensembl chrNW_004624843:1,120,974...1,178,859
|
|
G
|
Irs2
|
insulin receptor substrate 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16127164 |
|
NCBI chrNW_004624793:2,615,092...2,636,835
Ensembl chrNW_004624793:2,614,589...2,636,947
|
|
G
|
Isg15
|
ISG15 ubiquitin like modifier
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28919514 |
|
NCBI chrNW_004624818:8,510,657...8,511,749
|
|
G
|
Itih3
|
inter-alpha-trypsin inhibitor heavy chain 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19363144 |
|
NCBI chrNW_004624822:4,415,962...4,429,660
Ensembl chrNW_004624822:4,416,074...4,429,623
|
|
G
|
Itih4
|
inter-alpha-trypsin inhibitor heavy chain 4
|
disease_progression
|
ISO
|
associated with hepatitis B;protein:decreased expression:serum
|
RGD |
PMID:24836184 |
RGD:40903002 |
NCBI chrNW_004624822:4,397,704...4,411,562
Ensembl chrNW_004624822:4,397,744...4,411,406
|
|
G
|
Jag1
|
jagged canonical Notch ligand 1
|
|
ISO
|
protein:increased expression:liver
|
RGD |
PMID:30660174 |
RGD:14694832 |
NCBI chrNW_004624741:11,647,723...11,683,137
Ensembl chrNW_004624741:11,647,463...11,683,488
|
|
G
|
Jak1
|
Janus kinase 1
|
|
ISO
|
|
RGD |
PMID:23788652 |
RGD:150524353 |
NCBI chrNW_004624742:29,631,391...29,723,981
Ensembl chrNW_004624742:29,689,965...29,723,981
|
|
G
|
Jak2
|
Janus kinase 2
|
exacerbates severity ameliorates treatment
|
ISO
|
protein:increased phosphorylation:liver (human) mRNA:decreased expression:liver (human) protein:increased phosphorylation:liver (mouse) L-JAK2 KO associated with Diseases of the Aged and non-alcoholic fatty liver disease
|
RGD |
PMID:22392353 PMID:22821478 PMID:25420511 PMID:28100771 PMID:29486150 PMID:31393852 More...
|
RGD:125097525 RGD:127285621 RGD:127285655 RGD:127285672 RGD:127285675 RGD:18182928 |
NCBI chrNW_004624736:9,724,876...9,827,364
Ensembl chrNW_004624736:9,724,369...9,830,365
|
|
G
|
Jdp2
|
Jun dimerization protein 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20214788 |
|
NCBI chrNW_004624734:26,228,147...26,276,485
Ensembl chrNW_004624734:26,224,961...26,276,612
|
|
G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20214788 |
|
NCBI chrNW_004624862:1,537,886...1,540,633
Ensembl chrNW_004624862:1,538,455...1,539,426
|
|
G
|
Jund
|
JunD proto-oncogene, AP-1 transcription factor subunit
|
|
ISO
|
associated with HBV;protein:increased expression:liver (human)
|
RGD |
PMID:15927205 |
RGD:153297768 |
NCBI chrNW_004624908:1,572,628...1,574,205
Ensembl chrNW_004624908:1,573,174...1,574,113
|
|
G
|
Kat2b
|
lysine acetyltransferase 2B
|
severity
|
ISO
|
protein:decreased expression:liver (human)
|
RGD |
PMID:23643089 |
RGD:9590314 |
NCBI chrNW_004624821:5,387,212...5,489,013
|
|
G
|
Kbtbd11
|
kelch repeat and BTB domain containing 11
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624861:1,085,143...1,111,528
Ensembl chrNW_004624861:1,101,415...1,103,340
|
|
G
|
Kcnh1
|
potassium voltage-gated channel subfamily H member 1
|
|
ISO
|
protein:increased expression:liver (human)
|
RGD |
PMID:17022810 |
RGD:9693723 |
NCBI chrNW_004624807:1,019,347...1,392,433
Ensembl chrNW_004624807:1,056,313...1,388,491
|
|
G
|
Kcnn2
|
potassium calcium-activated channel subfamily N member 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624733:7,429,681...7,931,192
Ensembl chrNW_004624733:7,429,681...7,578,596
|
|
G
|
Kdm1a
|
lysine demethylase 1A
|
severity
|
ISO
|
mRNA, protein:increased expression:liver (human)
|
RGD |
PMID:23236241 |
RGD:9681002 |
NCBI chrNW_004624764:7,664,550...7,742,494
|
|
G
|
Kdm3a
|
lysine demethylase 3A
|
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:21607773 |
RGD:9590222 |
NCBI chrNW_004624749:16,784,538...16,829,784
Ensembl chrNW_004624749:16,784,538...16,829,365
|
|
G
|
Kdm5c
|
lysine demethylase 5C
|
exacerbates
|
ISO
|
protein:increased expression:liver (human)
|
RGD |
PMID:26503415 |
RGD:11530160 |
NCBI chrNW_004624909:421,033...455,201
Ensembl chrNW_004624909:420,077...455,309
|
|
G
|
Kdm6a
|
lysine demethylase 6A
|
ameliorates
|
ISO
|
human cells in a mouse model
|
RGD |
PMID:32765772 |
RGD:150429729 |
NCBI chrNW_004624887:1,065,173...1,279,660
Ensembl chrNW_004624887:1,065,883...1,279,186
|
|
G
|
Kdm8
|
lysine demethylase 8
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624782:11,884,847...11,903,944
Ensembl chrNW_004624782:11,884,631...11,903,947
|
|
G
|
Kdr
|
kinase insert domain receptor
|
disease_progression treatment
|
ISO
|
associated with alcoholic liver cirrhosis;DNA:SNP: :1416A>T (human) protein:decreased expression:liver protein:increased expression:liver DNA:SNPs: :rs1870377, rs2071559, rs2305948 (human)
|
RGD |
PMID:19177438 PMID:23660204 PMID:24445728 PMID:25182707 PMID:25333267 |
RGD:126848806 RGD:126848810 RGD:126848812 RGD:126848813 RGD:126848814 |
NCBI chrNW_004624761:14,330,224...14,380,680
Ensembl chrNW_004624761:14,330,489...14,379,051
|
|
G
|
Kif11
|
kinesin family member 11
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624737:3,835,788...3,874,360
|
|
G
|
Kif14
|
kinesin family member 14
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624807:10,093,518...10,144,484
Ensembl chrNW_004624807:10,092,934...10,143,399
|
|
G
|
Kif15
|
kinesin family member 15
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624730:75,644,242...75,707,159
Ensembl chrNW_004624730:75,644,163...75,707,043
|
|
G
|
Kif18a
|
kinesin family member 18A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624766:17,565,072...17,622,342
Ensembl chrNW_004624766:17,564,560...17,622,932
|
|
G
|
Kif18b
|
kinesin family member 18B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624795:376,659...394,750
Ensembl chrNW_004624795:377,001...391,934
|
|
G
|
Kif1b
|
kinesin family member 1B
|
susceptibility severity
|
ISO
|
DNA:snp:intron:c.2537+518A>G (rs17401966) (human) mRNA, protein:decreased expression:liver (human)
|
RGD |
PMID:26217094 PMID:27122668 |
RGD:11052488 RGD:12738461 |
NCBI chrNW_004624818:2,282,999...2,428,586
Ensembl chrNW_004624818:2,282,999...2,428,563
|
|
G
|
Kif20a
|
kinesin family member 20A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624743:30,994,664...31,003,858
Ensembl chrNW_004624743:30,995,526...31,011,396
|
|
G
|
Kif23
|
kinesin family member 23
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624781:4,048,997...4,074,836
Ensembl chrNW_004624781:4,048,902...4,073,257
|
|
G
|
Kif2c
|
kinesin family member 2C
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624906:633,635...660,149
Ensembl chrNW_004624906:633,754...660,254
|
|
G
|
Kif4a
|
kinesin family member 4A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624903:261,084...386,670
|
|
G
|
Kifc1
|
kinesin family member C1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624754:23,405,951...23,421,696
Ensembl chrNW_004624754:23,410,007...23,413,902
|
|
G
|
Klf4
|
KLF transcription factor 4
|
disease_progression treatment
|
ISO
|
|
RGD |
PMID:22677193 |
RGD:14402023 |
NCBI chrNW_004624758:4,047,217...4,052,257
Ensembl chrNW_004624758:4,047,219...4,051,983
|
|
G
|
Kmt2a
|
lysine methyltransferase 2A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22634756 |
|
NCBI chrNW_004624784:13,824,507...13,912,672
Ensembl chrNW_004624784:13,824,541...13,908,077
|
|
G
|
Kmt2b
|
lysine methyltransferase 2B
|
|
ISO
|
DNA:insertions, translocations:intron:IVS3, multiple (human) CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:18320596 PMID:22634754 |
RGD:9588597 |
NCBI chrNW_004624794:10,023,229...10,046,128
Ensembl chrNW_004624794:10,023,492...10,045,820
|
|
G
|
Kmt2c
|
lysine methyltransferase 2C
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22634756 |
|
NCBI chrNW_004624800:4,510,669...4,785,909
Ensembl chrNW_004624800:4,511,549...4,784,053
|
|
G
|
Kras
|
KRAS proto-oncogene, GTPase
|
induced
|
ISO
|
aflatoxin B1 induced:DNA:transversion,transition mutations:cds: mRNA,protein:increased expression:liver CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:8446626 PMID:11286481 PMID:11563603 PMID:29275358 |
RGD:11568697 RGD:14398750 |
NCBI chrNW_004624752:13,809,741...13,847,020
Ensembl chrNW_004624752:13,809,775...13,844,166
|
|
G
|
Krt18
|
keratin 18
|
|
ISO
|
OMIM:114550
|
MouseDO |
|
|
NCBI chrNW_004624904:1,011,675...1,015,319
Ensembl chrNW_004624904:1,011,755...1,015,416
|
|
G
|
Lcat
|
lecithin-cholesterol acyltransferase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624746:18,438,308...18,441,650
Ensembl chrNW_004624746:18,437,429...18,441,806
|
|
G
|
Lect2
|
leukocyte cell derived chemotaxin 2
|
ameliorates
|
ISO
|
human cells in mouse model protein:increased expression:blood serum (mouse) protein:increased expression:blood serum (human)
|
RGD |
PMID:21394108 PMID:24892551 |
RGD:153323333 RGD:153323335 |
NCBI chrNW_004624733:11,158,202...11,169,912
Ensembl chrNW_004624733:11,157,690...11,169,912
|
|
G
|
Lep
|
leptin
|
severity susceptibility
|
ISO
|
protein:increased expression:liver (human) DNA:SNP:enhancer:-2548G>A (rs7799039) (human)
|
RGD |
PMID:18573568 PMID:28452232 |
RGD:15039399 RGD:25330348 |
NCBI chrNW_004624783:7,708,820...7,721,610
Ensembl chrNW_004624783:7,708,588...7,721,727
|
|
G
|
Lepr
|
leptin receptor
|
susceptibility
|
ISO
|
associated with Hepatitis B, Chronic;DNA:missense mutations:cds:p.Q223R, p.K109R (human)
|
RGD |
PMID:23090836 |
RGD:21079466 |
NCBI chrNW_004624742:29,221,742...29,313,273
Ensembl chrNW_004624742:29,223,392...29,337,049
|
|
G
|
Letm1
|
leucine zipper and EF-hand containing transmembrane protein 1
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:23392203 |
|
NCBI chrNW_004624755:25,604,636...25,631,974
Ensembl chrNW_004624755:25,604,454...25,631,716
|
|
G
|
Lifr
|
LIF receptor subunit alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624759:16,368,390...16,478,486
Ensembl chrNW_004624759:16,410,687...16,472,014
|
|
G
|
LOC101698463
|
HLA class II histocompatibility antigen, DP alpha 1 chain
|
|
ISO
|
DNA:hypomethylation: CpG islands:
|
RGD |
PMID:20165882 |
RGD:14694974 |
NCBI chrNW_004624754:23,674,935...23,683,044
Ensembl chrNW_004624754:23,674,448...23,683,662
|
|
G
|
LOC101703821
|
HLA class II histocompatibility antigen, DQ beta 1 chain
|
treatment
|
ISO
|
associated with hepatitis C;DNA:SNPs,haplotypes associated with hepatitis B
|
RGD |
PMID:27288300 PMID:28921602 |
RGD:14928325 RGD:14974233 |
NCBI chrNW_004624754:23,895,509...23,902,487
Ensembl chrNW_004624754:23,895,607...23,906,713
|
|
G
|
LOC101707509
|
cytochrome P450 1A1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15341023 |
|
NCBI chrNW_004627988:7...1,323
|
|
G
|
LOC101714280
|
cytochrome P450 26B1
|
disease_progression
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004624762:1,455,828...1,474,201
Ensembl chrNW_004624762:1,456,440...1,472,381
|
|
G
|
LOC101717854
|
24-hydroxycholesterol 7-alpha-hydroxylase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624754:13,980,180...14,033,591
Ensembl chrNW_004624754:13,980,354...14,034,098
|
|
G
|
LOC101719726
|
cytochrome c oxidase subunit 7B, mitochondrial
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624761:20,336,164...20,336,517
|
|
G
|
LOC101722366
|
cytochrome P450 2E1
|
|
ISO
|
associated with alcohol dependence DNA, mRNA:SNP, Decreased expression:liver: rs2031920 (human) CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:15162526 PMID:20364586 PMID:29765251 |
RGD:14700882 RGD:14700899 |
NCBI chrNW_004624737:12,335,733...12,345,278
Ensembl chrNW_004624737:12,335,681...12,345,514
|
|
G
|
LOC101724812
|
C-C chemokine receptor type 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16284949 |
|
NCBI chrNW_004624730:74,822,848...74,828,614
Ensembl chrNW_004624730:74,826,659...74,827,726
|
|
G
|
LOC101726496
|
steroid 17-alpha-hydroxylase/17,20 lyase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15341023 |
|
NCBI chrNW_004624831:2,155,851...2,166,621
Ensembl chrNW_004624831:2,157,048...2,166,539
|
|
G
|
Loxl3
|
lysyl oxidase like 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:35841383 |
|
NCBI chrNW_004624749:28,959,682...28,980,428
Ensembl chrNW_004624749:28,960,593...28,980,428
|
|
G
|
Lpar1
|
lysophosphatidic acid receptor 1
|
|
ISO
|
|
RGD |
PMID:19000703 |
RGD:2317680 |
NCBI chrNW_004624758:518,070...668,915
Ensembl chrNW_004624758:519,249...669,471
|
|
G
|
Lrat
|
lecithin retinol acyltransferase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624853:2,936,426...2,941,993
Ensembl chrNW_004624853:2,936,109...2,945,101
|
|
G
|
Lrp1b
|
LDL receptor related protein 1B
|
exacerbates
|
ISO
|
protein:increased expression:liver (human) DNA:mutations:multiple: (human)
|
RGD |
PMID:33324588 PMID:33391418 |
RGD:150429776 RGD:150429785 |
NCBI chrNW_004624732:39,993,972...41,903,552
Ensembl chrNW_004624732:39,993,907...41,902,824
|
|
G
|
Lrrc1
|
leucine rich repeat containing 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624850:1,105,844...1,232,595
Ensembl chrNW_004624850:1,105,926...1,234,504
|
|
G
|
Lrrc56
|
leucine rich repeat containing 56
|
|
ISO
|
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
|
ClinVar |
PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20301680 PMID:20660566 PMID:20859122 PMID:20937837 PMID:20979192 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26619011 PMID:26778095 PMID:27195699 PMID:27283355 PMID:27444071 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:30191474 PMID:31222966 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32371413 PMID:32732226 PMID:33027564 PMID:33372952 PMID:34008892 PMID:34958143 PMID:168335863 More...
|
|
NCBI chrNW_004624766:21,895,967...21,910,727
Ensembl chrNW_004624766:21,896,933...21,907,911
|
|
G
|
Lrrc59
|
leucine rich repeat containing 59
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:30705370 |
|
NCBI chrNW_004624795:6,317,677...6,328,554
Ensembl chrNW_004624795:6,316,472...6,329,166
|
|
G
|
Lyve1
|
lymphatic vessel endothelial hyaluronan receptor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624766:2,634,355...2,648,354
Ensembl chrNW_004624766:2,633,120...2,648,413
|
|
G
|
Lztr1
|
leucine zipper like post translational regulator 1
|
|
ISO
|
DNA:missense mutation:cds, liver (human)
|
RGD |
PMID:28622513 |
RGD:151893487 |
NCBI chrNW_004624945:691,063...709,599
Ensembl chrNW_004624945:691,059...709,564
|
|
G
|
Map2k2
|
mitogen-activated protein kinase kinase 2
|
exacerbates
|
ISO
|
protein:increased expression:liver, cytosol (rat) mRNA:increased expression:liver (human)
|
RGD |
PMID:9397988 PMID:33553243 |
RGD:150530475 RGD:150530477 |
NCBI chrNW_004624828:5,489,085...5,511,166
Ensembl chrNW_004624828:5,488,814...5,511,445
|
|
G
|
Map2k4
|
mitogen-activated protein kinase kinase 4
|
|
ISO
|
protein:decreased expression:liver (human)
|
RGD |
PMID:32850377 |
RGD:150429765 |
NCBI chrNW_004624786:14,457,382...14,597,027
Ensembl chrNW_004624786:14,457,452...14,597,027
|
|
G
|
Map3k1
|
mitogen-activated protein kinase kinase kinase 1
|
exacerbates
|
ISO
|
mRNA:decreased expression:liver (human)
|
RGD |
PMID:31310010 |
RGD:150573714 |
NCBI chrNW_004624759:2,360,655...2,429,189
Ensembl chrNW_004624759:2,363,076...2,428,273
|
|
G
|
Map3k8
|
mitogen-activated protein kinase kinase kinase 8
|
ameliorates
|
ISO
|
|
RGD |
PMID:26560698 |
RGD:11342977 |
NCBI chrNW_004624805:2,611,297...2,633,650
Ensembl chrNW_004624805:2,611,038...2,633,943
|
|
G
|
Map4k4
|
mitogen-activated protein kinase kinase kinase kinase 4
|
ameliorates severity treatment
|
ISO
|
human cell line in a mouse model human recombinant gene and cell line in a mouse model
|
RGD |
PMID:21196414 PMID:27010469 PMID:31922225 |
RGD:151347673 RGD:151347674 RGD:151347839 |
NCBI chrNW_004624749:6,332,686...6,495,942
Ensembl chrNW_004624749:6,332,534...6,495,942
|
|
G
|
Mapk1
|
mitogen-activated protein kinase 1
|
|
ISO
|
protein:increased expression:liver
|
RGD |
PMID:27468214 |
RGD:401976278 |
NCBI chrNW_004624747:1,296,062...1,389,674
Ensembl chrNW_004624747:1,296,221...1,389,757
|
|
G
|
Mapk14
|
mitogen-activated protein kinase 14
|
treatment exacerbates
|
ISO
|
|
RGD |
PMID:23271722 PMID:25216638 |
RGD:151665347 RGD:151665348 |
NCBI chrNW_004624754:21,528,121...21,598,064
Ensembl chrNW_004624754:21,527,333...21,597,733
|
|
G
|
Mapk8
|
mitogen-activated protein kinase 8
|
ameliorates
|
ISO
|
protein:decreased phosphorylation:liver (human)
|
RGD |
PMID:33875785 |
RGD:150340688 |
NCBI chrNW_004624928:1,442,216...1,494,275
Ensembl chrNW_004624928:1,439,146...1,494,266
|
|
G
|
Mapt
|
microtubule associated protein tau
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624849:2,320,887...2,421,099
|
|
G
|
Marco
|
macrophage receptor with collagenous structure
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624732:26,203,345...26,236,001
Ensembl chrNW_004624732:26,203,219...26,236,057
|
|
G
|
Mat1a
|
methionine adenosyltransferase 1A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12060674 |
|
NCBI chrNW_004624841:6,843,725...6,864,700
Ensembl chrNW_004624841:6,843,741...6,862,683
|
|
G
|
Mbl2
|
mannose binding lectin 2
|
no_association susceptibility severity
|
ISO
|
associated with viral hepatitis;DNA:polymorphisms:exon: associated with hepatitis B;DNA:SNP:exon: DNA:SNPs:promoter:rs7096206(human) associated with hepatitis C;DNA:SNP: :221C>G(rs709620)(human) protein:decreased expression:plasma associated with hepatitis B-related cirrhosis;DNA:SNP: :rs11003123(G>A)(human)
|
RGD |
PMID:18221301 PMID:21733090 PMID:25787238 PMID:26857650 PMID:27298104 PMID:27557564 More...
|
RGD:14696813 RGD:14696814 RGD:14696829 RGD:14696833 RGD:14696835 RGD:14696836 |
NCBI chrNW_004624791:10,881,319...10,886,294
Ensembl chrNW_004624791:10,881,268...10,886,297
|
|
G
|
Mbtps1
|
membrane bound transcription factor peptidase, site 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:14563831 |
|
NCBI chrNW_004624746:3,466,723...3,521,830
Ensembl chrNW_004624746:3,455,995...3,523,262
|
|
G
|
Mbtps2
|
membrane bound transcription factor peptidase, site 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:14563831 |
|
NCBI chrNW_004624829:6,795,563...6,839,416
Ensembl chrNW_004624829:6,795,528...6,834,604
|
|
G
|
Mcm10
|
minichromosome maintenance 10 replication initiation factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624805:5,728,781...5,766,796
Ensembl chrNW_004624805:5,728,569...5,765,862
|
|
G
|
Mcm7
|
minichromosome maintenance complex component 7
|
susceptibility
|
ISO
|
associated with hepatitis B;DNA:SNP:promoter: (rs999885) (human) associated with hepatitis B;miRNA:increased expression:liver (human)
|
RGD |
PMID:24416400 PMID:27298561 |
RGD:15042853 RGD:15042885 |
NCBI chrNW_004624740:16,887,699...16,895,224
Ensembl chrNW_004624740:16,887,775...16,899,934
|
|
G
|
Mcm9
|
minichromosome maintenance 9 homologous recombination repair factor
|
|
ISO
|
OMIM:114550
|
MouseDO |
|
|
NCBI chrNW_004624798:11,287,882...11,370,040
Ensembl chrNW_004624798:11,290,074...11,367,495
|
|
G
|
Me1
|
malic enzyme 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21147110 |
|
NCBI chrNW_004624799:11,166,398...11,382,662
|
|
G
|
Mecp2
|
methyl-CpG binding protein 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver
|
CTD RGD |
PMID:11844796 PMID:26189965 |
RGD:2289670 |
NCBI chrNW_004624946:620,581...685,339
Ensembl chrNW_004624946:628,284...685,246
|
|
G
|
Med1
|
mediator complex subunit 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20007298 |
|
NCBI chrNW_004624795:3,572,025...3,605,675
Ensembl chrNW_004624795:3,572,266...3,607,126
|
|
G
|
Melk
|
maternal embryonic leucine zipper kinase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624930:247,018...333,240
|
|
G
|
Met
|
MET proto-oncogene, receptor tyrosine kinase
|
severity susceptibility
|
ISO
|
protein:increased expression:liver (human) ClinVar Annotator: match by term: Hepatocellular cancer
|
RGD OMIM ClinVar |
PMID:21774103 PMID:21970370 PMID:22703879 PMID:24728327 PMID:25741868 PMID:26467025 PMID:28259294 PMID:28492532 PMID:29303510 PMID:29641532 PMID:29684080 PMID:34882875 PMID:35264596 More...
|
RGD:152995524 |
NCBI chrNW_004624827:2,589,157...2,724,065
Ensembl chrNW_004624827:2,587,966...2,723,995
|
|
G
|
Mfsd2a
|
MFSD2 lysolipid transporter A, lysophospholipid
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624764:22,422,520...22,435,332
Ensembl chrNW_004624764:22,422,423...22,435,416
|
|
G
|
Mki67
|
marker of proliferation Ki-67
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624737:18,935,686...18,963,907
|
|
G
|
Mlxipl
|
MLX interacting protein like
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21147110 |
|
NCBI chrNW_004624740:14,150,425...14,187,687
Ensembl chrNW_004624740:14,168,238...14,187,264
|
|
G
|
Mme
|
membrane metalloendopeptidase
|
|
ISO
|
|
RGD |
PMID:8302012 |
RGD:13801035 |
NCBI chrNW_004624730:32,601,835...32,691,368
Ensembl chrNW_004624730:32,601,488...32,689,080
|
|
G
|
Mmp14
|
matrix metallopeptidase 14
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:33010264 |
|
NCBI chrNW_004624820:9,667,371...9,677,488
Ensembl chrNW_004624820:9,667,262...9,677,774
|
|
G
|
Mmp2
|
matrix metallopeptidase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20084675 |
|
NCBI chrNW_004624757:1,450,680...1,479,160
Ensembl chrNW_004624757:1,448,698...1,479,255
|
|
G
|
Mmp9
|
matrix metallopeptidase 9
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:20084675 PMID:21681821 |
RGD:8547864 |
NCBI chrNW_004624790:8,584,399...8,591,763
Ensembl chrNW_004624790:8,583,457...8,591,713
|
|
G
|
Mogat2
|
monoacylglycerol O-acyltransferase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624817:1,450,238...1,468,503
Ensembl chrNW_004624817:1,450,300...1,468,514
|
|
G
|
Mpl
|
MPL proto-oncogene, thrombopoietin receptor
|
|
ISO
|
human cells in mouse model
|
RGD |
PMID:23157389 |
RGD:126925755 |
NCBI chrNW_004624892:2,656,260...2,671,455
Ensembl chrNW_004624892:2,656,260...2,669,946
|
|
G
|
Mpo
|
myeloperoxidase
|
disease_progression susceptibility
|
ISO
|
associated with liver cirrhosis with Hepatitis C;DNA:SNP:promoter:-463G>A(human) associated with liver cirrhosis; DNA:SNP:promoter:-463G>A( rs2333227)(human) CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:19731237 PMID:21907168 |
RGD:26923907 RGD:27095879 |
NCBI chrNW_004624871:121,026...131,433
Ensembl chrNW_004624871:121,026...131,323
|
|
G
|
Mro
|
maestro
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624778:14,352,071...14,359,861
Ensembl chrNW_004624778:14,352,856...14,359,678
|
|
G
|
Msh3
|
mutS homolog 3
|
|
ISO
|
ClinVar Annotator: match by term: Hepatocellular cancer
|
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004624743:1,461,952...1,581,524
Ensembl chrNW_004624743:1,461,077...1,581,180
|
|
G
|
Msh5
|
mutS homolog 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624754:24,453,750...24,477,574
Ensembl chrNW_004624754:24,453,902...24,473,051
|
|
G
|
Mtbp
|
MDM2 binding protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29765550 |
|
NCBI chrNW_004624763:18,228,820...18,299,706
Ensembl chrNW_004624763:18,228,252...18,299,925
|
|
G
|
Mtdh
|
metadherin
|
treatment
|
ISO
|
human cells in a mouse model
|
RGD |
PMID:26351209 |
RGD:11096879 |
NCBI chrNW_004624763:4,905,261...4,967,014
Ensembl chrNW_004624763:4,905,044...4,967,014
|
|
G
|
Mthfd2
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
|
|
ISO
|
mRNA:increased expression:liver
|
RGD |
PMID:3878730 |
RGD:2302305 |
NCBI chrNW_004624749:29,264,577...29,276,769
|
|
G
|
Mthfr
|
methylenetetrahydrofolate reductase
|
susceptibility disease_progression onset
|
ISO
|
DNA:SNP,haplotype: :677C>T, 1298A>C(human) DNA:SNPs: :677C>T, 1298A>C(human) DNA:SNP: :677C>T(human) DNA:SNP: :1298A>C(human)
|
RGD |
PMID:17503006 PMID:17659576 PMID:19035314 PMID:23996892 |
RGD:14696703 RGD:14696704 RGD:14696707 RGD:14696708 |
NCBI chrNW_004624818:1,184,736...1,202,708
Ensembl chrNW_004624818:1,187,869...1,199,168
|
|
G
|
Mtor
|
mechanistic target of rapamycin kinase
|
severity
|
ISO
|
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver (human)
|
CTD RGD |
PMID:21147110 PMID:25371154 |
RGD:152995471 |
NCBI chrNW_004624818:1,570,155...1,698,264
Ensembl chrNW_004624818:1,570,276...1,698,259
|
|
G
|
Mtrr
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
susceptibility
|
ISO
|
DNA:SNP: :66A>G(human)
|
RGD |
PMID:19035314 |
RGD:14696707 |
NCBI chrNW_004624751:5,445,274...5,469,386
Ensembl chrNW_004624751:5,445,241...5,469,657
|
|
G
|
Mvk
|
mevalonate kinase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21147110 |
|
NCBI chrNW_004624747:10,837,743...10,858,758
Ensembl chrNW_004624747:10,834,306...10,857,595
|
|
G
|
Mybl2
|
MYB proto-oncogene like 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624790:10,629,771...10,665,187
Ensembl chrNW_004624790:10,630,158...10,664,982
|
|
G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
treatment severity
|
ISO
|
OMIM:114550 mRNA:increased expression:liver (rat) mRNA:increased expression:liver (human) CTD Direct Evidence: marker/mechanism
|
RGD MouseDO CTD |
PMID:9029167 PMID:12029619 PMID:15565109 PMID:21644509 PMID:22076107 PMID:22129741 PMID:22434528 PMID:29698666 More...
|
RGD:6903288 RGD:7240567 RGD:7240695 RGD:7241004 |
NCBI chrNW_004624735:27,780,338...27,784,714
Ensembl chrNW_004624735:27,780,037...27,784,806
|
|
G
|
Myd88
|
MYD88 innate immune signal transduction adaptor
|
exacerbates treatment ameliorates
|
ISO
|
mRNA:increased expression:liver (human) human gene and cell in a mouse model protein:increased expression:liver (human) mouse cell line in a mouse model human cell line in a mouse model protein, mRNA:decreased expression:liver (human)
|
RGD |
PMID:17615358 PMID:24603331 PMID:26985932 PMID:28370778 PMID:29022910 PMID:31068809 PMID:31074165 PMID:32144747 PMID:33575076 More...
|
RGD:150520022 RGD:150520169 RGD:150521532 RGD:150521534 RGD:150524327 RGD:150524329 RGD:150524330 RGD:150524334 RGD:150530285 |
NCBI chrNW_004624731:2,677,259...2,681,408
Ensembl chrNW_004624731:2,677,290...2,681,489
|
|
G
|
Nbn
|
nibrin
|
|
ISO
|
ClinVar Annotator: match by term: Hepatocellular cancer
|
ClinVar |
PMID:9590180 PMID:9590181 PMID:9620777 PMID:10398434 PMID:10799436 PMID:10848790 PMID:10852373 PMID:11093281 PMID:11279524 PMID:11953735 PMID:12123493 PMID:12505263 PMID:12833396 PMID:12845677 PMID:14973119 PMID:15185344 PMID:15279809 PMID:16033915 PMID:16544999 PMID:17103455 PMID:18606567 PMID:18940477 PMID:19635536 PMID:19908051 PMID:20444919 PMID:22131123 PMID:22293976 PMID:22373003 PMID:22491912 PMID:22941933 PMID:23317186 PMID:24033266 PMID:24113799 PMID:25485873 PMID:25741868 PMID:25980754 PMID:26083025 PMID:26467025 PMID:26822949 PMID:26845104 PMID:27150568 PMID:27616075 PMID:28492532 PMID:28873162 PMID:29368341 PMID:29419426 PMID:30426508 PMID:31173646 PMID:32295079 PMID:33050356 PMID:33471974 PMID:33471991 PMID:33840814 PMID:34072463 PMID:34072659 PMID:34544220 PMID:35309086 More...
|
|
NCBI chrNW_004624744:2,013,936...2,061,726
Ensembl chrNW_004624744:2,013,922...2,061,708
|
|
G
|
Ncapg
|
non-SMC condensin I complex subunit G
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624755:14,067,931...14,100,593
Ensembl chrNW_004624755:14,068,009...14,100,438
|
|
G
|
Ncaph
|
non-SMC condensin I complex subunit H
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624749:2,411,952...2,439,981
Ensembl chrNW_004624749:2,411,970...2,444,446
|
|
G
|
Ncoa2
|
nuclear receptor coactivator 2
|
exacerbates
|
ISO
|
|
RGD |
PMID:22556267 PMID:28273073 |
RGD:153002573 RGD:153002576 |
NCBI chrNW_004624744:20,795,385...21,078,706
Ensembl chrNW_004624744:20,938,555...21,078,690
|
|
G
|
Ndc80
|
NDC80 kinetochore complex component
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624770:12,937,887...12,974,352
Ensembl chrNW_004624770:12,939,763...12,974,162
|
|
G
|
Neil3
|
nei like DNA glycosylase 3
|
disease_progression
|
ISO
|
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (human)
|
CTD RGD |
PMID:28284560 PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004624769:8,436,526...8,480,336
Ensembl chrNW_004624769:8,448,226...8,480,439
|
|
G
|
Nek2
|
NIMA related kinase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624771:17,334,782...17,351,609
Ensembl chrNW_004624771:17,334,681...17,352,259
|
|
G
|
Nf2
|
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
|
disease_progression
|
ISO
|
DNA, protein:SNP, increased expression:intron, liver protein:decreased expression:liver
|
RGD |
PMID:26443326 PMID:27289045 PMID:29130106 |
RGD:11076529 RGD:150530489 RGD:150530504 |
NCBI chrNW_004624747:5,923,827...6,011,276
Ensembl chrNW_004624747:5,923,834...6,011,939
|
|
G
|
Nfe2l1
|
NFE2 like bZIP transcription factor 1
|
|
ISO
|
OMIM:114550
|
MouseDO |
|
|
NCBI chrNW_004624795:4,652,221...4,663,341
Ensembl chrNW_004624795:4,652,637...4,662,454
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:22561517 PMID:31546024 |
RGD:21201310 |
NCBI chrNW_004624787:14,355,330...14,381,353
Ensembl chrNW_004624787:14,355,791...14,381,251
|
|
G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
disease_progression treatment
|
ISO
|
associated with Chronic Hepatitis B;DNA:insertion/deletion:3'utr: -94ins/delATTG (rs28720239) (human)
|
RGD |
PMID:19797428 PMID:25999787 |
RGD:152177911 RGD:40400751 |
NCBI chrNW_004624830:5,334,273...5,430,887
Ensembl chrNW_004624830:5,333,616...5,408,723
|
|
G
|
Nfkbia
|
NFKB inhibitor alpha
|
disease_progression susceptibility
|
ISO
|
associated with Chronic Hepatitis B;DNA:SNPs,haplotype:3'utr,promoter: 826C>T,881A>G (rs2233406,rs3138053) (human) CTD Direct Evidence: therapeutic associated with hepatitis B;DNA:SNP:promoter:-826C>T (rs2233406) (human)
|
RGD CTD |
PMID:19797428 PMID:22022477 PMID:25223483 |
RGD:40400751 RGD:40902986 |
NCBI chrNW_004624838:1,384,337...1,387,602
Ensembl chrNW_004624838:1,384,204...1,390,205
|
|
G
|
Nkx3-1
|
NK3 homeobox 1
|
treatment
|
ISO
|
mRNA:decreased expression:liver human gene in a mouse model
|
RGD |
PMID:28972178 |
RGD:14401599 |
NCBI chrNW_004624758:18,874,399...18,876,982
Ensembl chrNW_004624758:18,875,475...18,876,971
|
|
G
|
Nlrc3
|
NLR family CARD domain containing 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:30081150 |
|
NCBI chrNW_004624824:1,356,587...1,375,403
Ensembl chrNW_004624824:1,357,326...1,375,688
|
|
G
|
Nlrc5
|
NLR family CARD domain containing 5
|
|
ISO
|
protein:increased expression:liver
|
RGD |
PMID:27338800 |
RGD:15003194 |
NCBI chrNW_004624746:28,954,009...29,030,337
Ensembl chrNW_004624746:28,954,016...29,030,322
|
|
G
|
Nnmt
|
nicotinamide N-methyltransferase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624784:9,765,582...9,783,004
Ensembl chrNW_004624784:9,765,582...9,783,004
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
treatment
|
ISO
|
|
RGD |
PMID:25999787 |
RGD:152177911 |
NCBI chrNW_004624786:491,944...530,427
Ensembl chrNW_004624786:489,311...528,271
|
|
G
|
Notch3
|
notch receptor 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624901:2,292,257...2,328,433
Ensembl chrNW_004624901:2,292,640...2,328,433
|
|
G
|
Nr0b2
|
nuclear receptor subfamily 0 group B member 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23811326 |
|
NCBI chrNW_004624764:10,896,728...10,899,898
Ensembl chrNW_004624764:10,892,481...10,899,215
|
|
G
|
Nr1h2
|
nuclear receptor subfamily 1 group H member 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21147110 |
|
NCBI chrNW_004624832:4,136,052...4,141,648
Ensembl chrNW_004624832:4,132,904...4,140,896
|
|
G
|
Nr1h4
|
nuclear receptor subfamily 1 group H member 4
|
|
ISO
|
mRNA:splice variant(s):liver (human) OMIM:114550 intestinally expressed human gene in mouse model CTD Direct Evidence: marker/mechanism
|
RGD MouseDO CTD |
PMID:23213087 PMID:23811326 PMID:24954587 PMID:25496033 |
RGD:14696796 RGD:14928330 RGD:14928334 |
NCBI chrNW_004624750:7,222,306...7,303,809
Ensembl chrNW_004624750:7,219,251...7,303,834
|
|
G
|
Nras
|
NRAS proto-oncogene, GTPase
|
disease_progression severity
|
ISO
|
human gene in mouse model mRNA, protein:increased expression:liver (mouse, human)
|
RGD |
PMID:21993994 PMID:30685691 |
RGD:14696775 RGD:14696793 |
NCBI chrNW_004624772:10,358,554...10,369,371
|
|
G
|
Nrg1
|
neuregulin 1
|
disease_progression
|
ISO
|
mRNA:increased expression:liver (human) associated with hepatitis C;mRNA:altered expression:liver (human
|
RGD |
PMID:17393520 PMID:27514687 |
RGD:39456104 RGD:39456110 |
NCBI chrNW_004624780:11,297,306...11,525,236
Ensembl chrNW_004624780:11,301,182...12,424,066
|
|
G
|
Nrp1
|
neuropilin 1
|
disease_progression
|
ISO
|
protein:decreased expression:liver
|
RGD |
PMID:25333267 |
RGD:126848812 |
NCBI chrNW_004624805:8,438,485...8,574,845
Ensembl chrNW_004624805:8,438,498...8,574,508
|
|
G
|
Nuf2
|
NUF2 component of NDC80 kinetochore complex
|
disease_progression treatment
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:28284560 PMID:30653265 PMID:31933938 |
RGD:28867240 RGD:28912742 |
NCBI chrNW_004624826:1,794,084...1,831,009
Ensembl chrNW_004624826:1,798,737...1,831,112
|
|
G
|
Nusap1
|
nucleolar and spindle associated protein 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624804:8,510,628...8,541,007
Ensembl chrNW_004624804:8,510,739...8,540,306
|
|
G
|
Oit3
|
oncoprotein induced transcript 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624754:6,624,612...6,652,039
Ensembl chrNW_004624754:6,624,353...6,654,282
|
|
G
|
Olfml2a
|
olfactomedin like 2A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624760:10,356,950...10,386,053
Ensembl chrNW_004624760:10,361,778...10,379,949
|
|
G
|
Olfml2b
|
olfactomedin like 2B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624826:440,584...477,986
Ensembl chrNW_004624826:440,026...478,037
|
|
G
|
Orc1
|
origin recognition complex subunit 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624859:833,360...863,631
Ensembl chrNW_004624859:833,793...863,539
|
|
G
|
Otc
|
ornithine transcarbamylase
|
severity
|
ISO
|
mRNA:altered expression:liver tumor (human)
|
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chrNW_004624762:17,038,223...17,104,853
Ensembl chrNW_004624762:17,038,223...17,104,965
|
|
G
|
Pafah1b1
|
platelet activating factor acetylhydrolase 1b regulatory subunit 1
|
disease_progression
|
ISO
|
mRNA,protein:decreased expression:liver:
|
RGD |
PMID:21569763 |
RGD:12790589 |
NCBI chrNW_004624786:5,223,890...5,306,033
Ensembl chrNW_004624786:5,224,982...5,302,436
|
|
G
|
Pamr1
|
peptidase domain containing associated with muscle regeneration 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624767:11,681,209...11,753,310
Ensembl chrNW_004624767:11,681,203...11,754,194
|
|
G
|
Park7
|
Parkinsonism associated deglycase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624818:3,900,917...3,915,457
Ensembl chrNW_004624818:3,900,917...3,911,042
|
|
G
|
Parp1
|
poly(ADP-ribose) polymerase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18695907 |
|
NCBI chrNW_004624807:446,662...478,571
Ensembl chrNW_004624807:446,647...479,069
|
|
G
|
Pbk
|
PDZ binding kinase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624758:22,603,076...22,625,817
Ensembl chrNW_004624758:22,603,039...22,625,763
|
|
G
|
Pck1
|
phosphoenolpyruvate carboxykinase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19363144 PMID:28284560 |
|
NCBI chrNW_004624741:23,985,257...23,990,354
Ensembl chrNW_004624741:23,985,675...23,989,790
|
|
G
|
Pclaf
|
PCNA clamp associated factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624781:8,195,256...8,207,357
Ensembl chrNW_004624781:8,195,451...8,206,187
|
|
G
|
Pcna
|
proliferating cell nuclear antigen
|
treatment
|
ISO
|
protein:increased expression:liver:
|
RGD |
PMID:23219601 PMID:25999787 |
RGD:10448993 RGD:152177911 |
NCBI chrNW_004624741:6,143,584...6,148,055
Ensembl chrNW_004624741:6,143,332...6,148,898
|
|
G
|
Pdcd1
|
programmed cell death 1
|
disease_progression
|
ISO
|
associated with hepatitis B associated with hepatitis B;DNA:SNP: : +8669 A>G (human)
|
RGD |
PMID:21912640 PMID:27034168 |
RGD:40818257 RGD:41410800 |
NCBI chrNW_004624847:5,732,922...5,741,908
Ensembl chrNW_004624847:5,732,767...5,742,269
|
|
G
|
Pdgfb
|
platelet derived growth factor subunit B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20506153 |
|
NCBI chrNW_004624752:9,072,471...9,088,289
Ensembl chrNW_004624752:9,072,512...9,088,593
|
|
G
|
Pdgfrl
|
platelet derived growth factor receptor like
|
|
ISO
|
ClinVar Annotator: match by term: Hepatocellular carcinoma
|
OMIM ClinVar |
PMID:7898930 |
|
NCBI chrNW_004624769:21,617,268...21,668,709
Ensembl chrNW_004624769:21,616,954...21,668,771
|
|
G
|
Pdia3
|
protein disulfide isomerase family A member 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624804:10,754,978...10,784,641
Ensembl chrNW_004624804:10,755,103...10,784,337
|
|
G
|
Pdk4
|
pyruvate dehydrogenase kinase 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28003426 |
|
NCBI chrNW_004624813:2,258,279...2,270,540
Ensembl chrNW_004624813:2,258,279...2,270,824
|
|
G
|
Pfas
|
phosphoribosylformylglycinamidine synthase
|
|
ISO
|
protein:increased activity:hepatoma (rat) protein:increased expression:liver
|
RGD |
PMID:6722784 |
RGD:5135276 |
NCBI chrNW_004624786:10,831,287...10,854,526
Ensembl chrNW_004624786:10,836,943...10,853,274
|
|
G
|
Pfn2
|
profilin 2
|
disease_progression
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004624730:27,306,452...27,312,493
Ensembl chrNW_004624730:27,307,030...27,312,501
|
|
G
|
Pgd
|
phosphogluconate dehydrogenase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19363144 |
|
NCBI chrNW_004624818:2,261,658...2,274,878
Ensembl chrNW_004624818:2,261,940...2,274,723
|
|
G
|
Pgk1
|
phosphoglycerate kinase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624836:2,657,320...2,676,124
Ensembl chrNW_004624836:2,653,474...2,676,766
|
|
G
|
Phb1
|
prohibitin 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624795:5,556,728...5,565,969
Ensembl chrNW_004624795:5,556,450...5,565,988
|
|
G
|
Phf6
|
PHD finger protein 6
|
exacerbates
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:30888215 PMID:31329335 |
RGD:155260288 RGD:155260308 |
NCBI chrNW_004624797:14,081,381...14,140,180
Ensembl chrNW_004624797:14,081,302...14,128,487
|
|
G
|
Phlda1
|
pleckstrin homology like domain family A member 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624750:22,012,245...22,018,338
|
|
G
|
Pik3ca
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
treatment susceptibility no_association severity
|
ISO
|
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma DNA:SNPs: :rs17849071,rs17849079(human) DNA:mutation:exon: DNA:mutations:exons:
|
OMIM ClinVar RGD |
PMID:15016963 PMID:15520168 PMID:15608678 PMID:16331247 PMID:17376864 PMID:17673550 PMID:20593314 PMID:22370636 PMID:22658544 PMID:22729222 PMID:22729224 PMID:23066039 PMID:23100325 PMID:23946963 PMID:24033266 PMID:24673525 PMID:24782230 PMID:25741868 PMID:25999787 PMID:26266975 PMID:26266985 PMID:26627007 PMID:26822237 PMID:26823876 PMID:27126994 PMID:27626068 PMID:27631024 PMID:28492532 PMID:29988677 PMID:31536475 PMID:31775759 PMID:33054853 PMID:34008892 PMID:34496175 PMID:35483878 PMID:37667289 PMID:37712948 PMID:39825153 More...
|
RGD:11556371 RGD:14402404 RGD:14402405 RGD:152177911 |
NCBI chrNW_004624730:56,895,065...56,970,563
Ensembl chrNW_004624730:56,938,215...56,966,137
|
|
G
|
Pik3cb
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
|
treatment
|
ISO
|
|
RGD |
PMID:25999787 |
RGD:152177911 |
NCBI chrNW_004624730:15,226,786...15,399,097
Ensembl chrNW_004624730:15,226,379...15,355,857
|
|
G
|
Pik3r1
|
phosphoinositide-3-kinase regulatory subunit 1
|
treatment
|
ISO
|
|
RGD |
PMID:25999787 PMID:31801250 |
RGD:151893509 RGD:152177911 |
NCBI chrNW_004624815:1,290,106...1,376,961
Ensembl chrNW_004624815:1,289,997...1,369,610
|
|
G
|
Pik3r2
|
phosphoinositide-3-kinase regulatory subunit 2
|
treatment
|
ISO
|
|
RGD |
PMID:25999787 |
RGD:152177911 |
NCBI chrNW_004624908:1,513,916...1,523,723
Ensembl chrNW_004624908:1,513,969...1,523,295
|
|
G
|
Pinx1
|
PIN2 (TERF1) interacting telomerase inhibitor 1
|
disease_progression
|
ISO
|
associated with Chronic Hepatitis B; DNA:SNP::rs1469557(human)
|
RGD |
PMID:27221889 |
RGD:152977752 |
NCBI chrNW_004624758:24,589,990...24,666,355
Ensembl chrNW_004624758:24,589,743...24,666,598
|
|
G
|
Pitpnm3
|
PITPNM family member 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624786:7,484,829...7,568,020
Ensembl chrNW_004624786:7,485,092...7,567,993
|
|
G
|
Pitx1
|
paired like homeodomain 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624733:12,028,497...12,034,612
Ensembl chrNW_004624733:12,029,298...12,034,413
|
|
G
|
Pkm
|
pyruvate kinase M1/2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19363144 |
|
NCBI chrNW_004624781:1,796,909...1,823,787
Ensembl chrNW_004624781:1,796,801...1,824,144
|
|
G
|
Pkmyt1
|
protein kinase, membrane associated tyrosine/threonine 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624824:715,818...724,535
Ensembl chrNW_004624824:715,770...724,530
|
|
G
|
Pkp1
|
plakophilin 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624807:9,374,206...9,419,075
Ensembl chrNW_004624807:9,372,099...9,419,067
|
|
G
|
Plac8
|
placenta associated 8
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624900:134,075...157,982
Ensembl chrNW_004624900:133,889...158,050
|
|
G
|
Plau
|
plasminogen activator, urokinase
|
|
ISO
|
OMIM:114550
|
MouseDO |
|
|
NCBI chrNW_004624754:7,405,637...7,415,870
Ensembl chrNW_004624754:7,408,983...7,416,559
|
|
G
|
Plcg1
|
phospholipase C gamma 1
|
ameliorates
|
ISO
|
human cell line in a mouse model
|
RGD |
PMID:30623526 |
RGD:151356937 |
NCBI chrNW_004624919:1,766,533...1,800,130
Ensembl chrNW_004624919:1,766,149...1,803,097
|
|
G
|
Plk1
|
polo like kinase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624782:8,811,593...8,823,060
Ensembl chrNW_004624782:8,811,616...8,826,749
|
|
G
|
Plk4
|
polo like kinase 4
|
sexual_dimorphism
|
ISO
|
DNA:hypermethylation:promoter
|
RGD |
PMID:21324136 |
RGD:27226690 |
NCBI chrNW_004624777:8,804,372...8,825,669
Ensembl chrNW_004624777:8,804,593...8,825,257
|
|
G
|
Plod3
|
procollagen-lysine,2-oxoglutarate 5-dioxygenase 3
|
treatment
|
ISO
|
mRNA, protein:increased expression:liver (human)
|
RGD |
PMID:29059470 |
RGD:155791679 |
NCBI chrNW_004624740:16,074,027...16,082,139
Ensembl chrNW_004624740:16,074,141...16,082,223
|
|
G
|
Plvap
|
plasmalemma vesicle associated protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624908:602,388...613,445
Ensembl chrNW_004624908:601,687...614,975
|
|
G
|
Plxdc1
|
plexin domain containing 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624795:3,756,641...3,793,006
Ensembl chrNW_004624795:3,757,668...3,792,506
|
|
G
|
Pml
|
PML nuclear body scaffold
|
ameliorates exacerbates disease_progression
|
ISO
|
mRNA:increased expression:liver (mouse) associated with hepatitis C protein:increased expression:liver (human)
|
RGD |
PMID:11511788 PMID:26118777 PMID:31144474 |
RGD:41404685 RGD:41404687 RGD:41404690 |
NCBI chrNW_004624781:464,858...498,146
Ensembl chrNW_004624781:464,658...497,775
|
|
G
|
Pms2
|
PMS1 homolog 2, mismatch repair system component
|
|
ISO
|
ClinVar Annotator: match by term: Hepatocellular carcinoma
|
ClinVar |
|
|
NCBI chrNW_004624740:31,315,121...31,345,137
|
|
G
|
Pnpt1
|
polyribonucleotide nucleotidyltransferase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624833:5,883,300...5,923,758
Ensembl chrNW_004624833:5,883,318...5,923,758
|
|
G
|
Polg
|
DNA polymerase gamma, catalytic subunit
|
susceptibility
|
ISO
|
DNA:SNPs:introns: (rs1061316, rs758130) (human)
|
RGD |
PMID:28457473 |
RGD:15039387 |
NCBI chrNW_004624768:16,493,123...16,509,747
Ensembl chrNW_004624768:16,491,555...16,509,900
|
|
G
|
Pon1
|
paraoxonase 1
|
disease_progression
|
ISO
|
mRNA:decreased expression:liver (human)
|
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004624813:1,953,796...1,979,846
Ensembl chrNW_004624813:1,949,614...1,979,882
|
|
G
|
Pot1
|
protection of telomeres 1
|
disease_progression
|
ISO
|
associated with hepatitis B;DNA:SNP: :rs7784168(human)
|
RGD |
PMID:23907815 |
RGD:152975963 |
NCBI chrNW_004624783:11,138,222...11,223,329
Ensembl chrNW_004624783:11,138,303...11,223,044
|
|
G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
susceptibility
|
ISO
|
associated with hepatitis B;DNA:missense mutation:cds:p.L162V (human)
|
RGD |
PMID:19119483 |
RGD:15042881 |
NCBI chrNW_004624752:3,646,499...3,702,553
Ensembl chrNW_004624752:3,650,922...3,701,672
|
|
G
|
Pparg
|
peroxisome proliferator activated receptor gamma
|
severity
|
ISO
|
CTD Direct Evidence: therapeutic protein:decreased expression:liver
|
CTD RGD |
PMID:16374840 PMID:27451128 |
RGD:14694822 |
NCBI chrNW_004624956:84,673...207,176
Ensembl chrNW_004624956:83,842...149,481
|
|
G
|
Ppat
|
phosphoribosyl pyrophosphate amidotransferase
|
|
ISO
|
protein:increased activity:hepatoma (rat)
|
RGD |
PMID:6327016 |
RGD:5135035 |
NCBI chrNW_004624761:12,980,508...13,017,818
Ensembl chrNW_004624761:12,980,513...13,019,011
|
|
G
|
Ppp1r1a
|
protein phosphatase 1 regulatory inhibitor subunit 1A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15010824 |
|
NCBI chrNW_004624904:2,608,891...2,617,202
Ensembl chrNW_004624904:2,608,895...2,617,543
|
|
G
|
Ppp1r9a
|
protein phosphatase 1 regulatory subunit 9A
|
onset
|
ISO
|
protein:increased expression:liver (rat)
|
RGD |
PMID:20935162 |
RGD:10002734 |
NCBI chrNW_004624813:1,587,567...1,951,620
Ensembl chrNW_004624813:1,588,261...1,945,788
|
|
G
|
Ppp1r9b
|
protein phosphatase 1 regulatory subunit 9B
|
severity
|
ISO
|
mRNA, protein:decreased expression:liver (human)
|
RGD |
PMID:23591196 |
RGD:10043803 |
NCBI chrNW_004624795:6,124,273...6,137,776
Ensembl chrNW_004624795:6,124,159...6,137,955
|
|
G
|
Prc1
|
protein regulator of cytokinesis 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624768:17,266,850...17,289,051
Ensembl chrNW_004624768:17,266,964...17,288,430
|
|
G
|
Prdm1
|
PR/SET domain 1
|
disease_progression
|
ISO
|
associated with hepatitis B; associated with hepatitis B;DNA:SNP: :rs1010273(human)
|
RGD |
PMID:31100710 PMID:31376415 |
RGD:150530465 RGD:150530466 |
NCBI chrNW_004624780:16,205,056...16,227,382
Ensembl chrNW_004624780:16,204,838...16,227,390
|
|
G
|
Prdx1
|
peroxiredoxin 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27517622 |
|
NCBI chrNW_004624906:1,405,253...1,414,980
Ensembl chrNW_004624906:1,405,253...1,414,926
|
|
G
|
Prdx2
|
peroxiredoxin 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624901:407,240...410,902
Ensembl chrNW_004624901:406,257...410,866
|
|
G
|
Prdx6
|
peroxiredoxin 6
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624771:8,282,622...8,293,799
Ensembl chrNW_004624771:8,282,062...8,294,340
|
|
G
|
Prex2
|
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2
|
exacerbates
|
ISO
|
mRNA:increased expression:liver (human) protein:increased expression:liver (human) mRNA:decreased expression:liver (human)
|
RGD |
PMID:25151370 PMID:28000796 PMID:28205209 PMID:31776854 |
RGD:151665185 RGD:151665186 RGD:151665188 RGD:151665343 |
NCBI chrNW_004624744:22,941,194...23,208,987
Ensembl chrNW_004624744:22,946,979...23,172,122
|
|
G
|
Prkn
|
parkin RBR E3 ubiquitin protein ligase
|
severity
|
ISO
|
protein:decreased expression:liver (human)
|
RGD |
PMID:28862485 |
RGD:13432206 |
NCBI chrNW_004624855:430,148...1,992,121
Ensembl chrNW_004624855:430,260...1,989,747
|
|
G
|
Prl
|
prolactin
|
onset
|
ISO
|
protein:increased expression:serum (human)
|
RGD |
PMID:22392353 |
RGD:125097525 |
NCBI chrNW_004624756:4,585,542...4,593,285
|
|
G
|
Prom1
|
prominin 1
|
|
ISO
|
mRNA:increased expression:liver (mouse)
|
RGD |
PMID:26569409 |
RGD:11344640 |
NCBI chrNW_004624755:15,765,162...15,886,023
Ensembl chrNW_004624755:15,771,286...15,886,348
|
|
G
|
Ptch1
|
patched 1
|
severity disease_progression
|
ISO
|
|
RGD |
PMID:18538319 PMID:22911366 |
RGD:150523837 RGD:150523842 |
NCBI chrNW_004624753:16,929,503...16,995,255
Ensembl chrNW_004624753:16,935,251...16,995,389
|
|
G
|
Pten
|
phosphatase and tensin homolog
|
exacerbates severity treatment
|
ISO
|
associated with hepatitis C, liver cirrhosis;protein:decreased expression:liver (human) OMIM:114550 associated with hepatitis B;protein:decreased expression:liver (human) CTD Direct Evidence: marker/mechanism
|
RGD MouseDO CTD |
PMID:12115563 PMID:12673720 PMID:27022031 PMID:29303510 PMID:30690477 PMID:31801250 More...
|
RGD:127285591 RGD:127285603 RGD:127285610 RGD:151893509 RGD:152995524 |
NCBI chrNW_004624791:13,975,235...14,056,900
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
severity treatment susceptibility
|
ISO
|
protein:increased expression:liver, cytosol mRNA,protein:decreased expression:liver CTD Direct Evidence: marker/mechanism DNA:SNP:promoter:-1195A>G (rs689466) (human)
|
RGD CTD |
PMID:11872629 PMID:12024111 PMID:14563831 PMID:15800977 PMID:16374840 PMID:17510421 PMID:18373278 PMID:24720952 PMID:24759835 PMID:25999787 More...
|
RGD:14695010 RGD:14695011 RGD:14695012 RGD:152177911 RGD:2300283 |
NCBI chrNW_004624814:6,897,818...6,904,890
Ensembl chrNW_004624814:6,897,857...6,903,728
|
|
G
|
Pth1r
|
parathyroid hormone 1 receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624730:74,371,614...74,392,344
Ensembl chrNW_004624730:74,371,294...74,390,262
|
|
G
|
Ptk2
|
protein tyrosine kinase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:14578863 PMID:17203219 |
RGD:2292584 |
NCBI chrNW_004624735:15,356,911...15,713,219
Ensembl chrNW_004624735:15,461,178...15,714,071
|
|
G
|
Ptpn13
|
protein tyrosine phosphatase non-receptor type 13
|
susceptibility disease_progression
|
ISO
|
DNA:SNP: :p.Y2081D(human)
|
RGD |
PMID:16489062 PMID:26801674 |
RGD:152176666 RGD:152599190 |
NCBI chrNW_004624872:3,183,381...3,406,339
Ensembl chrNW_004624872:3,226,000...3,405,805
|
|
G
|
Ptprb
|
protein tyrosine phosphatase receptor type B
|
disease_progression
|
ISO
|
mRNA:decreased expression:liver (human)
|
RGD |
PMID:30237408 |
RGD:151361293 |
NCBI chrNW_004624750:27,188,858...27,320,470
Ensembl chrNW_004624750:27,188,729...27,316,150
|
|
G
|
Pttg1
|
PTTG1 regulator of sister chromatid separation, securin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624733:29,134,720...29,147,261
|
|
G
|
Pycard
|
PYD and CARD domain containing
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17471463 |
|
NCBI chrNW_004624782:14,247,333...14,249,861
Ensembl chrNW_004624782:14,247,864...14,249,000
|
|
G
|
Pygl
|
glycogen phosphorylase L
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:2885971 |
|
NCBI chrNW_004624731:17,990,877...18,028,351
Ensembl chrNW_004624731:17,990,977...18,028,186
|
|
G
|
Rac1
|
Rac family small GTPase 1
|
exacerbates
|
ISO
|
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human) mRNA:increased expression:liver (human)
|
CTD RGD |
PMID:18506888 PMID:20522449 PMID:33482578 |
RGD:153298967 RGD:153350129 |
NCBI chrNW_004624740:30,912,841...30,933,882
Ensembl chrNW_004624740:30,911,598...30,934,025
|
|
G
|
Racgap1
|
Rac GTPase activating protein 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624816:2,268,879...2,303,305
Ensembl chrNW_004624816:2,273,856...2,303,375
|
|
G
|
Rad21
|
RAD21 cohesin complex component
|
susceptibility treatment exacerbates
|
ISO
|
associated with hepatitis c, liver cirrhosis;mRNA:increased expression:liver (human) human cells in a mouse model protein:increased expression:liver (human)
|
RGD |
PMID:28434945 PMID:30698808 PMID:32596342 PMID:33251678 |
RGD:150520026 RGD:150520029 RGD:150520030 RGD:150520035 |
NCBI chrNW_004624763:15,131,106...15,157,512
Ensembl chrNW_004624763:15,131,005...15,158,155
|
|
G
|
Rad50
|
RAD50 double strand break repair protein
|
|
ISO
|
ClinVar Annotator: match by term: Hepatocellular carcinoma
|
ClinVar |
PMID:16385572 PMID:18281469 PMID:19409520 PMID:24894818 PMID:25452441 PMID:25741868 PMID:26467025 PMID:28492532 PMID:29961768 PMID:31159747 PMID:31589614 PMID:32295079 More...
|
|
NCBI chrNW_004624733:39,445,083...39,544,415
Ensembl chrNW_004624733:39,447,461...39,544,409
|
|
G
|
Rad52
|
RAD52 homolog, DNA repair protein
|
onset susceptibility
|
ISO
|
mRNA,protein:increased expression:liver (human) associated with hepatitis B;DNA:SNP:3'utr: (rs7963551) (human)
|
RGD |
PMID:24729511 PMID:31719794 |
RGD:151361199 RGD:151361207 |
NCBI chrNW_004624735:9,123,599...9,153,373
|
|
G
|
Rad54l
|
RAD54 like
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624906:2,164,711...2,194,262
Ensembl chrNW_004624906:2,165,780...2,193,764
|
|
G
|
Rara
|
retinoic acid receptor alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18026104 |
|
NCBI chrNW_004624795:2,935,432...2,975,226
Ensembl chrNW_004624795:2,934,731...2,967,232
|
|
G
|
Rb1
|
RB transcriptional corepressor 1
|
treatment
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:12029619 PMID:14961299 PMID:33841550 |
RGD:152998960 |
NCBI chrNW_004624748:6,358,588...6,533,217
Ensembl chrNW_004624748:6,358,180...6,533,249
|
|
G
|
Rbm10
|
RNA binding motif protein 10
|
disease_progression
|
ISO
|
mRNA:decreased expression:liver
|
RGD |
PMID:32572914 |
RGD:151356975 |
NCBI chrNW_004624887:3,921,934...3,953,739
Ensembl chrNW_004624887:3,923,986...3,957,133
|
|
G
|
Rcan1
|
regulator of calcineurin 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624745:22,683,600...22,764,735
Ensembl chrNW_004624745:22,683,016...22,764,720
|
|
G
|
Recql
|
RecQ like helicase
|
disease_progression
|
ISO
|
protein:increased expression:liver
|
RGD |
PMID:18422747 |
RGD:2317370 |
NCBI chrNW_004624752:17,183,624...17,220,954
Ensembl chrNW_004624752:17,185,129...17,220,707
|
|
G
|
Ret
|
ret proto-oncogene
|
severity
|
ISO
|
protein:increased expression:liver (human) ClinVar Annotator: match by term: Hepatocellular carcinoma
|
RGD ClinVar |
PMID:7784092 PMID:7845675 PMID:7911697 PMID:8807338 PMID:8918855 PMID:9111992 PMID:9242375 PMID:9263528 PMID:9506724 PMID:10445857 PMID:11230481 PMID:12116277 PMID:14715928 PMID:15184865 PMID:15271413 PMID:15855933 PMID:16736292 PMID:17047083 PMID:17097365 PMID:18062802 PMID:25810047 PMID:26046350 PMID:26467025 PMID:28350084 PMID:28492532 PMID:29656518 PMID:33340421 More...
|
RGD:150340602 |
NCBI chrNW_004624922:382,462...413,227
Ensembl chrNW_004624922:382,399...413,281
|
|
G
|
Rgn
|
regucalcin
|
|
ISO
|
protein:decreased expression:liver
|
RGD |
PMID:21683810 |
RGD:5509919 |
NCBI chrNW_004624887:3,881,624...3,900,144
Ensembl chrNW_004624887:3,883,213...3,899,277
|
|
G
|
Rictor
|
RPTOR independent companion of MTOR complex 2
|
severity
|
ISO
|
mRNA, protein:increased expression:liver (human)
|
RGD |
PMID:25371154 PMID:29303510 |
RGD:152995471 RGD:152995524 |
NCBI chrNW_004624759:15,837,027...15,973,248
Ensembl chrNW_004624759:15,837,064...15,968,894
|
|
G
|
Rit1
|
Ras like without CAAX 1
|
ameliorates
|
ISO
|
human cells in mouse model
|
RGD |
PMID:31247273 |
RGD:152999016 |
NCBI chrNW_004624885:1,275,765...1,284,613
|
|
G
|
Rnd3
|
Rho family GTPase 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624866:3,346,747...3,363,962
Ensembl chrNW_004624866:3,345,774...3,364,345
|
|
G
|
Rnf157
|
ring finger protein 157
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624801:6,031,594...6,128,112
Ensembl chrNW_004624801:6,031,594...6,128,183
|
|
G
|
Rnf43
|
ring finger protein 43
|
exacerbates
|
ISO
|
human cells in a mouse model
|
RGD |
PMID:23136185 |
RGD:151361219 |
NCBI chrNW_004624871:191,534...259,134
Ensembl chrNW_004624871:191,546...259,120
|
|
G
|
Rnf6
|
ring finger protein 6
|
disease_progression
|
ISO
|
|
RGD |
PMID:30496760 |
RGD:151665757 |
NCBI chrNW_004624776:12,353,441...12,365,512
Ensembl chrNW_004624776:12,354,340...12,363,505
|
|
G
|
Robo1
|
roundabout guidance receptor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624874:4,234,640...5,359,333
Ensembl chrNW_004624874:4,949,538...5,357,690
|
|
G
|
Rps6
|
ribosomal protein S6
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21147110 |
|
NCBI chrNW_004624736:23,332,556...23,336,234
Ensembl chrNW_004624736:23,328,002...23,336,140
|
|
G
|
Rps6ka3
|
ribosomal protein S6 kinase A3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22561517 |
|
NCBI chrNW_004624829:4,978,181...5,087,493
Ensembl chrNW_004624829:4,983,282...5,087,485
|
|
G
|
Rrm1
|
ribonucleotide reductase catalytic subunit M1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18230555 |
|
NCBI chrNW_004624817:5,523,648...5,568,997
Ensembl chrNW_004624817:5,523,665...5,568,994
|
|
G
|
Rrm2
|
ribonucleotide reductase regulatory subunit M2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18230555 PMID:28284560 |
|
NCBI chrNW_004624865:4,984,353...4,990,187
Ensembl chrNW_004624865:4,985,620...4,990,120
|
|
G
|
Rspo3
|
R-spondin 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624753:1,520,337...1,600,054
Ensembl chrNW_004624753:1,520,210...1,600,432
|
|
G
|
Rtkn
|
rhotekin
|
|
ISO
|
mRNA:increased expression:liver
|
RGD |
PMID:27922690 |
RGD:19165144 |
NCBI chrNW_004624749:29,061,202...29,077,928
Ensembl chrNW_004624749:29,060,934...29,076,451
|
|
G
|
Rtp3
|
receptor transporter protein 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17693185 |
|
NCBI chrNW_004624730:74,605,692...74,609,946
|
|
G
|
Runx3
|
RUNX family transcription factor 3
|
|
ISO
|
mRNA:decreased expression:liver CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:17094378 PMID:28458013 |
RGD:126775147 |
NCBI chrNW_004624764:9,192,067...9,218,617
Ensembl chrNW_004624764:9,191,556...9,248,252
|
|
G
|
Ryr3
|
ryanodine receptor 3
|
disease_progression
|
ISO
|
DNA:SNP:3'UTR:rs1044129(human)
|
RGD |
PMID:26309413 |
RGD:155882454 |
NCBI chrNW_004624804:467,207...1,030,873
Ensembl chrNW_004624804:467,295...1,030,212
|
|
G
|
S100a9
|
S100 calcium binding protein A9
|
disease_progression
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004624885:767,455...770,023
Ensembl chrNW_004624885:762,934...770,129
|
|
G
|
Sardh
|
sarcosine dehydrogenase
|
severity
|
ISO
|
mRNA:altered expression:liver tumor (human)
|
RGD |
PMID:30901224 |
RGD:152995286 |
NCBI chrNW_004624760:2,030,835...2,070,517
Ensembl chrNW_004624760:2,032,326...2,066,584
|
|
G
|
Sav1
|
salvador family WW domain containing protein 1
|
|
ISO
|
OMIM:114550
|
MouseDO |
|
|
NCBI chrNW_004624731:18,262,110...18,282,386
|
|
G
|
Scap
|
SREBF chaperone
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:14563831 |
|
NCBI chrNW_004624730:73,926,978...73,975,337
Ensembl chrNW_004624730:73,927,010...73,975,337
|
|
G
|
Serpinb5
|
serpin family B member 5
|
disease_progression
|
ISO
|
associated with hepatitis B;
|
RGD |
PMID:26296971 |
RGD:11520929 |
NCBI chrNW_004624792:9,196,932...9,220,147
Ensembl chrNW_004624792:9,198,657...9,221,264
|
|
G
|
Serpinf1
|
serpin family F member 1
|
|
ISO
|
associated with Human Viral Hepatitis, liver cirrhosis;protein:increased expression:serum (human)
|
RGD |
PMID:27748324 |
RGD:27226704 |
NCBI chrNW_004624786:4,487,005...4,497,706
Ensembl chrNW_004624786:4,486,978...4,497,585
|
|
G
|
Set
|
SET nuclear proto-oncogene
|
|
ISO
|
ClinVar Annotator: match by term: Hepatocellular carcinoma
|
ClinVar |
PMID:26822237 |
|
NCBI chrNW_004624760:6,293,452...6,304,237
|
|
G
|
Sf3b1
|
splicing factor 3b subunit 1
|
treatment disease_progression
|
ISO
|
protein:increased expression:liver mRNA, protein:increased expression:liver
|
RGD |
PMID:29954402 PMID:33038489 |
RGD:126790493 RGD:126790494 |
NCBI chrNW_004624889:2,796,351...2,835,592
|
|
G
|
Sf3b4
|
splicing factor 3b subunit 4
|
severity treatment
|
ISO
|
mRNA, protein:increased expression:liver (human) human cells in mouse model mRNA, protein:increased expression:liver(human) mRNA, protein:increased expression:liver (rat)
|
RGD |
PMID:29059470 PMID:30391496 |
RGD:155791679 RGD:155804298 |
NCBI chrNW_004624772:17,701,930...17,706,613
Ensembl chrNW_004624772:17,701,341...17,706,550
|
|
G
|
Sfn
|
stratifin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624764:10,859,556...10,860,876
Ensembl chrNW_004624764:10,859,667...10,860,413
|
|
G
|
Sfrp1
|
secreted frizzled related protein 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624780:2,133,105...2,172,301
Ensembl chrNW_004624780:2,132,960...2,174,508
|
|
G
|
Sh3gl1
|
SH3 domain containing GRB2 like 1, endophilin A2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:33838155 |
|
NCBI chrNW_004624828:5,304,887...5,330,440
Ensembl chrNW_004624828:5,305,070...5,330,440
|
|
G
|
Shc1
|
SHC adaptor protein 1
|
|
ISO
|
protein:increased expression, increased phosphorylation:hepatocyte
|
RGD |
PMID:15375560 |
RGD:1643188 |
NCBI chrNW_004624885:2,511,039...2,520,883
Ensembl chrNW_004624885:2,511,240...2,521,155
|
|
G
|
Shh
|
sonic hedgehog signaling molecule
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:26189965 |
|
NCBI chrNW_004624800:2,202,986...2,215,309
Ensembl chrNW_004624800:2,203,393...2,212,068
|
|
G
|
Sik2
|
salt inducible kinase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34491613 |
|
NCBI chrNW_004624784:6,728,504...6,900,557
Ensembl chrNW_004624784:6,745,595...6,895,747
|
|
G
|
Six1
|
SIX homeobox 1
|
severity
|
ISO
|
protein:increased expression:liver (human)
|
RGD |
PMID:17008870 |
RGD:11561961 |
NCBI chrNW_004624734:40,453,445...40,457,551
Ensembl chrNW_004624734:40,453,420...40,459,671
|
|
G
|
Ska1
|
spindle and kinetochore associated complex subunit 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624778:13,948,567...13,968,643
Ensembl chrNW_004624778:13,953,390...13,968,683
|
|
G
|
Ska3
|
spindle and kinetochore associated complex subunit 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624776:16,412,683...16,450,784
Ensembl chrNW_004624776:16,413,048...16,445,892
|
|
G
|
Skp2
|
S-phase kinase associated protein 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism protein:increased expression:liver
|
CTD RGD |
PMID:12717389 PMID:19533683 |
RGD:2315050 |
NCBI chrNW_004624759:18,796,055...18,858,692
Ensembl chrNW_004624759:18,830,323...18,858,712
|
|
G
|
Slc25a47
|
solute carrier family 25 member 47
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624734:3,816,570...3,821,437
Ensembl chrNW_004624734:3,817,097...3,821,680
|
|
G
|
Slc26a6
|
solute carrier family 26 member 6
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624730:2,639,940...2,649,358
Ensembl chrNW_004624730:2,640,208...2,649,203
|
|
G
|
Slc2a1
|
solute carrier family 2 member 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:8364915 |
|
NCBI chrNW_004624892:2,110,310...2,148,023
Ensembl chrNW_004624892:2,117,561...2,148,037
|
|
G
|
Slc2a2
|
solute carrier family 2 member 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:8364915 |
|
NCBI chrNW_004624730:49,026,603...49,056,363
Ensembl chrNW_004624730:49,025,766...49,056,284
|
|
G
|
Slc38a1
|
solute carrier family 38 member 1
|
disease_progression ameliorates
|
ISO
|
|
RGD |
PMID:26389641 |
RGD:151361140 |
NCBI chrNW_004624816:5,988,625...6,025,987
Ensembl chrNW_004624816:5,989,601...6,025,987
|
|
G
|
Slc5a5
|
solute carrier family 5 member 5
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:15347726 PMID:15520214 |
|
NCBI chrNW_004624908:1,401,812...1,410,471
Ensembl chrNW_004624908:1,401,829...1,409,538
|
|
G
|
Slc7a5
|
solute carrier family 7 member 5
|
ameliorates disease_progression
|
ISO
|
mRNA:increased expression:liver
|
RGD |
PMID:7532544 PMID:23696029 PMID:26389641 |
RGD:151361140 RGD:151361280 RGD:634202 |
NCBI chrNW_004624746:1,325,368...1,349,616
|
|
G
|
Slit2
|
slit guidance ligand 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19100240 |
|
NCBI chrNW_004624755:11,470,810...11,819,800
Ensembl chrNW_004624755:11,472,377...11,819,266
|
|
G
|
Smad2
|
SMAD family member 2
|
|
ISO
|
|
RGD |
PMID:18971187 |
RGD:12880056 |
NCBI chrNW_004624778:11,380,656...11,460,566
Ensembl chrNW_004624778:11,384,769...11,501,078
|
|
G
|
Smad4
|
SMAD family member 4
|
disease_progression
|
ISO
|
protein:decreased expression:liver protein:increased expression:liver:
|
RGD |
PMID:18971187 PMID:22799322 PMID:23922662 PMID:29924446 |
RGD:12880056 RGD:18182921 RGD:21066341 RGD:21066342 |
NCBI chrNW_004624778:14,570,025...14,629,950
Ensembl chrNW_004624778:14,570,348...14,630,325
|
|
G
|
Smad7
|
SMAD family member 7
|
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:25602745 |
RGD:14401589 |
NCBI chrNW_004624778:12,415,364...12,444,882
Ensembl chrNW_004624778:12,415,282...12,444,835
|
|
G
|
Smarca4
|
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4
|
|
ISO
|
DNA:SNPs: :rs11879293, rs2072382 (human)
|
RGD |
PMID:24556940 |
RGD:127285650 |
NCBI chrNW_004624828:2,893,075...2,985,968
Ensembl chrNW_004624828:2,893,096...2,985,968
|
|
G
|
Smarcb1
|
SWI/SNF related BAF chromatin remodeling complex subunit B1
|
disease_progression
|
ISO
|
mRNA:decreased expression:liver
|
RGD |
PMID:27111394 |
RGD:127285647 |
NCBI chrNW_004624747:10,362,149...10,396,580
Ensembl chrNW_004624747:10,361,260...10,396,719
|
|
G
|
Smarcc1
|
SWI/SNF related BAF chromatin remodeling complex subunit C1
|
ameliorates
|
ISO
|
mRNA, protein:increased expression:liver (human)
|
RGD |
PMID:32514535 |
RGD:151347860 |
NCBI chrNW_004624730:73,696,734...73,856,082
Ensembl chrNW_004624730:73,696,749...73,856,082
|
|
G
|
Smc3
|
structural maintenance of chromosomes 3
|
exacerbates
|
ISO
|
mRNA:increased editing:cds:p.K96R,p.Q103R(human)
|
RGD |
PMID:29996118 |
RGD:156430111 |
NCBI chrNW_004624737:35,698,722...35,730,854
Ensembl chrNW_004624737:35,694,566...35,730,829
|
|
G
|
Smg9
|
SMG9 nonsense mediated mRNA decay factor
|
severity
|
ISO
|
|
RGD |
PMID:34456727 |
RGD:155882446 |
NCBI chrNW_004624907:1,237,658...1,255,589
Ensembl chrNW_004624907:1,237,451...1,255,586
|
|
G
|
Smo
|
smoothened, frizzled class receptor
|
disease_progression
|
ISO
|
DNA:SNP: :rs3824 (human)
|
RGD |
PMID:25944162 |
RGD:150340548 |
NCBI chrNW_004624783:7,012,385...7,039,302
Ensembl chrNW_004624783:7,011,899...7,039,921
|
|
G
|
Snai1
|
snail family transcriptional repressor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:35841383 |
|
NCBI chrNW_004624790:5,509,541...5,515,240
Ensembl chrNW_004624790:5,509,311...5,515,266
|
|
G
|
Snrpe
|
small nuclear ribonucleoprotein polypeptide E
|
|
ISO
|
human gene in a mouse model
|
RGD |
PMID:21688285 |
RGD:10768833 |
NCBI chrNW_004624807:7,079,944...7,086,973
Ensembl chrNW_004624807:7,079,090...7,087,215
|
|
G
|
Snw1
|
SNW domain containing 1
|
severity
|
ISO
|
protein:increased expression:liver (human)
|
RGD |
PMID:23696020 |
RGD:11035253 |
NCBI chrNW_004624734:24,161,974...24,191,943
Ensembl chrNW_004624734:24,161,662...24,191,937
|
|
G
|
Snx27
|
sorting nexin 27
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:36029209 |
|
NCBI chrNW_004624772:19,305,355...19,385,298
Ensembl chrNW_004624772:19,305,359...19,385,292
|
|
G
|
Soat1
|
sterol O-acyltransferase 1
|
exacerbates
|
ISO
|
associated with hepatitis B;protein:increased expression:liver (human)
|
RGD |
PMID:30814741 |
RGD:126925204 |
NCBI chrNW_004624771:2,992,752...3,055,842
Ensembl chrNW_004624771:2,994,696...3,055,916
|
|
G
|
Soat2
|
sterol O-acyltransferase 2
|
|
ISO
|
|
RGD |
PMID:16274362 |
RGD:1581190 |
NCBI chrNW_004624904:1,160,275...1,170,249
Ensembl chrNW_004624904:1,160,203...1,170,935
|
|
G
|
Socs1
|
suppressor of cytokine signaling 1
|
treatment
|
ISO
|
DNA:hypermethylation:CpG island, 5'untranslated region: associated with liver cirrhosis;DNA:altered methylation:liver:
|
RGD |
PMID:14614012 PMID:15235874 PMID:18843197 PMID:22318090 |
RGD:150573687 RGD:150573689 RGD:150573700 RGD:150573703 |
NCBI chrNW_004624824:8,444,877...8,446,628
|
|
G
|
Socs2
|
suppressor of cytokine signaling 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624750:13,333,393...13,339,018
|
|
G
|
Socs3
|
suppressor of cytokine signaling 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16831601 |
|
NCBI chrNW_004624801:7,841,230...7,843,912
Ensembl chrNW_004624801:7,840,889...7,843,860
|
|
G
|
Sod1
|
superoxide dismutase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:33010264 |
|
NCBI chrNW_004624745:20,032,003...20,037,958
Ensembl chrNW_004624745:20,032,011...20,037,958
|
|
G
|
Sod2
|
superoxide dismutase 2
|
disease_progression susceptibility
|
ISO
|
CTD Direct Evidence: marker/mechanism protein:increased expression:saliva associated with liver cirrhosis; DNA:SNP:cds:p.Ala16Val(rs1799725)(human)
|
RGD CTD |
PMID:15869407 PMID:16767786 PMID:18760346 PMID:19731237 PMID:21472284 PMID:27221200 PMID:31041878 PMID:33010264 More...
|
RGD:1581242 RGD:26923907 RGD:26923955 RGD:27095881 |
NCBI chrNW_004624855:3,260,800...3,271,864
Ensembl chrNW_004624855:3,260,809...3,271,367
|
|
G
|
Sox30
|
SRY-box transcription factor 30
|
exacerbates disease_progression
|
ISO
|
|
RGD |
PMID:30312695 |
RGD:151660341 |
NCBI chrNW_004624733:31,774,341...31,855,539
Ensembl chrNW_004624733:31,774,616...31,807,516
|
|
G
|
Spag9
|
sperm associated antigen 9
|
|
ISO
|
associated with Human Viral Hepatitis
|
RGD |
PMID:29344208 |
RGD:30296654 |
NCBI chrNW_004624795:6,748,513...6,863,201
Ensembl chrNW_004624795:6,745,537...6,863,173
|
|
G
|
Spc25
|
SPC25 component of NDC80 kinetochore complex
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624787:6,608,403...6,624,533
Ensembl chrNW_004624787:6,608,039...6,624,597
|
|
G
|
Spock1
|
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1
|
ameliorates
|
ISO
|
human cells in mouse model
|
RGD |
PMID:30710422 |
RGD:153344549 |
NCBI chrNW_004624733:9,556,024...10,080,703
Ensembl chrNW_004624733:9,556,763...10,080,703
|
|
G
|
Spop
|
speckle type BTB/POZ protein
|
exacerbates
|
ISO
|
human cells in mouse model mRNA:decreased expression:liver (human)
|
RGD |
PMID:26156804 PMID:33209975 |
RGD:11074965 RGD:153298924 |
NCBI chrNW_004624795:5,698,131...5,769,209
|
|
G
|
Spp1
|
secreted phosphoprotein 1
|
disease_progression
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:16047475 PMID:35693827 |
RGD:153344586 RGD:1581375 |
NCBI chrNW_004624872:4,505,796...4,513,247
Ensembl chrNW_004624872:4,505,522...4,513,742
|
|
G
|
Sprtn
|
SprT-like N-terminal domain
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25261934 |
|
NCBI chrNW_004624775:18,382,718...18,397,411
Ensembl chrNW_004624775:18,384,276...18,397,399
|
|
G
|
Src
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
disease_progression
|
ISO
|
|
RGD |
PMID:9581679 |
RGD:150521543 |
NCBI chrNW_004624842:2,212,561...2,260,514
Ensembl chrNW_004624842:2,211,020...2,230,132
|
|
G
|
Srebf1
|
sterol regulatory element binding transcription factor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:14563831 PMID:21147110 |
|
NCBI chrNW_004624849:3,602,103...3,623,922
Ensembl chrNW_004624849:3,602,261...3,623,465
|
|
G
|
Srebf2
|
sterol regulatory element binding transcription factor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21147110 |
|
NCBI chrNW_004624752:6,815,075...6,871,674
Ensembl chrNW_004624752:6,816,468...6,871,567
|
|
G
|
Srf
|
serum response factor
|
|
ISO
|
|
RGD |
PMID:9570363 |
RGD:1581428 |
NCBI chrNW_004624754:16,371,995...16,381,287
|
|
G
|
Srpx
|
sushi repeat containing protein X-linked
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624762:17,240,899...17,347,430
Ensembl chrNW_004624762:17,240,816...17,347,523
|
|
G
|
Srsf2
|
serine and arginine rich splicing factor 2
|
disease_progression treatment
|
ISO
|
|
RGD |
PMID:28082404 PMID:29278882 PMID:32372053 |
RGD:150429663 RGD:150429666 RGD:150429692 |
NCBI chrNW_004624801:6,575,322...6,578,429
Ensembl chrNW_004624801:6,575,325...6,578,468
|
|
G
|
St6gal1
|
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
|
|
ISO
|
protein:increased activity:liver:
|
RGD |
PMID:9331085 |
RGD:10043141 |
NCBI chrNW_004624730:69,746,207...69,871,020
Ensembl chrNW_004624730:69,745,865...69,845,367
|
|
G
|
Stab2
|
stabilin 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624750:4,866,438...5,016,958
Ensembl chrNW_004624750:4,866,792...5,016,335
|
|
G
|
Stat1
|
signal transducer and activator of transcription 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22488367 |
|
NCBI chrNW_004624854:5,067,578...5,106,052
Ensembl chrNW_004624854:5,067,535...5,102,106
|
|
G
|
Stat3
|
signal transducer and activator of transcription 3
|
|
ISO
|
protein:increased phosphorylation:liver (mouse)
|
RGD |
PMID:28100771 |
RGD:127285675 |
NCBI chrNW_004624795:1,648,235...1,680,788
Ensembl chrNW_004624795:1,648,080...1,681,200
|
|
G
|
Stat4
|
signal transducer and activator of transcription 4
|
susceptibility
|
ISO
|
CTD Direct Evidence: marker/mechanism Hepatitis B, Chronic; DNA:SNP: intron 3: (rs7574865) (human)
|
CTD RGD |
PMID:23242368 PMID:26745093 |
RGD:11553302 |
NCBI chrNW_004624854:4,975,724...5,056,940
Ensembl chrNW_004624854:4,976,507...5,057,391
|
|
G
|
Stc2
|
stanniocalcin 2
|
disease_progression
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004624733:16,773,422...16,787,475
Ensembl chrNW_004624733:16,773,644...16,785,214
|
|
G
|
Stim1
|
stromal interaction molecule 1
|
|
ISO
|
mRNA:increased expression:liver (human)
|
RGD |
PMID:23211538 |
RGD:152995401 |
NCBI chrNW_004624817:5,291,111...5,522,732
Ensembl chrNW_004624817:5,291,717...5,522,864
|
|
G
|
Stmn1
|
stathmin 1
|
disease_progression
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:28284560 PMID:28982915 |
RGD:21408578 |
NCBI chrNW_004624764:9,996,119...10,001,253
Ensembl chrNW_004624764:9,996,124...10,001,197
|
|
G
|
Tacc3
|
transforming acidic coiled-coil containing protein 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624755:25,683,314...25,695,102
Ensembl chrNW_004624755:25,683,137...25,692,504
|
|
G
|
Tagln2
|
transgelin 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624794:1,331,075...1,338,445
|
|
G
|
Taldo1
|
transaldolase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19436114 |
|
NCBI chrNW_004624766:21,758,821...21,766,052
Ensembl chrNW_004624766:21,758,821...21,766,027
|
|
G
|
Tatdn1
|
TatD DNase domain containing 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624735:30,667,293...30,714,863
|
|
G
|
Tbx3
|
T-box transcription factor 3
|
severity ameliorates disease_progression
|
ISO
|
protein:increased expression:liver (human) human cells in mouse model
|
RGD |
PMID:22811581 PMID:26922018 PMID:29295731 PMID:30578408 PMID:33577921 |
RGD:151361112 RGD:151361114 RGD:151361122 RGD:151361123 RGD:151361132 |
NCBI chrNW_004624747:18,128,003...18,142,366
Ensembl chrNW_004624747:18,128,028...18,142,451
|
|
G
|
Tcf19
|
transcription factor 19
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624754:24,766,212...24,770,136
Ensembl chrNW_004624754:24,765,742...24,770,135
|
|
G
|
Tcim
|
transcriptional and immune response regulator
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624780:3,514,082...3,515,411
Ensembl chrNW_004624780:3,515,018...3,515,335
|
|
G
|
Tedc2
|
tubulin epsilon and delta complex 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624824:209,758...215,362
Ensembl chrNW_004624824:209,879...218,659
|
|
G
|
Tek
|
TEK receptor tyrosine kinase
|
|
ISO
|
protein:increased expression
|
RGD |
PMID:16951510 |
RGD:1601490 |
NCBI chrNW_004624736:31,345,774...31,473,727
|
|
G
|
Tep1
|
telomerase associated protein 1
|
disease_progression susceptibility
|
ISO
|
associated with hepatitis B;DNA:SNPs: :rs1713449,rs1760898, rs872072 (human) DNA:SNP:intron:rs1760893(human)
|
RGD |
PMID:23907815 PMID:27305982 |
RGD:152975963 RGD:152977750 |
NCBI chrNW_004624825:4,770,678...4,812,879
Ensembl chrNW_004624825:4,774,662...4,812,769
|
|
G
|
Tert
|
telomerase reverse transcriptase
|
susceptibility disease_progression no_association treatment
|
ISO
|
DNA:mutations, polymorphisms:promoter,intron, exon:rs2736100,rs2736098(human) ClinVar Annotator: match by term: Hepatocellular carcinoma associated with hepatitis B;DNA:SNP: :rs13167280 (human) DNA:SNPs::rs2736098(human) DNA:mutations:promoter: DNA:SNP,mutations:promoter:rs2853669 (-245T >C), (-124C > T),(-146C > T)human
|
RGD ClinVar |
PMID:17175353 PMID:19184104 PMID:23000435 PMID:23907815 PMID:25123086 PMID:25339005 PMID:25741868 PMID:26575952 PMID:28416747 PMID:28492532 PMID:28677271 PMID:34019641 More...
|
RGD:11564803 RGD:14696767 RGD:14696768 RGD:14696769 RGD:14696770 RGD:150530496 RGD:152975963 |
NCBI chrNW_004624751:624,569...647,198
|
|
G
|
Tet1
|
tet methylcytosine dioxygenase 1
|
|
ISO
|
protein:decreased expression:liver
|
RGD |
PMID:23671639 |
RGD:9586747 |
NCBI chrNW_004624754:2,846,479...2,966,845
Ensembl chrNW_004624754:2,873,456...2,965,097
|
|
G
|
Tet2
|
tet methylcytosine dioxygenase 2
|
ameliorates severity disease_progression
|
ISO
|
human cells in mouse model mRNA, protein:decreased expression:liver (human) mRNA:decreased expression:liver (human) mRNA, protein:increased expression:liver (human)
|
RGD |
PMID:26366235 PMID:29331390 PMID:30070373 PMID:33097695 |
RGD:150429595 RGD:150429597 RGD:150429684 RGD:150429689 |
NCBI chrNW_004624830:3,446,331...3,543,450
Ensembl chrNW_004624830:3,446,141...3,519,084
|
|
G
|
Tfpi2
|
tissue factor pathway inhibitor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17464989 PMID:28284560 |
|
NCBI chrNW_004624813:571,592...577,268
Ensembl chrNW_004624813:571,414...577,858
|
|
G
|
Tfrc
|
transferrin receptor
|
|
ISO
|
mRNA:increased expression:liver
|
RGD |
PMID:16953838 |
RGD:2292036 |
NCBI chrNW_004624730:61,282,650...61,313,487
Ensembl chrNW_004624730:61,285,334...61,313,550
|
|
G
|
Tgfa
|
transforming growth factor alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism associated with Diabetes Mellitus, Experimental
|
CTD RGD |
PMID:9029167 PMID:9060843 PMID:15565109 |
RGD:2317471 |
NCBI chrNW_004624762:2,832,073...2,941,150
Ensembl chrNW_004624762:2,832,078...2,937,318
|
|
G
|
Tgfb1
|
transforming growth factor beta 1
|
|
ISO
|
mRNA:increased expression:liver (mouse) CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:9029167 PMID:28100771 |
RGD:127285675 |
NCBI chrNW_004624907:162,567...175,696
Ensembl chrNW_004624907:161,569...176,605
|
|
G
|
Tgfb2
|
transforming growth factor beta 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:33010264 |
|
NCBI chrNW_004624835:2,363,059...2,436,536
Ensembl chrNW_004624835:2,363,139...2,437,643
|
|
G
|
Tgfbr2
|
transforming growth factor beta receptor 2
|
|
ISO
|
mRNA, protein:decreased expression:liver
|
RGD |
PMID:14585397 |
RGD:1601598 |
NCBI chrNW_004624788:8,447,679...8,535,821
Ensembl chrNW_004624788:8,447,542...8,535,959
|
|
G
|
Tgm3
|
transglutaminase 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624741:3,543,887...3,585,600
Ensembl chrNW_004624741:3,543,982...3,585,109
|
|
G
|
Th
|
tyrosine hydroxylase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624767:15,003,073...15,010,207
Ensembl chrNW_004624767:15,003,092...15,010,154
|
|
G
|
Them4
|
thioesterase superfamily member 4
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:23392203 |
|
NCBI chrNW_004624772:19,673,079...19,704,635
Ensembl chrNW_004624772:19,673,066...19,698,710
|
|
G
|
Thy1
|
Thy-1 cell surface antigen
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624784:14,779,533...14,784,315
Ensembl chrNW_004624784:14,780,698...14,784,897
|
|
G
|
Ticrr
|
TOPBP1 interacting checkpoint and replication regulator
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624768:16,669,847...16,716,335
Ensembl chrNW_004624768:16,670,390...16,715,697
|
|
G
|
Timd4
|
T cell immunoglobulin and mucin domain containing 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624733:32,381,189...32,482,874
|
|
G
|
Tk1
|
thymidine kinase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624801:7,685,003...7,692,949
Ensembl chrNW_004624801:7,685,017...7,692,872
|
|
G
|
Tlr2
|
toll like receptor 2
|
susceptibility
|
ISO
|
associated with Hepatitis C, Chronic;DNA:deletion:promoter:-196 to -174(human)
|
RGD |
PMID:21500195 PMID:22859216 PMID:27183918 |
RGD:15090813 RGD:15090815 RGD:18337266 |
NCBI chrNW_004624858:4,931,820...4,984,175
Ensembl chrNW_004624858:4,979,485...4,981,833
|
|
G
|
Tlr3
|
toll like receptor 3
|
disease_progression
|
ISO
|
|
RGD |
PMID:23197495 |
RGD:21079421 |
NCBI chrNW_004624769:16,925,969...16,945,250
Ensembl chrNW_004624769:16,925,984...16,941,196
|
|
G
|
Tlr4
|
toll like receptor 4
|
susceptibility
|
ISO
|
DNA:SNPs, haplotype: :multiples CTD Direct Evidence: marker/mechanism DNA:SNP: :rs1057317(human) protein:increased expression:liver:
|
RGD CTD |
PMID:21559380 PMID:25179842 PMID:27022031 PMID:28578348 |
RGD:14700552 RGD:14700557 RGD:14700558 |
NCBI chrNW_004624760:17,596,516...17,608,955
Ensembl chrNW_004624760:17,598,630...17,609,120
|
|
G
|
Tlr7
|
toll like receptor 7
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:24990399 |
|
NCBI chrNW_004624882:1,375,216...1,379,705
|
|
G
|
Tmem70
|
transmembrane protein 70
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27914986 |
|
NCBI chrNW_004624744:17,256,749...17,265,507
Ensembl chrNW_004624744:17,259,245...17,266,115
|
|
G
|
Tnf
|
tumor necrosis factor
|
disease_progression
|
ISO
|
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver, blood serum (mouse)
|
CTD RGD |
PMID:26569409 PMID:26890368 PMID:27022031 |
RGD:11344640 RGD:14975171 |
NCBI chrNW_004624754:24,623,059...24,625,647
Ensembl chrNW_004624754:24,623,425...24,625,531
|
|
G
|
Tnfsf10
|
TNF superfamily member 10
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:17326159 |
|
NCBI chrNW_004624730:50,534,284...50,550,279
Ensembl chrNW_004624730:50,531,915...50,550,528
|
|
G
|
Tnfsf9
|
TNF superfamily member 9
|
|
ISO
|
|
RGD |
PMID:17325342 |
RGD:2317348 |
NCBI chrNW_004624828:3,615,860...3,623,377
|
|
G
|
Tnik
|
TRAF2 and NCK interacting kinase
|
disease_progression
|
ISO
|
protein:increased phosphorylation:liver, nucleus (human)
|
RGD |
PMID:25160513 |
RGD:151347837 |
NCBI chrNW_004624730:49,087,876...49,497,981
Ensembl chrNW_004624730:49,090,222...49,497,646
|
|
G
|
Tonsl
|
tonsoku like, DNA repair protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624735:12,413,953...12,426,193
|
|
G
|
Tp53
|
tumor protein p53
|
treatment
|
ISO
|
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma | ClinVar Annotator: match by term: LIVER CELL CARCINOMA
|
RGD OMIM ClinVar |
PMID:253702 PMID:960674 PMID:1349102 PMID:1349175 PMID:1359493 PMID:1565143 PMID:1565144 PMID:1569604 PMID:1591732 PMID:1631137 PMID:1631151 PMID:1672732 PMID:1673792 PMID:1679237 PMID:1683921 PMID:1686725 PMID:1849234 PMID:1915267 PMID:1918170 PMID:1975675 PMID:1978757 PMID:1999338 PMID:2046748 PMID:2259385 PMID:2531845 PMID:2554494 PMID:2654466 PMID:2932480 PMID:4122735 PMID:6736287 PMID:7478555 PMID:7565304 PMID:7651740 PMID:7707106 PMID:7718482 PMID:7732013 PMID:7737263 PMID:7750099 PMID:7761089 PMID:7783166 PMID:7791795 PMID:7881428 PMID:7885831 PMID:7887414 PMID:7969167 PMID:8001119 PMID:8023157 PMID:8062826 PMID:8080050 PMID:8099841 PMID:8118819 PMID:8164043 PMID:8242631 PMID:8242752 PMID:8276238 PMID:8308926 PMID:8336941 PMID:8344492 PMID:8364550 PMID:8401536 PMID:8402598 PMID:8423216 PMID:8425176 PMID:8464896 PMID:8479749 PMID:8527048 PMID:8550239 PMID:8631304 PMID:8633021 PMID:8649776 PMID:8718514 PMID:8825920 PMID:8829627 PMID:8829653 PMID:8843196 PMID:8869100 PMID:9047394 PMID:9049183 PMID:9049184 PMID:9150393 PMID:9218725 PMID:9242456 PMID:9268986 PMID:9290701 PMID:9364015 PMID:9399658 PMID:9399838 PMID:9405613 PMID:9407971 PMID:9472631 PMID:9482117 PMID:9525742 PMID:9546439 PMID:9569050 PMID:9572492 PMID:9582268 PMID:9598730 PMID:9607760 PMID:9627118 PMID:9632751 PMID:9662334 PMID:9667734 PMID:9704930 PMID:9704931 PMID:9825943 PMID:9839505 PMID:9891044 PMID:10064694 PMID:10089074 PMID:10229196 PMID:10366100 PMID:10411893 PMID:10432928 PMID:10486318 PMID:10519380 PMID:10557074 PMID:10567903 PMID:10589545 PMID:10616528 PMID:10629033 PMID:10713666 PMID:10753186 PMID:10754498 PMID:10761705 PMID:10797439 PMID:10802655 PMID:10864200 PMID:10871862 PMID:10914716 PMID:10922393 PMID:11051239 PMID:11051241 PMID:11101847 PMID:11139324 PMID:11152481 PMID:11180592 PMID:11313981 PMID:11315715 PMID:11370630 PMID:11403041 PMID:11429705 PMID:11479205 PMID:11481490 PMID:11494139 PMID:11521785 PMID:11590071 PMID:11593407 PMID:11600572 PMID:11668501 PMID:11753428 PMID:11782540 PMID:11793474 PMID:11896595 PMID:11900253 PMID:11920788 PMID:11920959 PMID:12007217 PMID:12019170 PMID:12034820 PMID:12076704 PMID:12124823 PMID:12406399 PMID:12506399 PMID:12509279 PMID:12567188 PMID:12619118 PMID:12672316 PMID:12695689 PMID:12700230 PMID:12726864 PMID:12779080 PMID:12782597 PMID:12792784 PMID:12826609 PMID:12885464 PMID:12901974 PMID:12909720 PMID:12917626 PMID:14559903 PMID:14584079 PMID:14673037 PMID:14743206 PMID:15004724 PMID:15017592 PMID:15037740 PMID:15060172 PMID:15077194 PMID:15121773 PMID:15161705 PMID:15221755 PMID:15308588 PMID:15355915 PMID:15381368 PMID:15390294 PMID:15541116 PMID:15564800 PMID:15580553 PMID:15607980 PMID:15607981 PMID:15611505 PMID:15703170 PMID:15722483 PMID:15741269 PMID:15781620 PMID:15825182 PMID:15850016 PMID:15925506 PMID:15951970 PMID:15958617 PMID:15977174 PMID:15982667 PMID:16000567 PMID:16033918 PMID:16199549 PMID:16206219 PMID:16209708 PMID:16247456 PMID:16258005 PMID:16288208 PMID:16322298 PMID:16337994 PMID:16401470 PMID:16474844 PMID:16489069 PMID:16494995 PMID:16508005 PMID:16551709 PMID:16633321 PMID:16682957 PMID:16736287 PMID:16741917 PMID:16750598 PMID:16754663 PMID:16778209 PMID:16818505 PMID:16827139 PMID:16861262 PMID:16933305 PMID:16964264 PMID:16969106 PMID:17015838 PMID:17170001 PMID:17308077 PMID:17311302 PMID:17390010 PMID:17401428 PMID:17417627 PMID:17427234 PMID:17530187 PMID:17535973 PMID:17540308 PMID:17541742 PMID:17567834 PMID:17572079 PMID:17599946 PMID:17606709 PMID:17636407 PMID:17638920 PMID:17724467 PMID:17875924 PMID:17881637 PMID:17940213 PMID:17974978 PMID:17999388 PMID:18208484 PMID:18248785 PMID:18270399 PMID:18307025 PMID:18373486 PMID:18391940 PMID:18453682 PMID:18477611 PMID:18511570 PMID:18555592 PMID:18628487 PMID:18685109 PMID:18689542 PMID:18818522 PMID:18937320 PMID:18940924 PMID:18989156 PMID:19012332 PMID:19046423 PMID:19101993 PMID:19127115 PMID:19147582 PMID:19171880 PMID:19336573 PMID:19367287 PMID:19367569 PMID:19378321 PMID:19405127 PMID:19454241 PMID:19462533 PMID:19468865 PMID:19521721 PMID:19556618 PMID:19681600 PMID:19711436 PMID:19714490 PMID:19717094 PMID:19834951 PMID:19850740 PMID:19877175 PMID:19881536 PMID:19913028 PMID:19930417 PMID:20013323 PMID:20028212 PMID:20113312 PMID:20118236 PMID:20127978 PMID:20128691 PMID:20182602 PMID:20234365 PMID:20301488 PMID:20308654 PMID:20407015 PMID:20436704 PMID:20455025 PMID:20505364 PMID:20506564 PMID:20516128 PMID:20520810 PMID:20522432 PMID:20538734 PMID:20586629 PMID:20589832 PMID:20593220 PMID:20689556 PMID:20693561 PMID:20805372 PMID:20878954 PMID:20972454 PMID:21056685 PMID:21059199 PMID:21080251 PMID:21113594 PMID:21115975 PMID:21118481 PMID:21159183 PMID:21187651 PMID:21192060 PMID:21232794 PMID:21305319 PMID:21343334 PMID:21356188 PMID:21440489 PMID:21445056 PMID:21445348 PMID:21464421 PMID:21468523 PMID:21483000 PMID:21484931 PMID:21514416 PMID:21519010 PMID:21535297 PMID:21552135 PMID:21561095 PMID:21590121 PMID:21601526 PMID:21619694 PMID:21626334 PMID:21630152 PMID:21665182 PMID:21665242 PMID:21672450 PMID:21674059 PMID:21747090 PMID:21761402 PMID:22004116 PMID:22006311 PMID:22052707 PMID:22090360 PMID:22110706 PMID:22114072 PMID:22170717 PMID:22186996 PMID:22198284 PMID:22233476 PMID:22265402 PMID:22319594 PMID:22427690 PMID:22455664 PMID:22484423 PMID:22553421 PMID:22553460 PMID:22619358 PMID:22653678 PMID:22672556 PMID:22698404 PMID:22703879 PMID:22710932 PMID:22713868 PMID:22729912 PMID:22744426 PMID:22768918 PMID:22811390 PMID:22822097 PMID:22862161 PMID:22869713 PMID:22887876 PMID:22899716 PMID:22915647 PMID:22919068 PMID:22923379 PMID:22955915 PMID:22983585 PMID:22999923 PMID:23028800 PMID:23031740 PMID:23056559 PMID:23161690 PMID:23172776 PMID:23175693 PMID:23246812 PMID:23259501 PMID:23263379 PMID:23265383 PMID:23315175 PMID:23334668 PMID:23406775 PMID:23469205 PMID:23484829 PMID:23538418 PMID:23570263 PMID:23612969 PMID:23624782 PMID:23625637 PMID:23630318 PMID:23639312 PMID:23667202 PMID:23713777 PMID:23733769 PMID:23792586 PMID:23794094 PMID:23887774 PMID:23894400 PMID:23939625 PMID:23950206 PMID:23967324 PMID:24033266 PMID:24038938 PMID:24065105 PMID:24076587 PMID:24122735 PMID:24307375 PMID:24381225 PMID:24382691 PMID:24384472 PMID:24395441 PMID:24487413 PMID:24501221 PMID:24573247 PMID:24590827 PMID:24603336 PMID:24641375 PMID:24651012 PMID:24651015 PMID:24677579 PMID:24702488 PMID:24728327 PMID:24744791 PMID:24764719 PMID:24810334 PMID:24835218 PMID:24857548 PMID:24884479 PMID:24936644 PMID:24940547 PMID:25059482 PMID:25119136 PMID:25123297 PMID:25131192 PMID:25157968 PMID:25186627 PMID:25256166 PMID:25293557 PMID:25294809 PMID:25326637 PMID:25339994 PMID:25404506 PMID:25433984 PMID:25503501 PMID:25504633 PMID:25516983 PMID:25525159 PMID:25584008 PMID:25584637 PMID:25612911 PMID:25619955 PMID:25634208 PMID:25691460 PMID:25736369 PMID:25741868 PMID:25757876 PMID:25765855 PMID:25773284 PMID:25787918 PMID:25896519 PMID:25925845 PMID:25927356 PMID:25945745 PMID:25952993 PMID:25980754 PMID:26014290 PMID:26024390 PMID:26066407 PMID:26205489 PMID:26225655 PMID:26230955 PMID:26270727 PMID:26271412 PMID:26332594 PMID:26425688 PMID:26452166 PMID:26467025 PMID:26497680 PMID:26554828 PMID:26556299 PMID:26572807 PMID:26580448 PMID:26585234 PMID:26619011 PMID:26628864 PMID:26641009 PMID:26659639 PMID:26681051 PMID:26681312 PMID:26681682 PMID:26718964 PMID:26781615 PMID:26786923 PMID:26787237 PMID:26818906 PMID:26822237 PMID:26845104 PMID:26878390 PMID:26911350 PMID:26976419 PMID:27022024 PMID:27077130 PMID:27081505 PMID:27101110 PMID:27146902 PMID:27149858 PMID:27153395 PMID:27179933 PMID:27189670 PMID:27223487 PMID:27276561 PMID:27276934 PMID:27311873 PMID:27328919 PMID:27374712 PMID:27458004 PMID:27463065 PMID:27489289 PMID:27493922 PMID:27501770 PMID:27516001 PMID:27523101 PMID:27533082 PMID:27557517 PMID:27601191 PMID:27616075 PMID:27621308 PMID:27622479 PMID:27663983 PMID:27680515 PMID:27683180 PMID:27714481 PMID:27724982 PMID:27730344 PMID:27813088 PMID:27873457 PMID:27895058 PMID:27911860 PMID:27959731 PMID:27993330 PMID:28135145 PMID:28152038 PMID:28154273 PMID:28160093 PMID:28166194 PMID:28176830 PMID:28271309 PMID:28279309 PMID:28349240 PMID:28356770 PMID:28369373 PMID:28387921 PMID:28453743 PMID:28453760 PMID:28472496 PMID:28477316 PMID:28492532 PMID:28573494 PMID:28664506 PMID:28724667 PMID:28756477 PMID:28772286 PMID:28780976 PMID:28802053 PMID:28861920 PMID:28864397 PMID:28873162 PMID:28949402 PMID:28968711 PMID:28975465 PMID:28984303 PMID:29025599 PMID:29058119 PMID:29070607 PMID:29076966 PMID:29126202 PMID:29300620 PMID:29324801 PMID:29392648 PMID:29470806 PMID:29478780 PMID:29489754 PMID:29522266 PMID:29575851 PMID:29581140 PMID:29752822 PMID:29753700 PMID:29785153 PMID:29922827 PMID:29956451 PMID:29958926 PMID:29979965 PMID:30042151 PMID:30076369 PMID:30092803 PMID:30093976 PMID:30107044 PMID:30107858 PMID:30128536 PMID:30130155 PMID:30147334 PMID:30152528 PMID:30216591 PMID:30224644 PMID:30287823 PMID:30299350 PMID:30311369 PMID:30318520 PMID:30322717 PMID:30327374 PMID:30352134 PMID:30374176 PMID:30450585 PMID:30546832 PMID:30583724 PMID:30588330 PMID:30596752 PMID:30630526 PMID:30675318 PMID:30709381 PMID:30720243 PMID:30816478 PMID:30840781 PMID:30851333 PMID:30918304 PMID:30982232 PMID:31016814 PMID:31050713 PMID:31081129 PMID:31089155 PMID:31105275 PMID:31119730 PMID:31121848 PMID:31127191 PMID:31159747 PMID:31168460 PMID:31206626 PMID:31212162 PMID:31296311 PMID:31300551 PMID:31321604 PMID:31472337 PMID:31494577 PMID:31559875 PMID:31567591 PMID:31742824 PMID:31744167 PMID:31748977 PMID:31775759 PMID:31845386 PMID:31882575 PMID:31978118 PMID:31983162 PMID:32000721 PMID:32019277 PMID:32039725 PMID:32126783 PMID:32156018 PMID:32164171 PMID:32179180 PMID:32187361 PMID:32292755 PMID:32295079 PMID:32318955 PMID:32322420 PMID:32371905 PMID:32401780 PMID:32427313 PMID:32475984 PMID:32592449 PMID:32658383 PMID:32671623 PMID:32817165 PMID:32832836 PMID:32885271 PMID:32888145 PMID:32899294 PMID:32906206 PMID:32959997 PMID:32980694 PMID:32986223 PMID:33087929 PMID:33138793 PMID:33163847 PMID:33208383 PMID:33245408 PMID:33257846 PMID:33258288 PMID:33300245 PMID:33332384 PMID:33372952 PMID:33407742 PMID:33471991 PMID:33603772 PMID:33633026 PMID:33635883 PMID:33637564 PMID:33674644 PMID:33818021 PMID:33840814 PMID:33841550 PMID:34026625 PMID:34088725 PMID:34166060 PMID:34240179 PMID:34249098 PMID:34266904 PMID:34299313 PMID:34308366 PMID:34503094 PMID:34529667 PMID:34540492 PMID:34670578 PMID:34675114 PMID:34709361 PMID:34754157 PMID:34793666 PMID:34805717 PMID:34885220 PMID:34994652 PMID:35033608 PMID:35043155 PMID:35127508 PMID:35367578 PMID:35802772 PMID:35820297 PMID:35938033 PMID:35974385 PMID:36003761 PMID:36008825 PMID:36219266 PMID:36309086 PMID:36329109 PMID:36988593 PMID:37179382 PMID:37653074 PMID:39060302 More...
|
RGD:152998960 |
NCBI chrNW_004624786:10,266,316...10,282,664
Ensembl chrNW_004624786:10,263,518...10,271,218
|
|
G
|
Tp73
|
tumor protein p73
|
exacerbates treatment
|
ISO
|
mRNA:increased expression:liver (human) protein:decreased phosphorylation:liver (human) human cells in a mouse model
|
RGD |
PMID:14760085 PMID:19664633 PMID:25371988 PMID:27359056 PMID:31429776 |
RGD:151347579 RGD:151347592 RGD:151347593 RGD:151347594 RGD:151347596 |
NCBI chrNW_004624818:6,775,588...6,817,187
Ensembl chrNW_004624818:6,775,599...6,809,289
|
|
G
|
Tpx2
|
TPX2 microtubule nucleation factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624741:707,267...772,543
Ensembl chrNW_004624741:709,322...772,423
|
|
G
|
Traf7
|
TNF receptor associated factor 7
|
treatment
|
ISO
|
mRNA:increased expression:liver
|
RGD |
PMID:31730901 |
RGD:151356961 |
NCBI chrNW_004624913:79,423...100,301
Ensembl chrNW_004624913:79,423...100,279
|
|
G
|
Traip
|
TRAF interacting protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624730:3,749,183...3,775,062
Ensembl chrNW_004624730:3,748,894...3,774,489
|
|
G
|
Trim24
|
tripartite motif containing 24
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18026104 |
|
NCBI chrNW_004624765:18,966,663...19,079,857
|
|
G
|
Trip13
|
thyroid hormone receptor interactor 13
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624751:439,195...459,033
Ensembl chrNW_004624751:439,119...459,080
|
|
G
|
Troap
|
trophinin associated protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624816:2,853,799...2,861,374
Ensembl chrNW_004624816:2,853,715...2,861,346
|
|
G
|
Tsc1
|
TSC complex subunit 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21499249 |
|
NCBI chrNW_004624760:3,479,028...3,536,612
Ensembl chrNW_004624760:3,498,692...3,532,011
|
|
G
|
Tsc2
|
TSC complex subunit 2
|
severity
|
ISO
|
protein:decreased expression:liver (human)
|
RGD |
PMID:24119083 |
RGD:21079731 |
NCBI chrNW_004624913:166,931...203,008
Ensembl chrNW_004624913:166,931...202,953
|
|
G
|
Tst
|
thiosulfate sulfurtransferase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21472284 |
|
NCBI chrNW_004624752:10,765,126...10,772,159
Ensembl chrNW_004624752:10,765,137...10,774,800
|
|
G
|
Ttc36
|
tetratricopeptide repeat domain 36
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624784:13,913,218...13,931,581
Ensembl chrNW_004624784:13,913,225...13,931,581
|
|
G
|
Ttk
|
TTK protein kinase
|
disease_progression
|
ISO
|
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (human)
|
CTD RGD |
PMID:28284560 PMID:35693827 |
RGD:153344586 |
NCBI chrNW_004624819:6,631,697...6,682,181
|
|
G
|
Ttr
|
transthyretin
|
disease_progression
|
ISO
|
protein:decreased expression:blood serum (human) protein:increased expression:blood serum (human) protein:increased expression:blood serum (rat)
|
RGD |
PMID:16240287 PMID:28876464 PMID:29534342 |
RGD:151356736 RGD:151664602 RGD:151665161 |
NCBI chrNW_004624770:1,255,401...1,262,019
Ensembl chrNW_004624770:1,251,716...1,262,213
|
|
G
|
Txnip
|
thioredoxin interacting protein
|
|
ISO
|
OMIM:114550
|
MouseDO |
|
|
NCBI chrNW_004624772:17,341,918...17,345,964
Ensembl chrNW_004624772:17,341,630...17,345,960
|
|
G
|
Tyms
|
thymidylate synthetase
|
susceptibility
|
ISO
|
CTD Direct Evidence: marker/mechanism DNA:deletion:3'UTR:1494del6(human)
|
CTD RGD |
PMID:17659576 PMID:18019677 PMID:18230555 |
RGD:14696708 |
NCBI chrNW_004624770:11,138,673...11,149,600
Ensembl chrNW_004624770:11,138,652...11,149,600
|
|
G
|
Uaca
|
uveal autoantigen with coiled-coil domains and ankyrin repeats
|
|
ISO
|
OMIM:114550
|
MouseDO |
|
|
NCBI chrNW_004624781:3,106,658...3,189,325
Ensembl chrNW_004624781:3,106,608...3,191,870
|
|
G
|
Ube2c
|
ubiquitin conjugating enzyme E2 C
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624790:8,756,758...8,760,078
Ensembl chrNW_004624790:8,751,662...8,760,057
|
|
G
|
Ube2t
|
ubiquitin conjugating enzyme E2 T
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624807:8,420,739...8,429,805
Ensembl chrNW_004624807:8,425,899...8,429,516
|
|
G
|
Ubr5
|
ubiquitin protein ligase E3 component n-recognin 5
|
treatment
|
ISO
|
|
RGD |
PMID:32087767 |
RGD:151665344 |
NCBI chrNW_004624763:19,414,582...19,530,539
Ensembl chrNW_004624763:19,414,549...19,530,517
|
|
G
|
Uchl1
|
ubiquitin C-terminal hydrolase L1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18666234 |
|
NCBI chrNW_004624761:25,786,028...25,797,641
Ensembl chrNW_004624761:25,784,257...25,797,549
|
|
G
|
Uhrf1
|
ubiquitin like with PHD and ring finger domains 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624828:4,898,786...4,929,136
Ensembl chrNW_004624828:4,898,677...4,929,872
|
|
G
|
Umps
|
uridine monophosphate synthetase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18230555 |
|
NCBI chrNW_004624731:761,235...780,355
Ensembl chrNW_004624731:761,210...779,321
|
|
G
|
Uroc1
|
urocanate hydratase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624773:72,871...107,686
Ensembl chrNW_004624773:72,847...107,686
|
|
G
|
Usp2
|
ubiquitin specific peptidase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21147110 |
|
NCBI chrNW_004624784:14,729,762...14,755,982
Ensembl chrNW_004624784:14,729,770...14,754,991
|
|
G
|
Usp4
|
ubiquitin specific peptidase 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:35841383 |
|
NCBI chrNW_004624730:3,252,980...3,306,439
Ensembl chrNW_004624730:3,253,407...3,306,341
|
|
G
|
Vasn
|
vasorin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25826090 |
|
NCBI chrNW_004624824:2,154,646...2,164,796
Ensembl chrNW_004624824:2,155,589...2,164,796
|
|
G
|
Vav1
|
vav guanine nucleotide exchange factor 1
|
|
ISO
|
mRNA:decreased expression:liver
|
RGD |
PMID:2064726 |
RGD:2306008 |
NCBI chrNW_004624828:3,838,464...3,896,698
Ensembl chrNW_004624828:3,838,706...3,897,080
|
|
G
|
Vcam1
|
vascular cell adhesion molecule 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22922871 |
|
NCBI chrNW_004624857:3,606,573...3,625,991
Ensembl chrNW_004624857:3,606,431...3,627,063
|
|
G
|
Vdr
|
vitamin D receptor
|
susceptibility
|
ISO
|
associated with Hepatitis B, Chronic;DNA:SNP: :rs2228570(human) ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma associated with alcoholic liver cirrhosis;DNA:haplotype::
|
RGD ClinVar |
PMID:20572305 PMID:24033266 PMID:25541958 PMID:25741868 PMID:28492532 |
RGD:14402025 RGD:14402026 |
NCBI chrNW_004624816:4,314,146...4,423,946
Ensembl chrNW_004624816:4,365,961...4,424,514
|
|
G
|
Vegfa
|
vascular endothelial growth factor A
|
treatment susceptibility disease_progression
|
ISO
|
protein:increased expression:serum: DNA:SNP: :2578C>A (human) associated with liver cirrhosis; protein:increased expression:platelet, liver: DNA:polymorphism:promoter:-2578C>A (rs699947)(human) protein:increased expression:liver
|
RGD |
PMID:16835748 PMID:18392108 PMID:18544126 PMID:24445728 PMID:25999787 PMID:26930285 PMID:27338800 PMID:28147320 More...
|
RGD:11527070 RGD:126848814 RGD:15003194 RGD:15003196 RGD:15003200 RGD:15014783 RGD:15036790 RGD:152177911 |
NCBI chrNW_004624754:15,929,414...15,943,637
|
|
G
|
Vegfc
|
vascular endothelial growth factor C
|
|
ISO
|
associated with liver cirrhosis; protein:increased expression:liver:
|
RGD |
PMID:18544126 |
RGD:15003200 |
NCBI chrNW_004624769:7,689,812...7,817,366
Ensembl chrNW_004624769:7,689,407...7,817,450
|
|
G
|
Vhl
|
von Hippel-Lindau tumor suppressor
|
disease_progression
|
ISO
|
|
RGD |
PMID:31321740 |
RGD:155882550 |
NCBI chrNW_004624731:5,350,912...5,359,286
|
|
G
|
Vipr1
|
vasoactive intestinal peptide receptor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624730:77,128,547...77,155,531
Ensembl chrNW_004624730:77,128,649...77,153,750
|
|
G
|
Vsig4
|
V-set and immunoglobulin domain containing 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624898:1,268,998...1,288,756
Ensembl chrNW_004624898:1,268,886...1,289,180
|
|
G
|
Wdr62
|
WD repeat domain 62
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624794:10,309,855...10,358,018
Ensembl chrNW_004624794:10,310,129...10,348,686
|
|
G
|
Wdr76
|
WD repeat domain 76
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624804:10,844,275...10,947,234
Ensembl chrNW_004624804:10,846,384...10,907,017
|
|
G
|
Wnt2
|
Wnt family member 2
|
susceptibility
|
ISO
|
associated with hepatitis B;DNA:SNP: :rs4730775(human)
|
RGD |
PMID:28328801 |
RGD:14402040 |
NCBI chrNW_004624827:2,045,733...2,088,284
Ensembl chrNW_004624827:2,045,595...2,089,442
|
|
G
|
Wrap53
|
WD repeat containing antisense to TP53
|
|
ISO
|
RNA:increased expression:liver:
|
RGD |
PMID:26551349 |
RGD:11096781 |
NCBI chrNW_004624786:10,283,721...10,296,568
Ensembl chrNW_004624786:10,283,984...10,296,729
|
|
G
|
Xdh
|
xanthine dehydrogenase
|
|
ISO
|
protein:decreased activity:tumor (rat)
|
RGD |
PMID:179860 |
RGD:5135059 |
NCBI chrNW_004624738:13,116,317...13,180,935
Ensembl chrNW_004624738:13,115,982...13,181,352
|
|
G
|
Xpo1
|
exportin 1
|
ameliorates exacerbates treatment
|
ISO
|
human cell line in a mouse model mRNA:increased expression:liver (human)
|
RGD |
PMID:25030088 PMID:27013579 PMID:31371628 |
RGD:151665796 RGD:151667433 RGD:151667441 |
NCBI chrNW_004624833:375,817...424,499
Ensembl chrNW_004624833:375,820...424,499
|
|
G
|
Xpo5
|
exportin 5
|
severity
|
ISO
|
DNA:snp, haplotype:3' utr:c.*659A>C (rs11077) (human)
|
RGD |
PMID:24676133 |
RGD:11041737 |
NCBI chrNW_004624754:16,083,356...16,124,682
Ensembl chrNW_004624754:16,083,407...16,123,407
|
|
G
|
Xrcc1
|
X-ray repair cross complementing 1
|
susceptibility severity disease_progression no_association
|
ISO
|
DNA:missense mutation:cds:c.1804C>A (p.G506A) (human) associated with Chronic Hepatitis C;DNA:SNP:exon 14: c.1517G>C, p.506G>A (human) DNA:SNPs:exon 9, exon 15: c.910A>G, c.1686C>G (human) DNA:SNP:exon 13: c.1471G>A, p.E491K (human) DNA:SNPs:cds: 194C>T, 280A>G (human) associated with Hepatitis C, Chronic;DNA:missense mutation:cds:p.R399Q (human) DNA:missense mutation:cds:p.R399Q (rs25487) (human) DNA:missense mutation:cds:p.R399Q (28152G>A) (rs25487) (human) DNA:missense mutations:cds:p.R194W, p.R280H, p.R399Q (human) DNA:missense mutations:cds:c.482C>T, c.1178G>A (p.P161L, p.R393H) (human) associated with Hepatitis C, Chronic;DNA:missense mutation:cds:p.R194W (human) DNA:silent mutation, missense mutation:cds:c.1161G>A, c.1779C>G (p.L387L, p.S593R) (human) DNA:SNPs:exons:c.1254C>T, c.1517G>C (human) associated with hepatitis B;DNA:missense mutation, haplotype:cds:p.R399Q (human)
|
RGD |
PMID:14519756 PMID:19194663 PMID:22502666 PMID:23454624 PMID:23493666 PMID:23534753 PMID:23984316 PMID:24446299 PMID:24526467 PMID:24570146 PMID:24634229 PMID:26918371 PMID:28058700 PMID:28927037 PMID:29682247 PMID:29935355 PMID:32334466 More...
|
RGD:14696702 RGD:14696772 RGD:14696773 RGD:14985238 RGD:14985240 RGD:14985242 RGD:14985243 RGD:15014789 RGD:15014790 RGD:15014791 RGD:15014792 RGD:15036794 RGD:15036797 RGD:150530503 RGD:150530624 RGD:150540332 RGD:150540333 |
NCBI chrNW_004624907:1,087,611...1,113,275
Ensembl chrNW_004624907:1,087,611...1,113,266
|
|
G
|
Yap1
|
Yes1 associated transcriptional regulator
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29698666 |
|
NCBI chrNW_004624878:621,214...776,363
|
|
G
|
Ythdf2
|
YTH N6-methyladenosine RNA binding protein F2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28104805 |
|
NCBI chrNW_004624764:12,533,317...12,567,514
Ensembl chrNW_004624764:12,533,257...12,567,514
|
|
G
|
Ywhaz
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta
|
severity
|
ISO
|
|
RGD |
PMID:27811373 |
RGD:14700875 |
NCBI chrNW_004624763:7,722,275...7,723,482
|
|
G
|
Zc3h12d
|
zinc finger CCCH-type containing 12D
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34545456 |
|
NCBI chrNW_004624785:8,588,480...8,613,199
|
|
G
|
Zfhx3
|
zinc finger homeobox 3
|
disease_progression severity
|
ISO
|
associated with Chronic Hepatitis B;protein:decreased expression:blood serum (human) human cell line in a mouse model
|
RGD |
PMID:20534899 PMID:32277050 |
RGD:151361162 RGD:151361169 |
NCBI chrNW_004624746:15,094,890...15,330,653
Ensembl chrNW_004624746:15,098,960...15,254,127
|
|
G
|
Zfp36
|
ZFP36 ring finger protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624794:12,732,222...12,738,006
Ensembl chrNW_004624794:12,734,191...12,737,971
|
|
G
|
Zic2
|
Zic family member 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624793:11,162,835...11,167,497
Ensembl chrNW_004624793:11,163,916...11,167,457
|
|
G
|
Zic4
|
Zic family member 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624730:24,416,601...24,436,312
Ensembl chrNW_004624730:24,416,490...24,439,579
|
|
G
|
Zic5
|
Zic family member 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624793:11,171,431...11,186,415
Ensembl chrNW_004624793:11,176,946...11,189,003
|
|
G
|
Znf23
|
zinc finger protein 23
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21965783 |
|
NCBI chrNW_004624746:13,633,182...13,676,121
Ensembl chrNW_004624746:13,633,902...13,639,348
|
|
G
|
Zwint
|
ZW10 interacting kinetochore protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28284560 |
|
NCBI chrNW_004624791:7,528,452...7,534,182
Ensembl chrNW_004624791:7,528,426...7,534,553
|
|
|
G
|
Ephx1
|
epoxide hydrolase 1
|
|
ISO
|
associated with estrogen excess;protein:increased activity;liver (rat)
|
RGD |
PMID:6133380 |
RGD:152998935 |
NCBI chrNW_004624835:6,161,930...6,181,016
Ensembl chrNW_004624835:6,162,111...6,168,714
|
|
G
|
Ggt1
|
gamma-glutamyltransferase 1
|
|
ISO
|
associated with estrogen excess;protein:increased activity;liver (rat)
|
RGD |
PMID:6133380 |
RGD:152998935 |
NCBI chrNW_004624747:10,030,034...10,048,554
|
|
|
G
|
Met
|
MET proto-oncogene, receptor tyrosine kinase
|
|
ISO
|
ClinVar Annotator: match by term: Pediatric hepatocellular carcinoma
|
ClinVar |
PMID:9927037 |
|
NCBI chrNW_004624827:2,589,157...2,724,065
Ensembl chrNW_004624827:2,587,966...2,723,995
|
|
|
G
|
Ca12
|
carbonic anhydrase 12
|
|
ISO
|
mRNA:increased expression:liver
|
RGD |
PMID:28304380 |
RGD:153352326 |
NCBI chrNW_004624781:9,140,753...9,195,651
Ensembl chrNW_004624781:9,140,837...9,196,400
|
|
G
|
Ctnnb1
|
catenin beta 1
|
|
ISO
|
protein:increased tyrosine phosphorylation:exon:
|
RGD |
PMID:19101982 |
RGD:14402052 |
NCBI chrNW_004624730:77,876,361...77,887,228
Ensembl chrNW_004624730:77,875,257...77,887,234
|
|
G
|
Fgfr1
|
fibroblast growth factor receptor 1
|
|
ISO
|
protein:increased expression:liver:
|
RGD |
PMID:24925055 |
RGD:11055933 |
NCBI chrNW_004624780:5,161,245...5,212,641
Ensembl chrNW_004624780:5,161,073...5,213,870
|
|
G
|
Prkaca
|
protein kinase cAMP-activated catalytic subunit alpha
|
|
ISO
|
mRNA,protein:increased expression:liver (human)
|
RGD |
PMID:27027723 |
RGD:151347845 |
NCBI chrNW_004624901:1,319,426...1,336,848
Ensembl chrNW_004624901:1,319,062...1,336,744
|
|
|
G
|
Idh1
|
isocitrate dehydrogenase (NADP(+)) 1
|
disease_progression
|
ISO
|
DNA:misssense mutation:cds:p.Arg132Cys(human) DNA:polymorphism: :rs12478635(human)
|
RGD |
PMID:25355558 PMID:28403884 |
RGD:14974227 RGD:14974228 |
NCBI chrNW_004624765:7,806,560...7,825,520
|
|
G
|
Idh2
|
isocitrate dehydrogenase (NADP(+)) 2
|
disease_progression
|
ISO
|
DNA:polymorphism: :rs11632348(human)
|
RGD |
PMID:25355558 |
RGD:14974228 |
NCBI chrNW_004624768:17,094,649...17,111,333
Ensembl chrNW_004624768:17,094,655...17,111,397
|
|
G
|
Lep
|
leptin
|
|
ISO
|
mRNA:increased expression:liver:
|
RGD |
PMID:20723213 |
RGD:14696785 |
NCBI chrNW_004624783:7,708,820...7,721,610
Ensembl chrNW_004624783:7,708,588...7,721,727
|
|
G
|
Lepr
|
leptin receptor
|
|
ISO
|
mRNA:increased expression:liver
|
RGD |
PMID:20723213 |
RGD:14696785 |
NCBI chrNW_004624742:29,221,742...29,313,273
Ensembl chrNW_004624742:29,223,392...29,337,049
|
|
G
|
Tert
|
telomerase reverse transcriptase
|
disease_progression
|
ISO
|
mRNA:increased expression:liver:
|
RGD |
PMID:20723213 PMID:28460432 |
RGD:14696783 RGD:14696785 |
NCBI chrNW_004624751:624,569...647,198
|
|
|
G
|
Prkaca
|
protein kinase cAMP-activated catalytic subunit alpha
|
susceptibility
|
ISO
|
|
RGD |
PMID:28923495 |
RGD:151347843 |
NCBI chrNW_004624901:1,319,426...1,336,848
Ensembl chrNW_004624901:1,319,062...1,336,744
|
|
|
G
|
Sprtn
|
SprT-like N-terminal domain
|
|
ISO
|
ClinVar Annotator: match by term: Progeroid features-hepatocellular carcinoma predisposition syndrome | ClinVar Annotator: match by term: SPRTN-related condition
|
OMIM ClinVar |
PMID:12503110 PMID:25261934 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004624775:18,382,718...18,397,411
Ensembl chrNW_004624775:18,384,276...18,397,399
|
|